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Chapter 1 INTRODUCTION
Section 1.1 The Cytochrome P450 System
Section 1.1.1 Biochemistry
The cytochrome P450 was initially identified by Klingenberg (1958) and Garfinkel (1958) as a
specialized cytochrome that absorbed light maximally at 450nm when complexed with carbon
monoxide. After many years of research into these proteins, the cytochrome P450 (CYP) system
is now known to constitute a superfamily of enzymes, possessing an iron protoporphyrin IX as
the prosthetic group and having a molecular weight of 45-55 kDa. Membrane-bound within the
endoplasmic reticulum, these enzymes are key enzymatic components of the microsomal mixed
function mono-oxygenase system (MFO). Microsomal cytochromes P450 enzymes are the ter-
minal electron acceptors from NADPH and the closely associated NADPH cytochrome P450
reductase in this electron-transport chain. Cytochromes P450 may be found in other organelles
as well as the ER. In the adrenal glands, P450 proteins are also found in the mitochondria, where
they accept electrons via adrenodoxin and adrenodoxin reductase instead.
Most P450-mediated metabolism catalyzes the oxidative transformation of a large number of en-
dogenous and exogenous substrates by the insertion of a single atom of oxygen, derived from O2,
into a substrate. Depending on the substrate, different reactions can occur, including oxidative
and reductive dehalogenation, N-hydroxylation and N-oxidation, oxidative deamination, S-,
N- and O- dealkylation and aliphatic and aromatic hydroxylation. As a result of the multiplicity
of P450s and their diverse and overlapping reactions which they catalyze, the cytochrome P450
system is thus able to metabolize a wide variety of chemicals ranging from endogenous lipids to
xenobiotics. For example, P450s can convert fatty acids and to their ω and/or ω-1hydroxylated
form (by the CYP4 family) (Gibson et al., 1982; Bains et al., 1985), or be involved in drug me-
tabolism (by the CYP2D subfamily) (eg Distlerath et al., 1985). The catalytic cycle of the cyto-
chrome P450 is shown in Figure 1.1. Initially, the substrate binds to a site on the enzyme close
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to the haem to interact with oxygen (Step 1). The iron atom is then reduced to the ferrous state
by an electron transferred from NADPH via the reductase (Step 2). Molecular oxygen then binds
the P450-substrate complex (Step 3), after which, a second electron is transferred from NADPH
via P450 reductase to the complex (Step 4). Finally, the complex then rearranges with insertion
of one atom of oxygen into the substrate to yield a product (Steps 5 and 6) and water or hydrogen
peroxide.
Figure 1.1 The catalytic cycle of the cytochrome P450. Step 1. Substrate binds to a site on the enzyme 
close to the haem to interact with oxygen. Step 2. Iron atom is reduced to the ferrous state by an electron 
transferred from NADPH via the reductase. Step 3. Molecular oxygen binds the P450-substrate complex. Step 4. A 
second electron is transferred from NADPH via P450 reductase to the complex. Steps 5/6. The complex 
rearranges with insertion of one atom of oxygen into the substrate to yield a product. 
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Section 1.1.2 Nomenclature
Nelson and coworkers (1996) have collated a nomenclature system that is constantly reviewed
and updated, based on the protein sequences of P450 proteins and the divergent evolution of the
superfamily. P450 genes have been identified and sequenced from plants, animals, bacteria and
yeast, indicating a profound importance of this gene superfamily throughout many different phy-
la. To date, 481 P450 genes have been reported. These genes have been described in 85 eukary-
ote and 20 prokaryote species. Of 74 gene families so far described, 14 families comprise 26
mammalian subfamilies,. Each subfamily usually represents a cluster of tightly linked genes widely
scattered throughout the genome. 
In the nomenclature, recommendations for naming a P450 gene include the italicized root sym-
bol ‘CYP’ (‘Cyp’ for the mouse and Drosophila), denoting cytochrome P450, an Arabic number
designating the P450 family, a letter indicating the subfamily when two or more subfamilies are
known to exist within that family, and an Arabic numeral representing the individual gene. For
example, the primary hepatic drug-metabolizing enzymes currently consist of 4 gene families
designated 1 through 4. Thus, ‘Cyp4a12’ refers to the cytochrome P450 gene number 12 of sub-
family 4A (genes of all other species are indicated by italicized and upper-cased names eg,
‘CYP4A2’ of the rat). Also, nonitalicized and all capital letters ‘CYP4A12’ represents the cDNA,
mRNA and protein for all species. A P450 protein sequence from one gene family is usually de-
fined as having more than 40% amino acid identity to another in the same family with 3 excep-
tions : (i) the CYP2D subfamily includes the most distant members of the CYP2 family (ii) the
cockroach CYP4C1 sequence which is only 32-36% identical to mammalian CYP4A and
CYP4B enzymes (Bradfield et al., 1991), is assigned to family 4 on the basis of the presence of a
13-amino acid peptide found exclusively in CYP4As (Bradfield et al., 1991) and (iii) two mito-
chondrial genes CYP11A1 and CYP11B1 are included in the same family even though the en-
zyme sequences are only 34%-39% identical. In genes examined thus far, genes within a defined
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subfamily have been found to be nonsegregating within the same ‘gene cluster’, an example of
which is the CYP2D subfamily (Matsunaga et al., 1990). Different subfamilies within a gene fam-
ily, however, are not necessarily genetically segregating distinct entities. For example, the
CYP1A and CYP1B are located on different chromosomes. 
Section 1.1.3 Evolution of Cytochrome P450 
The first ancestral gene underwent duplication around 1360 million years ago and gave rise to
cytochrome P450s found in 2 different cellular organelles, the mitochondria and the endoplasmic
reticulum (Nelson and Strobel, 1987). The early history of P450 proteins appears to be related
to the metabolism of cholesterol. The earliest eukaryotic P450 sequences yet known are of the
mitochondrial CYP11A1 protein which catalyze cholesterol side chain cleavage to produce preg-
nenolone, the precursor of all steroid hormones (Nelson and Strobel, 1987). Related to these
P450s are those that metabolize fatty acids such as the CYP4 family of lauric acid hydroxylases.
The cholesterol- and fatty acid-metabolizing P450s may have been involved in the maintenance
of membrane integrity of early eukaryotes (Nebert and Gonzalez, 1985). The formation of the
endogenous steroid-synthesizing P450s, CYP17, CYP19 and CYP21 subfamilies and the cata-
bolic enzymes then followed about 900 million years ago.
In eukaryotic genomes, the existence of gene families which contains more than one identical
member can be explained by the repeated duplication of specific DNA sequences over time. Spe-
ciation can then occur to form two lines, each containing the same number of members. In di-
vergent duplication, each of these members may then continue to diverge to become less and less
similar to each other. Due to the possible occurrence of deleterious mutations, duplication of a
functional gene may thus provide a buffer against such disadvantageous events and can be effec-
tive in increasing its frequency in a population.
Many other supergene families exist in eukaryotic genomes. A well studied example of this is the
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mouse β-globin gene family, which is physically clustered on the chromosome (eg. Jahn et al.,
1980). Cytochrome P450 gene members, like the CYP2D subfamily of genes, have also found
to be located on the same chromosome, forming the CYP2D cluster (Matsunaga et al., 1990).
Another recent example of a gene family arrangement is the genomic organization of the P450
cluster on human chromosome 19. This contains CYP2A, 2B and 2F subfamilies on a 350kb
stretch of DNA (Hoffman et al., 1995). It is therefore possible that other P450 subfamilies like
CYP4A could be similarly colocalized in the genome.
Gene conversion, referring to a nonreciprocal recombination event in which a segment of one
gene replaces the corresponding segment of a related gene (Baltimore, 1981), also serves to en-
hance the diversity of P450 genes, like the CYP2D subfamily. Gene conversion can also reestab-
lish 100% similarity in a portion (or all) of a gene that had been considerably diverged from its
neighbour. Therefore, gene conversion is an important molecular mechanism contributing to the
evolution of species-specific genes. Four of five rat CYP2D genes characterized appear to have
undergone gene conversion, leading to regions of exons and introns having high similarities rel-
ative to segments of the gene that have apparently not undergone gene conversion (reviewed in
Gonzalez and Nebert, 1990). Gene conversion events have maintained homogeneity in and
around the cysteine residue, which serves as the fifth ligand to haem iron and is important in the
oxygenative functions of all P450 enzymes (Nebert et al., 1987). This is also suggested by the
sequence similarities of exons 8 and 12 in the rat CYP4A1 and CYP4A2 genes. Both these genes
are about 85% identical to each other in these regions while only 66.5% identical at exon 6. In-
terestingly, exon 8 encodes for a highly conserved 13 amino acid sequence that is characteristic
of the CYP4 family of genes (Bradfield et al., 1991) while exon 12 encodes the amino acids mak-
ing up the haem-iron binding domain.
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Section 1.1.4 Structure of P450 Proteins 
Thus far, the 3-dimensional structure is not known for any eukaryotic P450 because these mem-
brane proteins have resisted crystallization for x-ray diffraction studies. However, the tertiary
structure is known only for several bacterial P450 proteins : that of the soluble CYP101
(P450cam) from Pseudomonas putida (Poulos et al., 1987) and CYP102 (BM-3) from Bacillus mega-
terium (Ravichandran et al., 1993; fig 1.2). There is however an obvious limitation to using bac-
terial P450 proteins as a structural framework for homologous modelling of eukaryotic P450s:
Figure 1.2 The 3-Dimensional structure of CYP102. The protein structure was deduced by MOLSCRIPT
program (Kraulis, 1991) and using the protein sequence of Ravichandran and coworkers (1993). 
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eukaryotic P450s are membrane bound while bacterial P450 proteins are soluble, which might
suggest very different structures. Nevertheless, Nelson and Strobel (1989) have aligned and pre-
dicted the secondary structure of numerous P450 proteins and used the P450cam crystal structure
as a guide. Their work concluded similarities exist between bacterial and eukaryotic P450 pro-
teins, that the helical hairpin at the NH2 terminal of P450cam is maintained in all P450 proteins
and the bulk of the enzyme would be exposed to the cytosolic side of the endoplasmic reticulum.
Many P450 proteins function to convert hydrophobic substrates to more hydrophilic derivatives
that can be easily eliminated from the body. Because of the hydrophobicity of many P450 sub-
strates, the membrane environment is quite suitable for P450 enzymes which are inserted into
the lipid bilayer by their amino-terminal hydrophobic segments called “signal sequences”, which
are then cleaved off (Sabatini et al., 1982). An acidic residue that is near the initiation methionine
is followed by about 14 to 20 residues of hydrophobic amino acids and then by several basic res-
idues (High and Dobberstein, 1992). Mitochondrial P450s have an amphipathic N-terminal sig-
nal sequence rich in positively charged amino acid residues that allows the protein to bind to the
mitochondrial surface at contact sites between the inner and outer membranes (Omura and Ito,
1991), and have an “extrapeptide” 37 to 56 amino acids long, a conserved region of periodic
arginine and lysine residues serves to transport the P450s across the outer membrane and into the
mitochondrial compartment (Morohashi et al., 1984).
It appears that only sequences immediately surrounding 2 key residues in P450s are absolutely
conserved : the C-terminal cysteine residue, and a highly conserved threonine in the I helix in-
volved in oxygen binding (Lesk and Chothia, 1985; Chothia and Lesk, 1980). The C-terminal
Cys residue is part of an antiparallel β turn beginning at Phe (F) and ending at Cys (C) and is part
of the highly conserved consensus sequence F(G/S)XGX(H/R)XCXGX(I/L/F)A, known as
the haem-binding domain at the active site, which can serve as a signature for a P450 protein
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(Kalb and Loper, 1988; Gonzalez, 1989). The threonine in the I helix points into the active site
of the enzyme and together with a Glu or Asp just N-terminal to it, is conserved. Other con-
served regions have been identified whose functional significance is less clear. These include an
N-terminal proline-rich region, Proline-Proline-Glycine-Proline, that may serve to join the
membrane-binding N-terminus to the globular region of the P450 (Black and Coon, 1986).
Other conserved residues of note are the Glycine at position 95, a Glycine/Proline at position
86 and a Trp at position 150 (Gotoh, 1989). In the CYP4 family, there also exists a 13-residue
peptide, EVDTFMFEGHDTT, that is wholly conserved around position 315 in the I helix
(Bradfield et al., 1991). 
The molecular mechanisms underlying the broad but specific metabolic capacities of mammalian
P450 systems are very poorly understood due to the lack of a crystal structure of such a mamma-
lian protein. The substrate binding sites of the bacterial CYP101 have previously been identified
by Poulos and coworkers (1987) and by inferences with alignments with this protein, Gotoh
(1992) has deduced six putative substrate binding sites, SRS 1 to 6, in the CYP2 proteins. Since
then, much work has gone to prove that the regions which were crucial for substrate recognition
were in or around these six previously assigned sites. For example, using amino acid substitions
within these SRS’, He and coworkers (1994) were able to provide experimental evidence for the
accuracy for the assignments of these sites in CYP2B1.
Section 1.1.5 Xenobiotic Induction of P450 genes 
Some P450 genes are expressed constitutively, while others are inducible. Xenobiotic-metabo-
lizing enzyme induction usually enhances detoxification. Thus, induction is a protective mech-
anism (Porter and Coon, 1991) and most often occurs at the level of transcription (Gonzalez,
1989). The inducible P450 genes represent interesting systems which can be studied whereby
molecules can regulate and enhance transcription of specific genes. Classical xenobiotic inducers
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of cytochrome P450s are well studied and include the polycyclic aromatic hydrocarbons, phe-
nobarbital, steroids and peroxisome proliferators.
Section 1.1.5.1 Aromatic Hydrocarbon (Ah) Induction
Polycyclic aromatic hydrocarbons, such as the carcinogens 3-methylcholanthrene (3-MC) and
benzo(a)pyrene, are prototypical inducers of several P450 proteins, most notably CYP1A1/2 and
CYP1B1 (Kimura et al., 1986; Sagami et al., 1986). Nuclear “run-on” experiments have shown
that the induction is due to an increase in the rate of transcription of these genes. (Whitlock,
1993; Sutter et al., 1994). A much more potent inducer of CYP1A1 than 3-MC is the environ-
mental contaminant 2,3,7,8, tetrachloridibenzo-p-dioxin (TCDD, dioxin) (Poland et al., 1982).
Later, Poland and his coworkers (1986) showed the existence of a mouse liver protein called “Ah
receptor” which bound TCDD (and the aromatic hydrocarbons) saturably, reversibly and with
high affinity. Hankinson (1995) identified and designated a protein termed Arnt that het-
erodimerizes with liganded AhR to generate an active, enhancer-binding transcription factor. El-
egant experiments have indicated the presence of a TCDD-inducible, AhR-dependent and
Arnt-dependent transcriptional enhancer and a transcriptional promoter upstream of the
CYP1A1 gene (Whitlock, 1993; Hankinson, 1995). Thus, binding of the AhR-Arnt to the en-
hancer bends the DNA and facilitates the binding of transcription factors to the promoter.
Section 1.1.5.2 Phenobarbital Induction
Phenobarbital (PB) induces CYP2B1/2 genes in rat liver (Waxman and Azaroff, 1992) and the
structurally related CYP2H1/2 in chick embryo liver (Gonzalez, 1989). Although PB induces
transcription of various P450 genes in bacteria, birds and mammals, the mechanisms of induction
are different. For example, ongoing protein synthesis is required for CYP2B1/2 induction but
not for CYP3A (Waxman and Azaroff, 1992). In Bacillus megaterium, a 17-base pair regulatory
element (called the “Barbie Box”) is located upstream of the barbiturate-inducible CYP102
(BM-3) gene (Fulco, 1991). PB response elements upstream of the CYP2B1/2 and CYP2H1
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genes (Waxman and Azaroff, 1992) have also been identified. Relatively little is understood,
however, about the mechanism by which PB and PB-related chemicals induce P450 gene ex-
pression. Ligand binding studies have failed to detect a specific PB-binding protein. It seems pos-
sible that PB-related compounds act indirectly causing an accumulation of an endogenous
steroid, as suggested by Shaw and his coworkers (1993), who demonstrated that PB responsive-
ness was influenced by glucocorticoids.
Section 1.1.5.3 Steroid Induction 
The “catatoxic” steroid, pregnenolone-16a-carbonitrile (PCN) has also been shown to induce
P450 enzymes (Okey, 1990), now designated the CYP3A family, which metabolize a variety of
substrates, including testosterone and various drugs (Gonzalez et al., 1986; Wrighton et al., 1985).
Exposure of rats to either PCN or dexamethasone leads to an increased rate of CYP3A gene tran-
scription (Simmons et al., 1987). A dexamethasone/PCN-response element has been identified
upstream of the CYP3A1 gene (Burger et al., 1992). Regulation of genes of the CYP3 family
also occurs at the post-transcriptional level. The rat CYP3A1/2 proteins are stabilized by the
macrolide antibiotic triacetyloleandomycin (TAO) (Watkins et al., 1986). However, steroid re-
ceptors have not been found to be directly responsible for the induction of PB-responsive genes
(Burger et al., 1992) 
Section 1.1.5.4 Peroxisome Proliferator Induction
Peroxisomal proliferators (PPs) cause an increase in transcription of CYP4 family of enzymes
(Hardwick et al., 1987). This induction has been demonstrated to be an early and crucial event,
prior to the induction of enzymes involved in the β-oxidation of fatty acids like acyl coA oxidase,
during the process of peroxisome proliferation in rat (Bell and Elcombe, 1991; Milton et al.,
1990). Chronic administration of peroxisome proliferators leads to liver carcinogenesis. The tran-
scriptional nature of the induction response led to the hypothesis that PPs act via a receptor pro-
tein related to steroid hormone receptors. A receptor, now termed the PPAR, has since been
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identified which could be activated by a variety of peroxisome proliferators including hypolipi-
daemic drugs and a plasticiser (Isseman and Green, 1990). In addition, response elements up-
stream of the clofibrate-responsive genes like the rat CYP4A1 (Aldridge et al., 1995), rabbit
CYP4A6 (Muerhoff et al., 1992a) and acyl CoA oxidase (Osumi et al., 1990) have been identified
and shown to bind PPARα in vitro. The PPARα has been formally demonstrated to be an im-
portant factor for peroxisome proliferation. Lee and coworkers (1995) utilized PPARα-null mice
to demonstrate that these ‘knockout’ mice were refractory to the effects of peroxisome prolifer-
ating chemicals. 
Section 1.2 The Cytochrome P450 4 Family (CYP4) 
Section 1.2.1 Discovery 
In 1982, Orton and Parker noted an approximately 28-fold increase in lauric acid ω-hydroxyla-
tion activity, increase in liver size and cytochrome P450 in rat after administration of clofibrate
(Orton and Parker, 1982). A clofibrate inducible lauric acid ω-hydroxylase, named CYP4A1,
was first purifed from rats (Tamburini et al., 1984). ω-hydroxylases have also been isolated from
the lungs of pregnant rabbbits (Williams et al., 1984), large colon (Kaku et al., 1984) and placenta
(Yamamoto et al., 1986) of the rabbit and human and rat (Kawashima et al., 1992) kidney. 
The common nomenclature of Nelson et al.(1996) designated this subfamily as CYP4A, typically
a group of cytochrome P450s with fatty acid ω and ω-1 hydroxylase activity. This family to date
contains 14 genes, including genes from the rat, mouse, guinea pig, rabbit and human. These
enzymes are thought to have a range of differing specificities for fatty acids and prostaglandins.
Many of these genes are found at high levels in the liver and kidney, while others are expressed
in sex- and tissue-specific patterns. The CYP4 family is further categorized into subfamilies and
contains 66 genes from the rat, rabbit, mouse, human, guinea pig, cockroach, mosquito, Droso-
phila, housefly, beetle roach tobacco hornworm (Nelson et al., 1996), including a newly cloned
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mouse Cyp4b1 gene (Imaoka et al., 1995).
Section 1.2.2 The CYP4A Subfamily 
The CYP4A subfamily in particular, contains 13 genes (Table 1.1). CYP4A1 (Hardwick et al.,
1987; Kimura et al., 1989a), CYP4A2 (Kimura et al., 1989b), CYP4A3 (Kimura et al., 1989b)
and CYP4A8 (Stromstedt et al., 1990) are rat genes; CYP4A4 (Matsubara et al., 1987; Palmer et
al., 1993), CYP4A5 (Johnson et al., 1990), CYP4A6 (Yokotani et al., 1989; Muerhoff et al., 1990)
and CYP4A7 (Yokotani et al., 1989) rabbit genes; CYP4A9 and CYP4A11 (Palmer et al., 1993;
Imaoka et al., 1993) human genes; CYP4A13 a guinea pig gene (Bell et al., 1993); and Cyp4a10
(Bell et al., 1993; Henderson et al., 1994) and Cyp4a12 (Bell et al., 1993) are mouse genes.
Gene Species
cDNA/
Genomic
References
CYP4A1 Rat cDNA
Genomic
Hardwick et al., 1987
Kimura et al., 1989a
CYP4A2 Rat Genomic Kimura et al., 1989a
CYP4A3 Rat cDNA Kimura et al., 1989b
CYP4A4 Rabbit cDNA
Genomic
Matsubara et al., 1987
Palmer et al., 1993a
CYP4A5 Rabbit cDNA Johnson et al., 1990
CYP4A6 Rabbit cDNA
Genomic
Yokotani et al., 1989
Muerhoff et al., 1992
CYP4A7 Rabbit cDNA Yokotani et al., 1989
CYP4A8 Rat cDNA Stromstedt et al., 1990
CYP4A9 Human cDNA (listed in Nelson et al., 1991)
Cyp4a10 Mouse cDNA Henderson et al., 1990
Bell et al., 1993
CYP4A11 Human cDNA Palmer et al., 1993b
Imaoka et al., 1993
Cyp4a12 Mouse cDNA Bell et al., 1993
CYP4A13 Guinea Pig cDNA Bell et al., 1993
Table 1.1 Genes in the CYP4A subfamily. The species from which the cDNA or genomic sequence 
was cloned are indicated. The laboratories of identification of the genes are listed as references.
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Section 1.2.2.1 Rat CYP4A genes
In the rat, only 4 CYP4A genes have been identified, two of which are genomic (CYP4A1 and
CYP4A2) and two are cDNA (CYP4A3 and CYP4A8). CYP4A1 has been isolated from a rat
genomic library and was found to span 14.14 kb and contains 13 exons, but only the first 12 are
coding regions (Kimura et al., 1989a). No TATA box was found within 40bp upstream of the
transcription start site. However, the gene possesses a GATTTA motif located between -20 and
-30 positions. Also, a 19bp sequence was found to be highly conserved between CYP4A1 and
CYP4A2 genes. CYP4A1 is deduced to encode for 509 amino acids.
CYP4A2 was isolated from a rat genomic library and was found to span 10.58 kb (Kimura et al.,
1989). It contains 12 exons and like CYP4A1, it possesses a GATTTA sequence motif instead of
a TATA box. An interesting feature of CYP4A2 is the presence of a large direct repeat of 378
bp located at -440 to -817 and -1045 to -1422 upstream of the start site. CYP4A2 is deduced to
encode for 504 amino acids. 
CYP4A3 was isolated from a cDNA library from clofibrate-treated rat liver by screening with a
CYP4A1 cDNA probe (Kimura et al., 1989b). The cDNA encodes a protein of 507 amino acids
and a calculated molecular weight of 58 kDa. The CYP4A3 cDNA shared 65% and 97% nucle-
otide and 72% and 96 % deduced amino acid sequence similarities with CYP4A1 and CYP4A2
respectively. 
A fourth rat CYP4A cDNA, termed CYP4A8, was isolated from rat prostate (Stromstedt et al.,
1990). It is deduced to encode for 506 amino acids and the deduced amino acid sequence shows
76 % identity with CYP4A1.
The identities of each protein based on their deduced amino acid sequences for CYP4A1,
CYP4A2, CYP4A3 and CYP4A8 are compared and shown in Table 1.2 below.
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Section 1.2.2.2 Rat CYP4A enzyme activity 
CYP4A1 is one of the most active fatty acid metabolizing P450s, and hydroxylates laurate, palm-
itate and arachidonate at the ω and, to a lesser extent, ω-1 position (Tamburini et al., 1984; Hard-
wick et al., 1987). The ω / ω-1 ratio is about nine-fold higher for laurate hydroxylation than
palmitate hydroxylation by CYP4A1 (Aoyama et al., 1990). CYP4A3 however has a preference
for hydroxylation of palmitate at the ω position compared to CYP4A1 (Aoyama et al., 1990).
The same group also found that CYP4A1 and CYP4A3 were also able to hydroxylate prostag-
landins E1 and F2α, albeit only at their ω positions and at considerably lower rates than those for
fatty acid oxidations (Aoyama et al., 1990). CYP4A2, however, does not appear to metabolize
prostaglandins A1 and A2 by oxidation (Yoshimoto et al., 1986). It is unknown whether fatty
acid hydroxylation by CYP4A proteins play a significant physiological role, although their role
in the metabolism of arachidonic acid has been shown to be important in regulating water and
electrolyte balance in the kidney (vide infra).
Section 1.2.2.3 Rat CYP4A gene expression
CYP4A1 is found at low constitutive levels in liver and kidney but is highly induced by clofi-
brate, especially in the liver. In the kidney, expression is localized to the proximal convoluted
tubule and in the liver, expression was found to be localized to the centrolobular region (Bell et
al., 1991). This gene has also been found to be expressed at very low levels in the lung (Strom-
stedt et al., 1994). 
CYP4A2 was found to be expressed at low constitutive levels in male liver but was highly in-
duced by clofibrate. In the kidney, the gene was found to be at high levels in untreated animals.
Clofibrate treatment only resulted in a slight induction (Kimura et al., 1989b). CYP4A2 was also
detected in seminal vesicle, brain cortex, prostate, cerebellum and brainstem (Stromstedt et al.,
1994). No protein was detected in female rat liver or kidney (Sundseth and Waxman, 1992). The
sex specificity of CYP4A2 is regulated by the different growth hormone profiles between the
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sexes (Waxman et al., 1991). In the male liver, ‘continuous’ infusion with growth hormone, a
female pattern, results in feminization and consequently a repression of this gene (Sundseth and
Waxman, 1992). In female rats, ‘pulsatile’ growth hormone treatment caused an increase in the
level of CYP4A2, suggesting that it is the female profile of continuous GH secretion which is
responsible for the suppression of CYP4A2 in female liver. 
CYP4A3, like CYP4A1, was found in liver and kidney and inducible by peroxisome prolifera-
tors. But unlike CYP4A1, CYP4A3 was found to be expressed in a sex-independent manner in
both tissues (Sundseth and Waxman, 1992). CYP4A3 was found to be expressed in lung, pros-
tate, brain cortex, cerebellum, hypothalamus-preoptic area (HPOA), and brainstem in a pattern
similar to CYP4A2. But unlike this gene, CYP4A3 was not found in seminal vesicle (Stromstedt
et al., 1994). 
The CYP4A8 gene was found expressed mainly in the prostate and kidney in Northern blot ex-
periments with a faint signal detected in the retina (Stromstedt et al., 1994). None was detectable
in liver RNA. In situ hybridization of kidney sections showed strongest expression in the prox-
imal tubules. In the same study, castrated rats and androgen releasing implants were used to ex-
amine the expression of this gene. In castrated rats, CYP4A8 in the prostate was completely
abolished, but was restored by testosterone treatment.
Section 1.2.2.4 Mouse Cyp4a genes
At present, 2 mouse genes, Cyp4a10, Cyp4a12 are listed (Nelson et al., 1996). Cyp4a10, a murine
cDNA has been cloned in two different laboratories (Bell et al., 1993; Henderson et al., 1994).
Bell and coworkers (1993) used a PCR-based method to clone a murine Cyp4a10 cDNA frag-
ment using primers derived from predicted highly conserved sequences in exon 8 and exon 12
of the gene. Henderson and coworkers (1994), on the other hand, isolated an identical but full
length Cyp4a10 cDNA clone of about 1.6 kb by screening a mouse liver cDNA library using a
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full-length rat CYP4A1 cDNA as probe. The protein is deduced to comprise of 509 amino acids
and its deduced sequence was found to be most identical (92%) to the rat CYP4A1 protein.
The second mouse Cyp4a gene to be identified is the Cyp4a12 (Bell et al., 1993). The cDNA
fragment of Cyp4a12 was cloned by PCR, also based on primers derived from the highly con-
served exons 8 and 12. The Cyp4a12 is the homologue of the rat CYP4A8, showing approxi-
mately 93% amino acid identity with it (Bell et al., 1993). Table 1.2 is a summary of the
percentage similarities of all full length rat and mouse CYP4A proteins compared. To date, no
murine genomic Cyp4a gene has been cloned. Also, it is not known if other genes exist which
belong to the Cyp4a subfamily in the mouse.
Section 1.2.2.5 Mouse Cyp4a enzyme activity
Little work has been done to investigate the metabolism of fatty acids by murine CYP4A pro-
teins. Henderson and coworkers (1990), showed the presence of ω-hydroxylase activity in un-
treated mice, and that male mice exhibited roughly 3-fold higher activity than female mice. They
also showed the presence of CYP4A proteins in Western blots; however the individual members
of the Cyp4a subfamily were undetectable with the anti-CYP4A1 antibody used. There has been
work, to show the constitutive levels of CYP4A-related proteins metabolizing lauric acid at the
ω and ω-1 positions, with a slight preference for ω-1 hydroxylation (Hiratsuka et al., 1996). This
work, however, makes no distinction between the individual CYP4A proteins, or indeed other
Protein CYP4A1 CYP4A2 CYP4A3 CYP4A8 CYP4A10
CYP4A1 100 72 72 76 92
CYP4A2 100 96 71 72
CYP4A3 100 72 72
CYP4A8 100 76
CYP4A10 100
Table 1.2 Percent similarities of rat and mouse CYP4A proteins. Deduced amino acid 
sequences of rat and mouse CYP4A proteins are compared and similarities with one another presented as 
a percentage value. Only full length protein sequences were compared.
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CYP families. 
Section 1.2.2.6 Mouse Cyp4a gene expression 
Treatment of mice with peroxisome proliferators induced Cyp4a10 RNA in liver and to a lesser
extent in the kidney (Bell et al., 1993). The Cyp4a12 gene exhibited distinct regulation, howev-
er, showing constitutively high levels in male liver and kidney, and did not show any induction
after treatment of male mice with a peroxisome proliferator (Bell et al., 1993). By contrast, in
untreated female kidney and liver, the expression of this gene was found to be at very low levels
but highly inducible by peroxisome proliferators. The regulation of mouse CYP4A proteins in
mouse liver and kidney has been studied previously. Work by McLeod and Shapiro (1989) has
shown that mice exhibit a sexually differentiated pattern of GH secretion, which is more fre-
quently pulsed in female than in male mice. A series of experiments were carried out on hypo-
physectomized mice and growth hormone (GH)-deficient ‘little’ mice to establish the role of
pituitary hormones in the regulation of hepatic and renal proteins (Henderson et al., 1994). In
their study, Henderson and workers used polyclonal CYP4A antibodies to demonstrate the sup-
pression of a supposedly male-specific protein under pulsatile GH treatment, which is female spe-
cific. Conversely, a protein was detected in ‘little’ mice when treated with pulsatile GH, implying
the female-specific expression of this protein. A major flaw with these experiments is the use of
a polyclonal CYP4A1 antibody which does not discriminate between the various isoenzymes,
thereby adding to the confusion. It is therefore unclear which expressed protein was indeed being
detected at all. Their paper also does not mention the effects of testosterone, a fundamental dif-
ference between the male and female animal. Testicular feminized mice (tfm) have been used in
experiments to study mouse renal sexual dimorphism and testosterone responsiveness (Hender-
son and Wolf, 1991). This strain of mice carry an androgen receptor defect, making them phe-
notypically female but genotypically male. The gonads, hypothalamus and pituitary form a
hormonal axis that regulate the expression of sex-specific enzymes, with the gonadal steroid act-
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ing through the hypothalamus and pituitary. Male ‘tfm’ mice possess female genitalia and would
not produce testosterone, would therefore differ fundamentally from normal male mice. As a re-
sult of the impaired gonadal-hypothalamic-pituitary axis of these ‘male’ mice, it is thus not pos-
sible to interpret any data obtained for these mice. 
Section 1.2.2.7 Rabbit CYP4A genes
CYP4A4, CYP4A5, CYP4A6 and CYP4A7 are the four genes that have been identified in the
rabbit (Nelson et al., 1996). CYP4A4 was isolated by Matsubara and coworkers (1987) in rabbit
lung. The deduced amino acid sequence shows it contains 506 amino acids with a calculated mo-
lecular weight of 58 515. It shows 74% and 77% similarity in the amino acid and the nucleotide
sequence respectively compared with CYP4A1. Palmer and coworkers (1993a) have reported
the gene structure of the CYP4A4 to be similar to the cofibrate-inducible genes CYP4A1 and
CYP4A2 in terms of intron/exon structure. However, the 5’ flanking sequences of these genes
show little similarity. Like the CYP4A genes, CYP4A4 promoter does not contain a TATA con-
sensus sequence or recognition elements for Sp1.
CYP4A6 and CYP4A7 are cDNA clones isolated from a rabbit kidney cDNA library (Yokotani
et al., 1989). Genomic DNA encoding the CYP4A6 has been also cloned (Muerhoff et al.,
1992b). The promoter region of this gene was found to contain an Sp1 consensus recognition
sequence at -46 to -37 upstream of the start site. Also, a sequence matching the first 11 of 12
nucleotides that constitute a consensus HNF-4 binding site occurs just upstream of the transcrip-
tion start site. There are also two CCAAT boxes located at -464 and - 448 in the 5’ flanking
region. A peroxisome proliferator response element (PPRE) was also found in a segment of the
5’ flanking region at -740 to -723, which has been shown to regulate the induction of this gene
by peroxisome proliferators in vitro (Muerhoff et al., 1992a; Palmer et al., 1994). 
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Section 1.2.2.8 Rabbit CYP4A enzyme activity
Unlike the rodent CYP4A proteins, CYP4A4 efficiently hydroxylates various prostaglandins
(PGs) such as PGE, PGE2, PGF2α, PGD2, PGA, or PGA2 (Kusunose et al., 1985; Williams et al.,
1984; Roman et al., 1993). None of the expressed CYP4A5, CYP4A6 or CYP4A7 hydroxylate
PGE1. Expressed CYP4A4 however, is unable to ω-hydroxylate lauric acid but palmitate me-
tabolism has been shown for both expressed and purified enzyme (Roman et al., 1993; Johnson
et al., 1990). CYP4A5 is active in the ω and ω-1 hydroxylation of laurate as are CYP4A6 and
CYP4A7 (Johnson et al., 1990) and to a lesser extent palmitic acid (Roman et al., 1993). Towards
arachidonic acid, all show significant ω-hydroxylase activity except CYP4A5 (Roman et al.,
1993). These data show that each enzyme in the subfamily exhibits a unique and marked substrate
specificity. 
Section 1.2.2.9 Rabbit CYP4A gene expression 
CYP4A4 mRNA has not been shown to be detectable in the liver or kidney of untreated or clof-
ibrated- treated rabbits but was shown to be induced in liver, lung, small intestine and uterus in
pregnant animals (Palmer et al., 1993a) or by treatment with progesterone (Matsubara et al.,
1987). Treatment of male rabbits with dexamethasone increased the levels of CYP4A4 mRNA
in the lung and liver, but the levels were eightfold less than those seen for pregnant rabbits (Palm-
er et al., 1993a). CYP4A5 was found to be expressed constitutively in the rabbit kidney, liver and
small intestine (Johnson et al., 1990; Roman et al., 1993) but was only induced two-fold in the
liver by clofibrate (Roman et al., 1993). The level of CYP4A5 mRNA in the kidney did not
appear to be affected by either clofibrate treatment or pregnancy (Roman et al., 1993). CYP4A6
expression, however, is distinctly different. The mRNA for CYP4A6 was barely detectable in
untreated animals but was increased by the administration of clofibrate in the liver (12-fold) and
kidney (6-fold) (Yokotani et al., 1989; Roman et al., 1993). In contrast, CYP4A7 was expressed
highly constitutively in the liver, kidney and small intestine, but its expression was enhanced only
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in the liver by clofibrate treatment (Yokotani et al., 1989; Roman et al., 1993), with no induction
in the kidney. Data on substrate specificity and expression patterns of the rabbit CYP4A proteins
combine to show the peculiarity of the rat CYP4A genes, which suggests a distinct metabolic
role for every isoform. This property makes the rabbit genes markedly different to the rodent
genes.
Section 1.2.2.10CYP4A in Other Species 
CYP4A9, CYP4A11 and CYP4A13 are the remaining CYP4A subfamily members listed (Nel-
son et al., 1996). Only their cDNAs have been cloned. CYP4A9 and CYP4A11 are cloned from
human (Palmer et al., 1993b; Imaoka et al., 1993). CYP4A11 cDNA was isolated from a human
kidney using the rat CYP4A3 cDNA as a probe (Imaoka et al., 1993). It was deduced to encode
a protein of 519 amino acids and shows 76 %, 72% and 80 % similarities to the rat CYP4A1,
CYP4A3 and rabbit CYP4A6 respectively. CYP4A13 was isolated by PCR as a partial cDNA
fragment from the guinea pig (Bell et al., 1993). 
Section 1.2.2.11CYP4A enzyme activity in other species
The human CYP4A11 was shown to catalyze the ω-hydroxylation of lauric acid, palmitic acid
and arachidonic acid in order of decreasing efficiency, with little or no activity towards prostag-
landins A1 and E1 (Palmer et al., 1993b). No data is available for CYP4A9 and CYP4A13.
Section 1.2.2.12CYP4A gene expression in other species
RNAse protection assays showed the presence of CYP4A11 mRNA in human kidney and liver
but none in lung, skin, colon, small bowel, ileum, stomach, uterus among others (Palmer et al.,
1993b). In contrast to the great inducibility of CYP4A genes in the rodent, even high doses of
methylclofenapate did not elicit an induction of CYP4A13 RNA in either male or female guinea
pig liver (Bell et al., 1993). 
Section 1.2.3 Importance of CYP4 Family in Peroxisome Proliferation 
The CYP4A family of enzymes, which are fatty acid hydroxylases, are one of the many enzymes
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induced during peroxisome proliferation (Sharma et al., 1988). The fact that peroxisome prolif-
eration and the CYP4 family of enzymes are linked to lipid metabolism prompted much research
to be directed towards the understanding of the function of the CYP4A gene subfamily. There
is considerable evidence that peroxisome proliferators alter hepatic lipid metabolism which sup-
ports the idea that this could lead to peroxisome proliferation. It has been shown that CYP4A1
is induced by medium-chain (C6-C8) fatty acids in cultured hepatocytes and that it metabolizes
preferentially long-chain fatty acids, which in turn can be converted to long-chain dicarboxylic
acids. Long chain dicarboxylic acids (C14-C18) induce peroxisomal β-oxidation but not microso-
mal ω-oxidation in hepatocytes and stimulate [3H] thymidine incorporation into DNA in hepa-
tocyte culture (Lock et al., 1989), thus contributing to the hyperplasia seen following peroxisome
proliferator administration. This hypothesis requires the induction of CYP4A proteins prior to
the induction of peroxisomal enzymes like acyl coA oxidase, which indeed is the case (Milton et
al., 1990; Bell et al., 1991; Bell and Elcombe, 1991). The dual administration of clofibrate and
the protein synthesis inhibitor cycloheximide did not prevent the transcription of CYP4A1
mRNA but inhibited both CYP4A1 and acyl coA oxidase activity inductions (Milton et al.,
1991). However, CYP4A1 mRNA induction by clofibrate was unimpeded whereas the corre-
sponding mRNA for acyl coA oxidase was not induced, suggesting the requirement of a protein,
possibly CYP4A, for the subsequent induction of acyl coA oxidase. Further evidence was pro-
vided by work which found that the specific inactivator of CYP4A1, 10-undecynoic acid
(UDYA), inhibited clofibrate-mediated induction of acyl coA oxidase mRNA but not the in-
duction of CYP4A1 mRNA in hepatocytes (Kaikaus et al., 1993). This study indicates that the
CYP4A1 ω-oxidation pathway, or even the CYP4A1 protein itself, plays an important part in
the peroxisome proliferator induction of peroxisomal β-oxidation. This work also demonstrates
that only long-chain dicarboxylic acids, the products of the ω-oxidation pathway, but not me-
dium-chain dicarboxylic acids or long-chain monocarboxylic fatty acids, also enhanced peroxi-
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somal β-oxidation activities (Kaikaus et al., 1993). However, they also show that the long-chain
dicarboxylic acids are poorly metabolized by hepatocytes and the sustained presence of these
compounds due to their slow utilization may explain their greater potency as peroxisome prolif-
erators compared to monocarboxylic fatty acids. Lee and coworkers (1995) have demonstrated
that “knockout” mice lacking PPARα, which is a key transcription factor regulating induction
of CYP4A, acyl coA oxidase and other enzymes, are not responsive to peroxisome proliferators.
It would certainly further our understanding of the phenemenon to examine if ‘knockout’ mice
lacking CYP4A genes undergo peroxisome proliferation. However, no mouse Cyp4a genes have
been cloned to date for such key experiments to be undertaken. The available experimental ev-
idence suggests that only rats and mice undergo peroxisome proliferation, with elevated levels of
CYP4A expression. However, attention has only focussed on the study of the expression of the
rat genes in an artificial cell line, using cotransfected PPARs from another species (eg. Aldridge
et al., 1994) when the mouse PPARs are the most well-characterized. It is clearly desirable to
study the true response of a promoter region of a murine gene in hepatocytes with its endogenous
PPAR as only this can demonstrate the real effects of peroxisome proliferators. It remains to be
seen if a murine CYP4A gene possesses regulatory elements that are associated with its transcrip-
tional activation by peroxisome proliferators.
Section 1.2.4 Importance of CYP4 in Arachidonic Acid Metabolism 
Arachidonic acid, like other fatty acids and their derivatives, is a substrate for CYP-dependent
oxidation reactions. The functional significance of arachidonic acid as the precursor of pros-
tanoids and leukotrienes is also well established (Nelson and Strobel, 1987). Arachidonic acid is
metabolized by CYP4A family proteins to ω and ω-1 hydroxyeicosatetraenoic acids (HETEs),
epoxyeicosatrienoic acids (epoxides/EETs) and dihydroxyeicosatetraenoic acids (diols/DHTs),
all which play important biological roles. In response to salt, urinary excretion of EETs was en-
hanced, reflecting increased renal synthesis of EETs (Capdevila et al., 1992). Other studies have
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described the capacity of exogenously added EETs to modify cell membrane permeability to pep-
tide hormones and to alter cellular concentrations of ions such as H+, Na+, K+ and Ca2+ (Fitz-
patrick and Murphy, 1989). HETEs have been found on the human skin and been increased
during psoriatic inflammation (Woollard, 1986). ω and ω-1 hydroxylated HETEs have been
identified at several sites intrarenally that are pivotal to the regulation of renal function (Imig et
al, 1993; Omata et al., 1992). 20-HETE was also shown to be a potent vasoconstrictor of isolated
perfused renal arteries (Ma et al., 1993). An inhibitor of microsomal 20-HETE production, 17-
octadecynoic acid (17-ODYA), has been shown to increase urine flow and sodium excretion
whereas renal blood flow and glomerular filtration rate were not significantly altered (Zou et al.,
1994). This suggests that endogenous cytochrome P450 derived metabolites of arachidonic acid
are important in regulating renal function. 20-HETE production is concentrated in the proximal
tubule with the highest specific activity in the S3 segment, although much can be produced by
other tubular segments and non-tubular structures like the thick ascending limb of Henle’s loop
(Carroll et al., 1991). In the spontaneously hypertensive rat (SHR), which displays higher renal
P450 arachidonate metabolism, specifically 20-HETE production (Omata et al., 1992; Sacerdoti
et al., 1987), all three CYP4A proteins, CYP4A1, CYP4A2 and CYP4A3 have been shown to
be expressed when 20-HETE production is at its maximum (Schwartzmann et al., 1996). This
suggests that the activation of one or more of the CYP4A isoforms is involved in increased 20-
HETE synthesis. Northern blot analysis used a CYP4A1 cDNA probe which could make no dis-
tinction between the isoforms due to the high sequence homology. The use of the highly sensi-
tive RNAse protection to distinguish between the 3 genes would therefore be preferable. The
cloning and understanding of the murine Cyp4a gene subfamily would enable the study of their
function in “knockout” animals in relation to renal function and disease. 
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Section 1.3 The Peroxisome Proliferator Activated Receptor 
Section 1.3.1 Discovery 
The identification of a cellular protein, known as the aryl hydrocarbon (Ah) receptor (Poland
and Knutson, 1982) enabled the understanding of the ‘structure activity’ relationship for dioxin
and its congeners. Although dioxin, a liver carcinogen, and peroxisome proliferators both evoke
a pleiotropic response, it is not clearly understood at a molecular level how peroxisome prolifer-
ators of varying chemical structures cause peroxisome proliferation. Lalwani and coworkers
(1987) were the among the first to isolate a binding protein for nafenopin, a peroxisome prolif-
erator. This protein has since been shown to be a member of the heat shock protein family
HSP70. This discovery then focussed efforts in isolating a receptor that is the equivalent of the
Ah receptor. A breakthrough was made in 1990 by Isseman and Green who isolated cDNAs for
members of the steroid hormone receptor superfamily from mouse liver. The first peroxisome
proliferator activated receptor was thus isolated, termed mPPARα (Isseman and Green, 1990).
The PPAR is a member of the nuclear hormone receptor superfamily which is characterized by
a DNA-binding domain composed of 2 highly conserved zinc fingers (Klug and Schwabe, 1995). 
Chimeras of the PPAR were used in trans-activation assays to show its involvement in the tran-
scription of reporter genes in response to the peroxisome proliferator nafenopin. A direct in-
volvement of mPPARα in peroxisome proliferation was demonstrated recently by a ‘knockout’
of this gene : mice which were null for PPARα did not undergo peroxisome proliferation (Lee
et al., 1995). 
Section 1.3.2 PPAR Subtypes 
The cloning of further PPAR genes soon followed after the identification of the first PPAR. To
date, PPARs have been cloned in the rat (rPPARα and rPPARβ) (Gottlicher et al., 1992), Xe-
nopus sp. (xPPARα, xPPARβ and xPPARγ) (Gottlicher et al., 1992; Dreyer et al., 1992; Dreyer
et al., 1993), human (hPPARα, hNUC1 or hPPARβ and hPPARγ1) (Sher et al.,1993; Schmidt
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et al., 1992; Greene et al., 1995), hamster (hamPPARγ) (Aperlo et al., 1995) and 2 other PPAR
genes in the mouse (mPPARβ or mPPARδ and mPPARγ1) (Chen et al., 1993; Zhu et al., 1993;
Kliewer et al., 1994; Tontonoz et al., 1994).
Section 1.3.3 Tissue Specificity, Relative Abundance and Regulation 
The physiological functions of the PPARs are very poorly understood. The tissue localization of
various PPAR subtypes, however, has been studied by various research groups in an attempt to
elucidate their physiological roles. By in situ hybridization using specific probes for PPARα, -β
and -γ, the expression patterns have been examined in the adult rat (Braissant et al., 1996). In the
rat kidney and liver, PPARα and -β were found to be expressed at most prominent levels com-
pared to the low -γ levels. PPARγ was expressed at very low levels in most tissues compared to
the -α and -β, except in the white adipose tissue and the immune system where the -γ was at
the highest level of the 3 subtypes. PPARβ was expressed at the highest level in the kidney, the
CNS and the genital system. In this work, rat PPARβ and PPARγ specific probes were obtained
by RT-PCR, using primers derived from the mouse PPARβ and -γ cDNA sequence, generating
a subtype specific oligonucleotide of 135 and 403 nucleotides respectively. Each of these oligo-
nucleotides is 96% homologous to its mouse PPAR counterpart. A similar study on the PPAR
tissue distribution in mouse was undertaken (Jones et al., 1995) using highly specific RNAse pro-
tection assays. In the liver, PPARα was the predominant PPAR, with 20- fold less PPARβ and
virtually negligible levels of PPARγ. PPARα was also present at appreciable levels in kidney,
brown adipose tissue (IBAT), brain and heart and at low levels elsewhere. PPARβ was present
at highest levels in liver, kidney, IBAT, WAT and spleen. IBAT was the principal site of expres-
sion of PPARγ, suggesting that this receptor subtype plays an important role in lipid metabolism
in brown adipose tissue.
The regulation of PPAR expression is not well understood and has only been studied in the PPA-
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Rα subtype. There have been reports that PPAR RNAs are inducible in liver after treatment
with peroxisome proliferators (Gebel et al., 1992; Zhu et al., 1993), however this was not ob-
served in work done by other groups (eg. Jones et al., 1995; Sorenson et al., 1993). Dexametha-
sone, a synthetic glucocorticoid, however, has been shown to stimulate expression of PPAR
mRNA up to 15 times over control (Steineger et al., 1994). In the same study, insulin blocked
this stimulatory effect totally and minor inductions of PPAR mRNA were observed when dif-
ferent fatty acids were administered. PPAR expression is also stimulated by stress and follows a
diurnal rhythm, as demonstrated by Lemberger and co-workers (1996). 
Section 1.3.4 PPAR Activation 
Exogenous compounds, known to cause peroxisome proliferation, such as hypolipidaemic fi-
brate drugs, phthalate ester plasticizers and herbicides, have been shown to activate the PPAR
(Isseman and Green, 1990; Dreyer et al., 1992). However, these are not the natural ligands for
PPAR. Fatty acids have been proposed as the endogenous activators of PPAR as high fat diets
stimulate peroxisomal β-oxidation and peroxisome proliferation. Indeed, this has been shown to
be true as a range of fatty acids has been demonstrated to activate PPARα (Keller et al., 1993;
Gottlicher et al., 1992). Despite this, none of these PPAR-activating chemicals has been shown
to bind it as a ligand would bind a receptor. Only recently, has it been shown that the arachidonic
acid-derived prostaglandin J metabolite, PGJ2, is a PPARγ ligand (Kliewer et al., 1995; Forman
et al., 1995). This is the first ever demonstration of an endogenous ligand of PPAR of any kind.
This follows the observation that an exogenous compound, the antidiabetic thiazolinediones, ac-
tivate and competitively bind PPARγ with high affinity (Lehmann et al., 1995). Interestingly,
PPARγ mediates adipocyte differentiation, a process which is shown to be enhanced by thiazo-
linediones (Kliewer et al., 1995; Forman et al., 1995) and prostaglandins (Russell and Ho, 1976).
These are key discoveries as this shows that PPARs are not only transcriptional mediators of the
induction of various genes during peroxisome proliferation, they possibly play an important
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physiological role in fatty acid and glucose metabolism as well. 
Section 1.3.5 Peroxisome Proliferator Response Elements (PPREs) 
Several nuclear hormone receptors possess the same P-box sequence as the PPARs and most of
the response elements of this class consist of direct repeats AGGTCA (or TGACCT) motifs with
a variable number of intervening nucleotides. These ‘spacer elements’ play an essential role in
selective hormonal response. The response elements that have been characterized in PPAR target
genes, termed peroxisome proliferator response elements (PPREs) are DR1, or direct repeats
with one spacer nucleotide. It is also well established that RXRs (retinoid X receptors) act as a
preferential partner in a functional PPAR-RXR heterodimeric receptor complex. The impor-
tance of RXR in this complex was shown in studies demonstrating that PPAR and RXR act
synergistically to confer peroxisome proliferator responsiveness on a DR1 driven promoter
(Kliewer et al., 1992), and since then, in the promoter regions of currently identified PPAR target
genes. PPREs have been identified in the genes for rat acyl coA oxidase (Osumi et al., 1991),
rabbit CYP4A6 (Muerhoff et al., 1992a), the liver fatty acid binding protein , L-FABP (Isseman
et al., 1992), rat CYP4A1 (Aldridge et al., 1995), the multifunctional enzyme (Zhang et al., 1992;
Bardot et al., 1993) and malic enzyme (Castelein et al., 1994). Mitochondrial enzymes like the rat
HMG coA synthase (Rodriguez et al., 1994), which is involved in ketogenesis, and the medium-
chain acyl coA dehydrogenase (MCAD) (Gulick et al., 1994) are also found to possess PPREs in
the proximal promoter region. Another extrahepatic gene in which PPREs have been identified
is the adipose tissue-specific aP2 gene (Tontonoz et al., 1994). 
Peroxisome proliferators induce the expression of CYP4A proteins (Gibson et al., 1982; Sharma
et al., 1988), mitochondrial b-oxidation enzymes and the rate of ketogenesis (Mannaerts et al.,
1978) during peroxisomal proliferation, together with cytosolic proteins such as the liver FABP
(Kaikaus et al., 1993; Isseman et al., 1992), aP2 (Tontonoz et al., 1994) and the malic enzyme
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(Hertz et al., 1991). All these genes possess a response element which is recognized by PPARs.
The rabbit CYP4A PPRE has been fairly well studied. Two distinct elements, named Z and X
have been identified as functional elements in the promoter of the gene (Muerhoff et al., 1992a).
The Z element has been shown to mediate the major portion of the response to peroxisome pro-
liferators by CYP4A6 reporter constructs in transient expression assays, binding PPAR-RXR
much more efficiently than the other CYP4A6 PPREs. However, further work demonstrated
that the typical PPRE motifs may not be sufficient to ensure a peroxisome proliferative response
(Palmer et al., 1994). Deletions or mutations within 6 nucleotides 5’ of the DR1 dramatically
diminished PPAR-RXR binding. PPAR-RXR binding, therefore, requires sequences immedi-
ately 5’ of the DR1, which are conserved in natural PPREs and promote binding of PPAR-
RXR heterodimers in preference to potential competitors such as ARP1 and RXRα ho-
modimers. The identification of PPRE as recognition elements of PPARs is an important step
in understanding the mechanism of transcriptional activation during peroxisome prolifereation.
However, there are major limitations in these studies that complicate our understanding of the
toxicological aspect of this phenomenon. For example, in the study of the CYP4A1 PPRE (Al-
dridge et al., 1995), the Hepa1c1c7 cell line was used in transient transfection assays. These cells
are known not to undergo peroxisome proliferation when treated with peroxisome proliferators.
As such, it is not possible to extend in vitro results to actual events in vivo. Cells which undergo
peroxisome proliferation, like liver hepatocytes, will give us a better understanding of the phe-
nomenon. Secondly, the PPRE caused a 3-5 fold induction, but failed to cause any induction
with the endogenous promoter of the gene, demonstrating that the in vivo response seen in the
liver is more complex than that of the model system. Therefore, it is difficult to say that PPAR
interacts with a DNA element in an artificial system and thus regulates peroxisome proliferation-
induced transcription in the liver. This clearly remains to be shown unequivocally in a hepatocyte
system with an endogenous promoter upstream of a reporter gene.
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might therefore have promoted spontaneously initiated lesions. However, it is possible that older
animals might be more susceptible to peroxisome proliferator-induced liver tumours due to re-
duced protective enzymes anyway. Nevertheless, the conflict of much of the data regarding the
carcinogenicity of peroxisome proliferators means that it is difficult to classify carcinogenic
chemicals into ‘initiators’ or ‘promoters’ simply by observations made with a single dose of a
chemical. It is thus necessary to explore a whole range of issues from the cellular to the biochem-
ical and molecular, regarding carcinogenicity so that a better understanding of the responses of
cells to these chemicals can be achieved. 
Section 1.3.6 Peroxisome Proliferation : Its Significance for Humans
Many attempts have been made to reproduce in other species the phenomenon of peroxisome
proliferation that is readily observed in rats and mice. However, the available experimental data
show that this phenemenon is restricted to these animals and that humans are clearly less respon-
sive to peroxisome proliferators, as are dogs, marmosets, rhesus monkeys, guinea pigs and ham-
sters at dose levels that produce a marked response in rats and mice (reviewed in Bentley et al.,
1993). Currently, what little is known about the mechanisms of carcinogenicity of peroxisome
proliferators suggests that the risk of these chemicals to humans is very low.
Section 1.4 Conclusion
The CYP4A subfamily of genes is believed to play a role in lipid metabolism and the regulation
of renal function. Additionally, genes in this subfamily are induced at an early stage, a crucial
event, during the process of peroxisome proliferation in mice and rats. While much effort has
been directed towards the study of these genes in the rat, relatively very little is understood about
them in the mouse. To date, only two cDNAs, Cyp4a10 and Cyp4a12, of the Cyp4a subfamily
of genes have been cloned from the mouse. It is not known if other members of the murine
Cyp4a subfamily exist.
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This is an attempt to isolate genomic clones of murine members of the Cyp4a subfamily. This
study will be important for several reasons. The genetics of the mouse are well understood and
powerful techniques like transgenic and ‘knockout’ technology are most well characterized using
a mouse model. A detailed understanding of the murine Cyp4a subfamily would be crucial for
understanding their evolution and regulation in mice and as a prelude to designing a strategy for
gene-targetting experiments. This would be a powerful way of understanding the function of the
Cyp4a gene subfamily in lipid and eicosanoid metabolism and their role in peroxisome prolifer-
ation.
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Chapter 2 MATERIALS AND METHODS 
Section 2.1 Materials 
Section 2.1.1 General Materials
All chemicals were obtained at the highest grade possible.  Polyethylene Glycol was obtained
from Sigma and was Molecular Biology grade and had molecular weight of 8000.  Hybond-N+
membranes were obtained from Amersham.  X-ray film was manufactured by Fuji and obtained
from Amersham. Methylclofenapate (synthesized by Lancaster Synthesis Ltd., Lancaster, UK)
was a kind gift of Dr CR Elcombe (Zeneca CTL, Macclesfield, Cheshire).  Oligonucleotides
were synthesized by John Keyte of the Biopolymer Synthesis and Analysis Unit, Department of
Biochemistry, University of Nottingham.  UHP grade water (>13MΩ/cm) was produced by us-
ing a Purite Select Bio system.  DEPC water was produced by adding 1ml of Diethyl Pyrocar-
bonate (dissolved in 5ml ethanol) to 1litre of UHP water.  This was then stood for 1 hour and
then autoclaved for 1 hour.  PCR PromoterFinder Kit was manufactured by Clontech Labora-
tories and obtained from Cambridge Bioscience.  Sequagel concentrate and diluent were manu-
factured by National Diagnostics and obtained from Flowgen.  Sequenase Version 2.0 T7
Polymerase and reagents were manufactured by United States Biochemicals and obtained from
Amersham.  The following radioactive isotopes were obtained from ICN Flow at the stated spe-
cific activities:
(i)     transcription grade [α-32P]-CTP (3000Ci/mmol; 0.5mCi), (ii)    endlabelling grade [γ-32P]-
ATP (7000Ci/mmol; 22.9mM) and (iii)   sequencing grade [α-35S]-dATP (6000Ci/mmol;
0.25mCi).
Section 2.1.2 Plasmids
λ genomic clones 4 and 16 are gifts of Dr David Bell (Department of Life Science, Nottingham
University), which were initially isolated from a genomic library using riboprobes transcribed
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from  Cyp4a10 and Cyp4a12 partial cDNA clones, originally described in Bell et al. (1993).  The
rat CYP4A1 cDNA was a kind gift of Professor Gordon Gibson (Surrey University; Earnshaw et
al., 1988) from which was derived a Cla I/Eco RI fragment termed pIV2 (D.R. Bell).  This was
the 3' most cDNA fragment, corresponding to nucleotide position 900 to the end (exon 8 to the
end).  pZErO Zero Background/Kan Cloning Kit was obtained from Invitrogen.  pGEM-T t-
tailed vector kit was obtained from Promega.
Section 2.1.3 Animals
Male C57Bl6 mice, 25-30g each, were obtained from the Queens Medical Centre, University
of Nottingham.  Mice were fed a standard laboratory diet (Harlan Teklad) ad libitum.  Groups
of two mice were treated by intraperitoneal injection with either corn oil vehicle control or me-
thylclofenapate (MCP) (25 mg/kg) daily for 3 days.
Section 2.1.4 Bacterial Genotypes
The E.coli strains below had the following genotypic traits and were obtained from Stratagene:
XL1-Blue {recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F' proAB  lacIqZDM15 Tn10
(Tetr) ; XL1-Blue MRA {D(mcrA) 183, D(mcrCB-hsdSMR-mrr)173, endA1, supE44, thi-1,
gyrA96, relA1, lac}; 
XL1-Blue SURE {e14- (McrA-) D (mcrCB-hsdSMR-mrr) 171 endA1 supE44 thi-1 gyrA96
relA1 lac recB recJ sbcC umuC :: Tn5 (Kanr) uvrC [F' proAB lacIqZ DM15 Tn10 (Tetr)};
XL1-Blue Top10F' had the following trait and was obtained from Invitrogen's Zero Background
Cloning Kit:
XL1- Blue Top 10F'  {F' [lacIq Tetr ] mcrA D(mrr-hsdRMS-mcrBC) f80lacZDM15 DlacX74
deoR recA1 araD139 D(ara-leu)7697 galU galK rpsL endA1 nupG}
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ElectroMAX DH10B cells had the following trait and were obtained from Gibco BRL:
DH10B {F- mcrA D (mrr -hsdRMS-mcrBC), 80d lacZDM15,  D lacX74, deoR, recA1, endA1
araD139, D(ara leu)7697, galU, galK, l-,rpsL, nupG}
Section 2.2 Methods
Section 2.2.1 General DNA Techniques
Section 2.2.1.1 Restriction Digest
DNA (5µg/µl) was digested with enzymes according to Sambrook et al (1988) in a 50µl reaction
volume.  The following were placed in a clean 1.5ml tube in this order :  
                     10X restriction enzyme digestion buffer         X µl         *        
                      DNA                                                         5 µl                      
                      dH20                                                         Y µl                      
                       Restriction enzyme (2U)                               2 µl, to make a total of 50µl.         
The mixture was then mixed by vortexing, and centrifuged in a Heraeus Benchtop Centrifuge
for 10 seconds, then incubated at 37 oC for 45 minutes.  The reaction was then stopped by adding
a quarter volume of 7.5 M ammonium acetate (12.5µl) and then 2 volumes of ethanol (125µl)
and placed on ice for 30 minutes.  This precipitates the DNA.  The tube was then centrifuged
at 15000rpm for 5 minutes and the supernatant removed by gentle pipetting.  The pellet was then
washed with 1ml of cold 70% ethanol and centrifuged again for 2 minutes.  The ethanol was then
removed and the pelleted DNA was then air-dried and resuspended in 5µl of clean UHP water.
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                                                                *    
Restriction Enzyme Buffer System Working Concentration
Bam HI 10X Universal Buffer 1 X 
Eco RI 10X Universal Buffer 1.5X
Not I 10X Buffer 6 1 X
Sac I 10X Buffer 2 1 X
Components of Buffer Systems
10X Universal Buffer (Stratagene) 10X Buffer System 2 (NBL)
1M KAc 33mM Tris-Acetate pH 8.2 
250mM Tris-Acetate pH 7.6 66mM KAc
100mM MgAc 10mM MgAc
5mM β-mercaptoethanol 0.5mM DTT 100mg/ml BSA
10X Buffer System 6 (NBL)
50mM Tris-HCl pH 7.8 
100mM NaCl 
10mM MgCl2 
1mM DTT
Section 2.2.1.2 Ligation
Ligation is the process of the formation of phosphodiester bonds in the presence of ATP between
double- stranded DNAs with 3'-hydroxyl and 5' phosphate termini.  Vector DNA and insert
DNA were both appropriately restriction digested, and gel-purified and resuspended in an ap-
propriate volume of clean UHP water.  The following were added in a 1.5ml reaction tube: 
1µg of vector 1 µl
3µg of insert DNA X µl (Where X can be varied) 
clean UHP H2O Y µl To give a total of   8.5 µl 
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5X T4 Ligase Buffer 1 µl
T4 ligase (Gibco BRL) 0.5 µl, making a total reaction volume of 10µl.  
The tube was then gently vortexed and touch-centrifuged in a Heraeus Benchtop Centrifuge to
collect the contents.  The tube was then incubated at 16oC overnight for the ligation to proceed.
Components of Buffer System
5X T4 Ligase Buffer (Gibco BRL)
250mM Tris-HCl, pH 7.6
50mM MgCl2
5mM ATP
5mM DTT
25% (w/v) polyethylene glycol-8000
Section 2.2.1.3 GeneClean
The GENECLEAN II kit (BIO 101 Inc.) contains a specially formulated silica matrix called
'glassmilk' which binds single and double stranded DNA without binding DNA contaminants.
This kit was used to purify DNA larger than 500bp from agarose gels made with 1X TAE.  The
reagents NaI solution (6.0M) and NEW wash (NaCl, ethanol, water) are provided in the kit.
DNA was visualized on an ethidium bromide (0.5mg/ml) stained agarose gel made with 1X
TAE, and gel- excised with a razor blade.  The agarose slice was then weighed in a 1.5ml tube
if the slice weighed less than 0.4g.  3 volumes of NaI stock solution were then added to the tube
containing the agarose slice, where 1g is approximately 1ml.  The tube was then incubated in a
waterbath at a temperature of 45 oC-55 oC for about 5 minutes, with mixing after every minute.
The gel slice should be completely dissolved.  5µl of 'glassmilk' was then added to approximately
5µg of DNA in solution and the whole suspension was then incubated at room temperature for
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about 10 minutes to allow binding of the DNA to the silica matrix, with mixing every 1-2 min-
utes.  The 'glassmilk' was then pelleted by centrifugation in a Heraeus benchtop centrifuge at
15000rpm for approximately 5 seconds.  The NaI supernatant was then removed with a pipette.
The pellet was then washed 3 times with NEW wash.  To do this, 500µl of ice-cold NEW wash
was pipetted into the tube, resuspending the 'glassmilk'.  After resuspension, the matrix was pel-
leted by centrifugation for 5 seconds and the wash repeated twice more.  The washed pellet was
then resuspended with 10µl UHP water to elute the bound DNA from the 'glassmilk' by incu-
bation of the tube between 45 oC-55 oC for 2-3 minutes.  The tube was then centrifuged again
for about 30 seconds to make a solid pellet.  The supernatant, which contains the DNA, was then
removed and placed in a clean tube for further manipulations.           
Section 2.2.1.4 Southern Blotting
DNA transfer to Hybond N+ membranes (Amersham) was performed according to the Amer-
sham Handbook.  DNA was run on a 0.6% agarose/TBE gel and photographed against a fluo-
rescent ruler.  The gel was then placed in a container of denaturation buffer for 30 minutes at
room temperature (or until 15 minutes after the dye colours have returned to normal, whichever
is longer).  The gel was then rinsed in dH20 and transferred to a container of neutralization buffer
for 15 minutes and then to another container of fresh solution for another 15 minutes.  To set
up a Southern Blot, a Tupperware box was filled with blotting buffer [10X SSC] to about 1.5cm
deep.  A platform (inverted Eppendorf racks) was then prepared by covering it with a wick made
from 1 sheet of Whatman 3MM filter paper, cut to size, and saturated with 2X SSC.  The gel
was then placed on the wick, wells facing down, making sure no air bubbles were trapped un-
derneath.  The gel was then surrounded with Nescofilm to prevent blotting buffer being directly
absorbed into the paper towels above.  A sheet of Hybond-N+ membrane was then cut to exact
size, wet with 2X SSC and placed on top of the gel, again making sure no air bubbles are trapped.
3 sheets of 3MM paper were then cut to size, saturated with 2X SSC and placed on top of the
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membrane.  A layer of nappy (Boots), was then placed on top of the 3MM paper.  A glass plate
was then placed on top of the nappy and a 1kg weight (1 litre of water) was then placed on top.
The transfer was then allowed to proceed overnight.  After blotting, the membrane was then
marked where the wells were with pencil to allow later identification of the tracks.  The mem-
brane was then washed briefly and carefully in 2X SSC to remove any adhering agarose.  The
DNA was then air-dried and fixed by baking, DNA-side up,  in an 80ºC oven for 2 hours.
Components of Buffers
Denaturation Buffer Blotting Buffer (10X SSC)
1.5M (w/v) NaCl 1.5M (w/v) NaCl  
0.5M (w/v) NaOH 0.15M (w/v) Na3Citrate pH 7.2 
Neutralization Buffer
1.5M (w/v) NaCl
0.5M Tris-HCl pH 7.2 
0.001M (w/v) EDTA
Section 2.2.1.5 DE-81 test
DE-81 filters (Whatman) are positively charged and strongly bind and retain nucleic acids, in-
cluding oligonucleotides.  Unincorporated nucleotides stick less tightly to the filters and are se-
lectively removed by washing the filter extensively in 0.5M Na2HPO4.  This property is used to
calculate the efficiency of incorporation of a radioactive precursor into a desired product.  For
every DE-81 test, 2 pieces of DE- 81 filters were prepared by labelling using a soft-lead pencil,
one to measure the total radioactivity in the reaction (ie, the 'unwashed' filter) and one to mea-
sure the incorporated activity (ie, the 'washed' filter). 1µl of the sample was spotted on each of
the 2 filters and left to dry.  Using forceps, the 'washed' filter was then swirled in 5ml of 0.5M
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Na2HPO4 for 5 minutes.  This was then repeated 4 more times with fresh buffer.  The filter was
then washed in 5ml of DEPC water for 1 minute and then in 5ml 70% ethanol for another 1
minute.  The filter was then left to dry at room temperature.  Both the 'washed' and 'unwashed'
filters were then measured for radioactivity with a geiger counter or in a scintillation counter.
The amount of radioactivity on both filters were then compared and the proportion of precursor
that has been incorporated can be calculated :
                                  cps in washed filter           =       % incorporation                                 
                               cps in unwashed filter
Section 2.2.1.6 DiethylAminoEthyl Cellulose (DEAE) Column
Radiolabelled oligonucleotides were separated from unincorporated radiolabel on a DE52 col-
umn.  Before preparing an ion-exchange column, pre-swollen DE52 Anion Exchange cellulose
(Whatman) was first prepared in slurry form.  5g of dry resin was weighed out and suspended in
100ml of 1M NaCl/TE buffer [1.0M NaCl, 10mM Tris-HCl, pH 8.0, 1mM EDTA], and stirred
for 2-3 minutes.  The slurry was then allowed to settle and the supernatant was then decanted
off.  The resin was then redispersed in 100ml 0.1M NaCl/TE buffer [0.1M NaCl, 10mM Tris-
HCl, pH 8.0, 1mM EDTA] and the slurry allowed to settle again.  After decanting off the su-
pernatant again, the slurry was then redispersed in 30ml of 0.1M NaCl/TE buffer.  To prepare
a column, 2.5ml-3ml of slurry was poured in a 1ml gilson pipette-tip using siliconized glass wool
as support.  The column was not allowed to dry up and was prepared just before use.
Section 2.2.1.7 Autoradiography
Gels containing 35S were dried on 3MM paper (Whatman) using a Bio-Rad 583 Gel Drier.  Gels
containing 32P were Southern transferred to Hybond N+ membrane and wrapped in Saran Wrap
to prevent contamination of intensifying screens and film cassettes.  The film was exposed at
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varying lengths of time at -80ºC to maximize the signal.  Just before developing the film, the
cassette was removed from the -80ºC freezer and placed at room temperature for 5 minutes to
thaw.  The film was then developed in a dark room by the following procedure.  The film was
washed in 1x X-ray developer (Kodak LX24) for 5 minutes. The film was then washed in a water
bath for 2 minutes, then washed in 1X Rapid Fixer (Ilford Hypam Fixer) for 5 minutes before
returning it to the water bath for a further minute before the lights were switched on.  The film
was then rinsed under a running tap for a further 5 minutes before being dried and aligned.
Section 2.2.2 Library Screening
Section 2.2.2.1 Phage Titreing
A mouse B6/CBA [C57Blck6 x CBA] genomic library constructed in λ FIX II vector (Strat-
agene)  was used.  10ml LB broth supplemented with 0.2% maltose and 10mM MgSO4 in a ster-
ile flask was inoculated with a single colony of host strain XL1-Blue MRA and grown overnight
with shaking at 30ºC.  The cells were then spun down in a sterile tube for 10 minutes at 2000rpm
in a Centaur Centrifuge.  The media was then decanted off and the cell pellet gently resuspended
in 10ml of 10mM MgSO4 without vortexing.  The cells were then diluted down to OD600 =
0.5 with 10mM MgSO4.  1µl of phage was then added to 200µl of diluted host cells and incu-
bated at 37ºC for 15 minutes to allow for phage adsorption in a sterilin tube. 1µl of a 1:10, 1:20,
1:100 and 1:200 dilution of phage was also used for titering.  3.5 ml of top agar (48ºC) was then
added to the mixture, quickly swirled and poured evenly on a 100mm LB plate.  The plates were
then incubated overnight at 37ºC.  The plaques were then counted and the plaque-forming units
per millilitre (pfu/ml) concentration of the library determined by the following formula:
                            No of plaques x dilution factor    =  pfu/ml           
                                Volume of extract plated                             
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Section 2.2.2.2 Library Plating
5ml LB broth supplemented with 0.2% maltose and 10mM MgSO4 in a sterile flask was inocu-
lated with a single colony of host strain XL1-Blue MRA and grown overnight with shaking at
30ºC.  The cells were then spun down in a sterile tube for 10 minutes at 2000rpm in a Beckman
Centrifuge.  The media was then decanted off and the cell pellet gently resuspended in 10ml of
10mM MgSO4 without vortexing.  The cells were then diluted down to OD600 = 0.5 with
10mM MgSO4.  The cells may be stored for 2-3 days at 4
oC.  The library was plated on large
150mm LB plates to 50 000 pfu/plate.  20 plates were used to screen 1 X 106 pfu.  The appro-
priately diluted phage and 600µl of bacteria were incubated for 15 minutes at 37oC to allow ph-
age adsorption in a sterilin tube.  To the mixture was then added 7ml top agar (48ºC), quickly
swirled and poured onto a plate.  The top agar was then allowed to set and the plate incubated
at 37ºC overnight without inverting and no more than 2  high.  Agar plates were then chilled at
4ºC the next day for 2 hours to prevent the agar sticking to the membranes during phage lifts.
Section 2.2.2.3 Phage Lifts
Phage lifts were done on Amersham Hybond-N+ membranes as described in the Amersham Hy-
bond N+ Handbook.  Each membrane was first labelled with a pencil before placing it carefully
on the agar surface. The membrane and agar were then marked asymmetrically using a sterile
needle to ensure correct orientation of plaques.  After 1 minute, the membrane was then re-
moved with a pair of forceps and placed, plaque side up, on a pad of 3MM paper (Whatman)
soaked in Denaturing Solution and left for 7 minutes. A duplicate membrane was prepared in the
same way, and marked through the holes used to align the first membrane.  After denaturing, the
membrane was then placed, plaque side up,  on a pad of 3MM paper (Whatman) soaked in Neu-
tralizing Solution and left for 3 minutes.  The neutralization was repeated with a fresh pad soaked
in the same solution.  The membrane was then washed in 2X SSC/0.1% SDS and placed on dry
paper towels to air dry, plaque side up.  The  DNA was then fixed on the membranes by baking
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at 80oC for 2 hours.
Composition of Solutions
Denaturing Solution Neutralizing Solution
1.5M NaCl 1.5M NaCl,
0.5M NaOH 0.5M Tris-HCl  pH 7.2                                             
0.001M EDTA
Section 2.2.2.4 Hybridization
Under stringent conditions, prehybridization was carried out for about 2 hours and hybridization
was performed overnight at 65ºC, in Hybridization Buffer in a Techne HB-1D Hybridiser, col-
ony-side towards the inside of the hybridization tubes.  Thereafter, membranes were rinsed in
2X SSC/0.1% SDS at room temperature and then washed 3 times in Wash Buffer at 65ºC for
15 minutes each.  Membranes were then exposed to autoradiographic film at -80ºC for varying
amounts of time to optimize the signal.  
Components of Buffers
Hybridization Buffer Wash Buffer
*0.5M Sodium Phosphate buffer  pH7.2 40mM sodium phosphate 
1% bovine serum albumin 0.1% SDS  
7% SDS
1mM EDTA
*NB.  To prepare 0.1M Sodium Phosphate buffer pH7.2, 68.4ml of 1M Na2HPO4 and 31.6ml
of 1M NaH2PO4 were mixed together and diluted to 1000ml with UHP water.  To prepare
0.5M solution, the phosphate mix was diluted to 200ml with UHP water.  
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Section 2.2.2.5 Secondary Screening
To orient the filters, the film was lined up and where the needle poked through the membrane.
The 'putative' clones were determined with help of the duplicate membranes.  The 'plug' of agar
was then removed with an inverted yellow Gilson pipette tip where the clone lined up with the
film spot.  The plug was then placed in 500µl of SM buffer and 50µl of chloroform and left at
room temperature for 1 hour. The candidate phage was then diluted appropriately and titred
with host cells on a 100mm LB plate so that one plate had approximately 50 plaques.  Plaque lifts
were then performed and hybridization performed as before.  Isolated plaques were then picked
from a secondary screen.  Where positive plaques were too close to the background plaques to
be distinguishable, a tertiary screen was performed until single, isolated plaques were isolated.      
Components of Buffer
SM Buffer
5.8g/l NaCl 
2.0g/l MgSO4.H20 
50.0ml/l of 1M Tris-HCl pH 7.5 
5.0ml/l 2% (w/v) gelatin
Section 2.2.3 Oligonucleotide Hybridization
The synthetic oligonucleotide was first end-labelled and purified as described (see 2.4.2). Prehy-
bridization was carried out for about 2 hours and hybridization was performed overnight at 60oC,
in Hybridization Buffer in a Techne HB-1D Hybridiser.  Hybridization was carried out accord-
ing to the method of Dilella and Woo (1987). The membrane was then rinsed in 2X SSC at room
temperature, then washed in TMACl Wash Buffer at 60oC.  The wash was then repeated twice
more before autoradiography.
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Components of Buffers
Hybridization Buffer 2X SSC
0.5M Sodium Phosphate Buffer pH 7.2 0.3M NaCl 
1% BSA 30mM NaCitrate, pH 7.2 
7% SDS 
1mM EDTA  
TMACl Wash Buffer
3M Tetramethylammonium Chloride (TMACl) 
2mM EDTA pH 8.0
50mM Tris-HCl
Oligonucleotides used
5'-CCA AAG GCT TCT GGA ATT TAT-3', spanning a 3 residue deletion in CYP4A2 after amino
acid 113 in exon 3, but not CYP4A3, was used as a probe to screen clones containing exon 3.
Section 2.2.4  Probe Preparation
Section 2.2.4.1 Transcribed RNA Probe
The appropriate subclone was first linearized by restriction digest and checked on an agarose gel.
The DNA was then ethanol precipitated and resuspended in DEPC water to 1µg/µl concentra-
tion.  The probe was then transcribed using either T7 or SP6 RNA polymerase and [α-32P]
CTP according to the protocol (Lambda FIX II Library, Stratagene).  The following were incu-
bated in a 1.5ml tube at 37oC for 45 minutes:
Linearized DNA 1 µl     
5X TCS Transciption Buffer 4 µl       
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Cold ATP/GTP/TTP mix [10mM each] 1 µl    
RNAse Inhibitor 1 µl  [40 Units]
DTT [0.75M] 1 µl      
[α32P] CTP [400-800 Ci/mmol, 10mCi/ml] 5 µl     
T7 or SP6 Polymerase 1 µl  [10 units]
DEPC water 6 µl
A DE-81 test was then performed to determine the efficiency of incorporation.  A quarter vol-
ume of 7.5M ammonium acetate was then added to the reaction, followed by 2 volumes of eth-
anol to precipitate the probe for 45 minutes at -20oC.  The contents were then centrifuged at
15000rpm in a Heraeus Benchtop Centrifuge for 15 minutes.  500µl of cold 70% ethanol was
then added to the tube and centrifuged again for 5 minutes to wash and pellet the probe.  The
pellet of RNA probe was then air-dried briefly and resuspended in 500µl of DEPC water.
Components of Buffer
10X TCS
200mM Tris-HCl, pH 8.0, 
40mM MgCl2 
10mM spermidine 
250mM NaCl
Section 2.2.4.2 Oligonucleotide Probe Endlabelling
T4 Polynucleotide Kinase catalyzes the transfer of the γ-phosphate from ATP to the 5' terminus
of polynucleotides or mononucleotides.  The labelling of oligonucleotide was carried out in a
1.5ml tube with the following contents:
Oligonucleotide (30pmol/µl) 1 µl         
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10X T4 Kinase Buffer 2 µl   
[γ-32P]ATP (7000mCi/mmol; 0.17mCi/ml) 2 µl   
H20 14 µl      
T4 Polynucleotide Kinase 1 µl   
The contents were mixed and incubated at 37ºC for 45 minutes.  The efficiency of transfer of
32P was then determined by DE-81 test.  To separate the radiolabelled oligonucleotide from the
unincorporated radioactivity, a DEAE ion-exchange column was used (see section 2.1.6).  100µl
of 0.1M NaCl/TE [0.1M NaCl, 10mM Tris-HCl, pH 8.0, 1mM EDTA] was added to the end-
labelling reaction, and then pipetted back up and loaded onto a DE52 column.  200µl aliquots
of 0.1M NaCl/TE were passed through until the radioactivity flowing out through the column
was less than 100 cps per 200µl fraction.  The radiolabelled oligonucleotide bound to the column
was then eluted in 100µl fractions by passing 1M NaCl/TE [1.0M NaCl, 10mM Tris-HCl, pH
8.0, 1mM EDTA] through the column, with the eluate monitored constantly with a geiger
counter.  The fractions containing the radiolabelled oligonucleotide were then pooled and tested
for incorporation by DE-81 test.
Components of Buffer
10X T4 Kinase Buffer
700mM Tris-HCl, pH 7.6 
100mM MgCl2 
50mM DTT
Section 2.2.5 Isolation of Phage DNA
Section 2.2.5.1 Maxi-Prep By Liquid Culture
5ml of fresh overnight E. coli XL1-Blue MRA host cells grown in LB containing 10mM MgSO4
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and 0.2% maltose, were mixed with various amounts of phage and incubated at room tempera-
ture for 5 minutes. They were then added to prewarmed 250ml of LB containing 10mM MgSO4
and 0.2% maltose and incubated in an orbital shaker at 37oC. Lysis was achieved after approxi-
mately 8 hours, and sodium chloride was then added to a concentration of 0.5M and together
with 1ml of chloroform and returned to the shaker for another 5 minutes.  The culture was then
centrifuged in a Beckman centrifuge using a JA20 rotor at 6500rpm for 10 minutes at 4oC.  The
supernatant was then treated with 250µl of DNAse I (1mg/ml stock) and 175µl RNAseA
(10mg/ml stock) and incubated for 1 hour at 37oC.  Polyethylene glycol (PEG) was then added
to a concentration of 10% (w/v) and stirred to dissolve and incubated in a bucket of ice water
for 1 hour.  The culture was then centrifuged as above to precipitate phage.  The pellet was then
resuspended in 5ml SM buffer and 500µl chloroform.  The suspension was then extracted with
an equal volume of chloroform using a Centaur centrifuge at 2500rpm for 10 minutes.  50µl of
10% SDS and 50µl 0.5M EDTA (pH 8.0) were then added and incubated at 68oC for 15 min-
utes.  The suspension was then phenol extracted, phenol/chloroform extracted and then chloro-
form extracted.  An equal volume of isopropanol was then added to precipitate the DNA at room
temperature for 30 minutes.  The suspension was then microfuged for 5 minutes at 15000rpm to
pellet the DNA.  The pellet was then washed with 70% ethanol and air dried.  The DNA was
then resuspended in 300µl of water.
Composition of Buffer 
SM Buffer
5.8g/l NaCl 
2.0g/l MgSO4.H20 
50.0ml/l of 1M Tris-HCl, pH 7.5 
5.0ml/l 2% (w/v) gelatin
Yee M. Heng Section 2.2.5
Page 60
Section 2.2.5.2 Mini-Prep By Plate Lysate
E.coli MRA host cells were grown overnight at 37oC in 5ml of LB broth containing 0.2% mal-
tose and 10mM MgSO4.  1.5ml of the fresh cells were then pelleted by centrifugation at
15000rpm in a benchtop centrifuge for 30 seconds.  The supernatant was then removed and the
pellet gently resuspended in 0.5ml of 10mM MgSO4.  The cells were then diluted to OD600 =
0.5 with 10mM MgSO4.  Meantime, the phage were serially diluted in SM buffer.  1µl of various
dilutions of phage were incubated with 200µl of cells in clean sterilin tubes at 37oC for 15 min-
utes to allow for phage attachment.  To the phage-cell mixture, 3.5ml of top agar (cooled to
48oC) were then added, quickly swirled to mix and poured evenly on 10mm LB agar plates.  The
top agar was then allowed to dry and the plates incubated, uninverted and no more than 2 high,
overnight at 37oC.  A cells-only control was poured and incubated in the same way.  After lysis,
the plates were then flooded with 5ml of SM buffer and stored at 4oC for several hours with gen-
tle shaking.  The phage were then harvested from the plate with a pipette and placed in a Beck-
man JA-21 centrifuge tube.  An extra 1ml of fresh SM buffer was added to the plate and stored
an extra 15 minutes in a tilted position to allow the fluid to drain.  This was then drained and
combined with the first harvest.  Sodium chloride was then added to a concentration of 0.5M
and together with 0.1ml of chloroform and incubated in a shaker for 5 minutes.  The culture was
then centrifuged in a Beckman centrifuge using a JA- 21 rotor at 6500rpm for 10 minutes at 4oC.
The supernatant was then treated with 5µl of DNAse I (1mg/ml stock) and 5µl RNAseA (10mg/
ml stock) and incubated for 1 hour at 37oC.  0.6g of polyethylene glycol (PEG) was then added
and stirred to dissolve and incubated in a bucket of ice water for 1 hour. The culture was then
centrifuged as above to precipitate phage.  The pellet was then resuspended in 0.5ml SM buffer
and 50µl chloroform.  The suspension was then extracted with an equal volume of chloroform
using a benchtop centrifuge at 15000rpm for 5 minutes.  5µl of 10% SDS and 5µl 0.5M EDTA
(pH 8.0) were then added and incubated at 68oC for 15 minutes.  The suspension was then phe-
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nol extracted, phenol/chloroform extracted and then chloroform extracted.  An equal volume
of isopropanol was then added to precipitate the DNA at room temperature for 30 minutes.  The
suspension was then microfuged for 5 minutes at 15000rpm to pellet the DNA.  The pellet was
then washed with 70% ethanol and air dried. The DNA was then resuspended in 50µl of water
and stored at 4oC.
Section 2.2.6 Subcloning
Section 2.2.6.1 Electrocompetent Cell Preparation
E. coli strains XL1-Blue, SURE and TOP10F' were cultured in 500ml of LB broth containing
10mg/ml of tetracycline, to an OD of 0.6. DH10B were cultured without any antibiotics.  The
cells were prepared for electroporation by centrifugation in 250ml Beckman buckets using a JA-
14 rotor in a Beckman JA2-21 centrifuge at 6000 rpm for 15 minutes.  The pellets were then
washed and resuspended 4 times in ice-cold, sterile UHP water and 4 times in ice-cold 10% glyc-
erol, before being resuspended in 1 ml 10% glycerol. The cells can then be used immediately or
stored at -80oC for future usage in 120µl aliquots.
Composition of Media
LB Broth
10 g/l bacto-tryptone 
5 g/l bacto-yeast extract 
10 g/l NaCl
Section 2.2.6.2 Electrotransformation
40µl of electrocompetent cells were mixed with approximately 10ng of DNA ligated into either
pGEM7Zf(+),  pGEM-T or pZErO and placed in a chilled Biorad Genepulser cuvette (1mm
path length) and electroporated at 1.8kV.  The cells were then immediately suspended in 1ml of
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LB broth and incubated at 37oC for 1 hour before plating out on selective media.   
Section 2.2.6.3 Vector Selection 
pGEM7Zf(+) and pGEM-T Selection
Cells were selected on LB agar plates containing 10 µg/ml tetracycline (where necessary) and 50
µg/ml ampicilllin to select for the vector.  To allow blue/white selection, the plates were spread
with 30µl X-gal (20mg/ml stock) and 40 µl IPTG (20 mg/ml stock) and allowed to dry.  The
plates were then spread with 50 µl of the cells and incubated at 37oC overnight.
pZErO Selection
By zero background selection, recombinant colonies grow on the selective media due to an in-
sertional disruption of a lethal gene ccdB.  The CcdB protein acts by poisoning bacterial DNA-
gyrase (topoisomerase II), an essential enzyme that catalyzes the ATP-dependent supercoiling of
DNA.  This causes DNA breakage, activation of the SOS response, and cell death.  The pZErO-
2 vector features the lacZα-ccdB fusion gene.  Cells were selected on LB containing 50µg/ml
kanamycin to select for the vector and 1mM IPTG to select for recombinants.  The plates were
spread with 50µl of the transformed TOP10F' cells and incubated at 37oC overnight.  
Section 2.2.6.4 DNA Extraction
Alkaline Lysis
Candidate clones, white colonies as picked by the use of blue/white selection, or just colonies
by zero background selection, were used to inoculate 5ml cultures of LB broth containing the
appropriate antibiotics and incubated at 37oC overnight.  DNA was extracted using the alkaline
lysis miniprep method.  1.5ml samples were taken from corresponding 5ml cultures and spun at
12 000g for 30 seconds to pellet the bacteria.  Pellets were then resuspended in 100 µl of Solution
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I.  200µl of freshly prepared Solution II was added and mixed by inversion at room temperature.
150µl of ice-cold Solution III was then added.  The mixtures were then inverted and mixed thor-
oughly, and the bacterial lysates allowed to precipitate on ice for 10 minutes.  The insoluble frac-
tions were then separated by centrifugation at 12 000g for 5 min and the supernatant transferred
to a fresh tube.  Samples were phenol/chloroform extracted twice and ethanol precipitated.  Pel-
lets were washed in 70% ethanol, allowed to dry and resuspended in 50µl of UHP water.
Components of Solutions
Solution I Solution II Solution III
50mM glucose 0.2M NaOH 600ml/l 5M potassium acetate
25mM Tris-Cl pH 8.0 1% SDS 115ml/l glacial acetic acid
10mM EDTA pH 8.0
Qiagen Mini Prep Kit
DNA was prepared by a Qiagen column for high purity for automated sequencing on an ABI
373A Fluorescent Sequencer.  3ml of an overnight culture were pelleted at 12 000g for 30 sec-
onds and then resuspended in 0.3ml of Buffer P1.  0.3ml of Buffer P2 was then added, mixed by
inversion and then incubated at room temperature for 5 minutes.  0.3ml of Buffer P3 was then
added, the tubed mixed by inversion and incubated on ice for 10 minutes.  The bacterial lysate
was pelleted by centrifugation for 15 minutes at 12 000g, keeping the supernatant for purifying
through a Qiagen tip.  Meantime, a Qiagen tip was equilibrated by allowing 1ml of buffer QBT
to drain through the column.  The supernatant from the centrifugation was then added and al-
lowed to enter the column.  The supernatant from the centrifugation was then put through the
column, followed by washing of the column with 1ml Buffer QC for 4 times.  The column was
then eluted with 0.8ml of Buffer QF.  The collected fraction was then precipitated in 0.7 vol-
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umes (0.56ml) of propan-2-ol for 15 minutes at room temperature.  The DNA was pelleted by
centrifugation at 12 000g for 30 minutes, washed in 1ml cold 70% ethanol and then air-dried.
The pure DNA sample was then resuspended in 20µl of clean UHP water.
Components of Qiagen Buffers
Buffer P1 Buffer P2 Buffer P3
50mM Tris-Cl 200mM NaOH 3 M potassium acetate (pH 5.5) 
10mM EDTA (pH 8.0) 1% SDS 100 mg/ml RNAse A
Buffer QBT Buffer QC
750mM NaCl 1.0M NaCl 
50mM MOPS 50mM MOPS 
15% ethanol 15% ethanol, pH 7.0  
0.15% Triton X-100, pH 7.0
Buffer QF
1.25M NaCl 
50mM Tris-Cl  
15% ethanol, pH 8.5
Section 2.2.6.5 PCR Cloning
A PromoterFinder DNA Walking kit (Clontech Laboratories) was used to walk upstream in mu-
rine genomic DNA.  The kit contains 5 libraries of uncloned, adaptor-ligated genomic DNA
fragments prepared from mice.  Primary PCR reaction was performed using a gene-specific
primer (GSP1) and an adaptor- specific  primer (AP1) in 0.5ml tubes, containing the following
master mix: 37.7µl H20, 5µl 10X Tth PCR reaction buffer, 1 µl dNTP [10mM each of dATP,
dTTP, dGTP and dCTP], 2.2µl Mg(OAc)2 [25mM], 1µl AP1 [10mM], 1µl GSP1 [10mM], 1µl
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50X Advantage Tth Polymerase Mix (Clontech) and 1µl of each of the 5 DNA libraries to an
appropriately labelled tube.  The  tube was then gently tapped to mix and briefly centrifuged to
collect the contents.  The reaction mix was then overlaid with 2 drops of mineral oil and capped
firmly.  The reaction was then cycled in a Perkin Elmer DNA Thermal Cycler 480 using the
following parameters : 
1)   7 cycles -  94oC for 25 seconds, 72oC for 4 minutes 
2)   32 cycles -    94oC for 25 seconds, 67oC for 4 minutes 
3)   67 oC for an additional 4 minutes.
8µl of the primary PCR reaction products were then run on a 1.5% agarose/TAE gel. For the
secondary PCR reaction, DNA bands were gel-excised, 'geneclean'-ed and re-amplified using a
second gene-specific primer (GSP2) and a second adaptor-specific primer (AP2) in 0.5µl tubes
containing the same mix except to use AP2 and GSP2 primers and 1µl of gel-excised DNA.
PCR was performed using the following parameters :
1)   5 cycles - 94oC for 25 seconds, 72oC for 4 minutes 
2)   18-22 cycles - 94oC for 25 seconds, 67oC for 4 minutes  
3)   67oC for an additional 4 minutes
5µl of the secondary PCR reaction products were then analyzed on a 1.2% (w/v) agarose/TBE
gel.
Gene Specific Primer Sequences
Cyp4a14 Walk 1 GSP 1 [5'-GAG ATA CCA TCC AAG TAC CTT GTA G-3'] 
                         GSP 2 [5'-CCC ATG GTT AGT AGT TTC TGG ATC GAG-3']
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Cyp4a14 Walk 2 GSP 1 [5'-GGA TAG CTA GGA AGG CCC TGA GGA TC-3'] 
                         GSP 2 [5'- GAG GTT GGA GGA AGG AAG GAA TAT G-3']
Cyp4a10 Walk 1 GSP 1 [5'-GCA GCA GGA GCA GAC CGA GCA CAG A-3'] 
                         GSP 2 [5'-GGC TTG GGC TTA GAG CAG AGA CAC TG-3']
Adaptor Primer Sequences AP 1 [5'-GTA ATA CGA CTC ACT ATA GGG C-3'] 
                                      AP 2 [5'-ACT ATA GGG CAC GCG TGG T-3']
Section 2.2.7 RNA Extractions
RNA was extracted from liver tissues using the method of Cathala and coworkers (1983).  0.5-
1.0g of liver, flash-frozen in liquid nitrogen, was placed in a clean flat-bottomed glass universal
and homogenized for 30 seconds in 5ml of lysis buffer using a Silverstone homogenizer.  The
homogenate was then quickly  added to 35ml of ice cold 4M LiCl and mixed by inversion and
allowed to precipitate overnight at 4oC.  The sample was then spun at 11 000g (9500rpm) for 90
minutes at 4oC in a JA-21 rotor.  The supernatant was removed and the pellet resuspended in
5ml of SDS/TE and 5ml phenol/chloroform (1:1).  The sample was then placed on ice for 45
minutes and vortexed for 20 seconds every 5 seconds.  Samples were frozen at -80oC for 30 min-
utes, allowed to defrost, and then spun at 11 000g for 15 minutes at 4oC in a JA-21 rotor. The
aqueous phase was removed and extracted with phenol/chloroform as above.  The aqeous phase
was removed and ethanol precipitated overnight at -20oC.  This was spun at 11 000g for 15 min-
utes at 4oC in a JA-21 rotor, the pellet washed in 90% ethanol and air-dried and resuspended in
500µl of DEPC water. The concentration of the RNA in solution was then determined by read-
ing the optical density at 260nm, and worked out according to the following parameter:
                         1  OD 260nm    Unit    =       40µg/ml   RNA
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To check for integrity, RNA was run out on a 0.7% agarose gel containing 0.1% SDS and 0.5µg/
ml of ethidium bromide for prestain. 
Components of Buffers
Lysis Buffer SDS/TE
5M guanidine thiocyanate 0.1% SDS 
10mM EDTA 1mM EDTA 
50mM Tris-Cl 10mM Tris-Cl 
8% (v/v) 2-mercaptoethanol
Section 2.2.8 Primer Extension
Radiolabelled synthetic oligonucleotides Primer 1 [5'-GAG ATA CCA TCC AAG TAC CTT GTA G-
3']  and Primer 2 [5' -CTG AGC AAG AAG GCC CAT TGG AAG AAC-3'] were used in First Strand
cDNA synthesis using SUPERSCRIPT II Reverse Transcriptase (Gibco BRL).  The following
were added into a 1.5ml tube:
Oligonucleotide (approximately 2 pmoles/µl) 1 µl         
RNA (3µg/µl) 10 µl     (= 30µg)    
Sterile DEPC water 1 µl 
making a total reaction volume of 12µl.  The mixture was heated to 70oC for 10 minutes and
placed on ice briefly, then touch-centrifuged to collect the contents of the tube.  To anneal, the
tube was then incubated at 55oC for 20 minutes.  For the reverse transcription reaction, the fol-
lowing were then added to the tube:
5X First Strand Buffer 4 µl      
0.1M DTT 2 µl        
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10mM dNTP mix 1 µl        [10mM each dATP, dGTP, dCTP and dTTP]
The contents were then mixed gently and incubated at 42oC for 2 minutes.  1µl SUPER-
SCRIPT II [200 units] was then added and the reaction mixed by gently pipetting up and down.
The reaction was then incubated at 42oC for 50 minutes.  The reaction was then inactivated by
heating at 70oC for 15 minutes. 0.1 volume of 3M sodium acetate (pH 5.2)(2µl) and 2.5 volumes
of ethanol (55µl) were then added to the tube to precipitate the cDNA at -20oC for 1 hour.  The
tube was then centrifuged in a Heraeus Benchtop Centrifuge for 15000 rpm for 10 minutes to
pellet the cDNA.  The supernatant was then removed and the pellet allowed to air-dry behind
a perspex screen.  The pellet was then resuspended in 6µl of clean water and 4µl of Load Buffer.
Components of Buffer
5X First Strand Buffer (Gibco BRL)
250mM Tris-HCl, pH 8.3 
375mM KCl 15mM MgCl2
Load Buffer
95% formamide 
20mM EDTA 
0.05% bromophenol blue 
0.05% xylene cyanol FF
Section 2.2.9 Sequencing
Section 2.2.9.1 Chain Termination Sequencing
DNA was prepared by Qiagen column and adjusted to about 1µg/µl in concentration.  5µl of
template DNA was first denatured in a tube containing 1µl GSP1 primer  [5'-GAG ATA CCA TCC
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AAG TAC CTT GTA G-3'] (0.2pmol/µl) and 1µl NaOH (1M) and incubated at 42oC for 10 min-
utes.  To neutralize, 1µl HCl (1M) was added to the sample, together with 2µl of 5X Sequenase
Reaction Buffer and 0.5µl DMSO.  The sample was then incubated at 42oC for 5 minutes.  For
labelling, the following were added to the sample : 
DTT 1 µl
1X Labelling Mix 2 µl
[α-35S] dATP 0.5 µl
Sequenase Version 2.0 T7  Polymerase
(freshly diluted 1 in 8 in enzyme dilution   buffer) 2µl
DMSO 0.61µl 
The sample was then incubated at 20ºC for 5 minutes.  Meantime, 4 tubes were prepared and
properly labelled, containing 2.5µl of each dideoxynucleotide (8mM each dideoxynucleotide)
and 0.28µl DMSO and preincubated at 42ºC.  3.5µl of labelling reaction was then added to each
tube containing ddNTP, and the incubation was continued for a further 5 minutes.  4µl of STOP
solution were then added to each tube which can then be stored at -80ºC.  Before loading 4.5µl
on a sequencing gel, tubes were boiled for 2-3 minutes.
Components of Buffers
5X Sequenase Reaction Buffer  Enzyme Dilution Buffer
200mM Tris-HCl, pH 7.5 10mM Tris-HCl, pH 7.5 
100mM MgCl2 5mM DTT 250mM NaCl 0.5mg/ml BSA
5X Labelling Mix ( For 1X ,dilute 1 in 5 in UHP water)
7.5mM each of dGTP, dCTP and dTTP
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STOP Solution
95% formamide,20mM EDTA, 0.05% bromophenol blue, 0.05% xylene cyanol FF
Section 2.2.9.2 Automated Fluorescent Sequencing   
DNA was purified by a Qiagen column before sequencing.  Automated cycle sequencing was
performed by J. Keyte, Biochemistry Dept, Nottingham University, using a Perkin Elmer ABI
373A Fluorescent Sequencer and an ABI Cycle Sequencing Kit.  Sequencing was performed us-
ing the universal M13 forward and reverse primers, T7 and SP6 primers and various custom-
made primers (see table below) for oligonucleotide-directed sequencing.
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Primer Name Sequence (5’ - 3’)
F1 GCA CCA TCT GGA AGG TTA GG
F2 CTA ATC TAG GTG GTC CTC TG
F3 GCT TCT CCC ATT TAT TAT CCT GTG
F4 ATG TGG TGT CAG CTA CAG AG 
F5 GCT ATG CTG TTG AGT GGG TG
F6 CCA TTA GCC AAA GAG CAG TG
F7  CAG CAG CTG AAG TCT CTG CC
F8 CCA GAA CCA CCT TCA CAT AGT C
F9 GCC TTC CTA GCT ATC CAT CT
F10  TGC TGG CAC ATC CCA CCC TGG
F11 GCC ATT CCC ATC CTC AAG TG
F12  CAT AAC CTG TGC CAG AGA CTG A
F13  GAG TTG GTT CAT TCA CCC CA
R1 GCA TAG TCA GCC ATT CCT AC
R2 GCT CCA CAT GAC TAA GGG GCA AAC
R3 GAC CAT TGC TGT GTC CCA GG
R4 GTG ACA CTT CAG CCA TCA ATG 
R5 AGC CCT GAG AAC CCA CAT TGA
R6 CTT CTG TCT TAG TCC CAG CAG
R7 ATG GAG AGG GAC TCC AGA ATG A
R8 CCC TTG CTG ATG AGG TTA G
R9 AGC CTG TGA CAG ACT CTT TC
Table 2.1 List of primers used in automated cycle sequencing of Cyp4a14 gene.  Primer 
synthesis and automated sequencing were performed by J. Keyte, Biochemistry Dept, Nottingham 
University.
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Section 2.2.10 Gel Electrophoresis
Section 2.2.10.1 Agarose Gel Electrophoresis
DNA agarose electrophoresis was performed using a Pharmacia GNA-100 Gel Electrophoresis
Kit or a Stratagene Gel Kit.  The appropriate amount of agarose was dissolved in the appropriate
amount of 1X TBE or 1X TAE buffer by boiling and allowed to cool to around 50oC, before
the addition of ethidium bromide (10mg/ml stock) to a concentration of 0.5µg/ml.  The gel mix
was then poured into a gel casting mould containing the appropriate well-forming comb and al-
lowed to set.  After setting, the gel was then placed in a gel tank and topped up with the appro-
priate buffer until just covering the gel.  Samples were then loaded in a 10% solution of 10X
loading buffer.  Electrophoresis was carried out at either 30V (overnight) or 160V (2hours) in a
Stratagene gel kit, or 80V (2 hours) in a Pharmacia Mini-gel Kit.  
Components of Buffers
10X TBE (1 litre) 50X TAE (1 litre)
107.8g Tris base 242g Tris base
55g Boric Acid to pH 8.3 57.1ml glacial acetic acid 
7.44g Disodium EDTA, dihydrate 100ml 0.5M EDTA pH 8.0, and adjust to pH 7.2   
Primer Name Sequence (5’ - 3’)
10f1 CGT TGT GCG AGT CAA GAG CAT TG
10f2 CTG TAC TTG GGT GCC CAT GTA
10f3 CAT CTA GGC ACT GCT GCT C
10r1 TAC ATG GGC ACC CAA GTA CAG 
10r2 CCC ATG AGA CTG GCC TAC CT
10r3 GCG TGC AGT ACC CAG GTG TTG
Table 2.2 List of primers used in automated cycle sequencing of the 5’ flanking region of 
Cyp4a10.   Primer synthesis and automated fluorescent sequencing were performed by J. Keyte, 
Biochemistry Dept, Nottingham University.
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10X Loading Buffer
30% glycerol 
0.25% bromophenol blue 
0.25% xylene cyanol
Section 2.2.10.2Sequencing Gel Electrophoresis
 Sequencing was performed on a Bio-Rad Sequi-gen Cell Electrophoresis Kit.  To make se-
quencing gel, spacers and electrophoresis glass plates were cleaned with 0.1% SDS and then with
ethanol and dried with tissue paper.  The heavier plate was then coated with 1.5ml of Sigmacote
(Sigma) and wiped clean with tissue.  The glass plates were then placed together with the spacers
(0.4mm thick) in place and clamped with the side pieces with the electrodes on the same side of
the plates as the lip.  The following chemicals were used: Sequagel 19:1 Acrylamide/Bis-acryla-
mide Concentrate, Sequagel Diluent and 10X TBE Buffer. The percentage of acrylamide in the
gel can be calculated from the following formulae:                 
1. Volume conc= (Volume total x (% acrylamide) ) / 25
2. Volume 10X TBE    =    0.1 ( Volumetotal )
3. Volume diluent       =    Volumetotal - (Volumeconc + Volume 10X TBE)
where Volumeconc = Volume of sequagel concentrate, Volumetotal  = total volume of gel, Vol-
ume 10X TBE = volume of 10X TBE and Volume diluent = volume of sequagel diluent.
To make a 6% gel, 24ml sequagel concentrate, 66ml sequagel diluent and 10ml 10X TBE buffer
were mixed in a beaker.  This is good for 2 gels.  Distilled water was poured through the lip to
just above the electrode level.  Then an 'acrylamide plug' for the bottom of the gel was prepared.
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5ml of the above Sequagel mix was measured out in a Falcon tube, and 10µl TEMED and 50µl
ammonium persulphate (25% stock concentration) were then added, and quickly mixed, to start
the gel polymerizing.  With the gel cast flat, the mixture was then pipetted into the base of the
glass plates to about 4-5cm deep.  The plug was then allowed to set for 45-60 minutes.  To cast
the remaining gel, 43ml of the Sequagel mix was then mixed with 25µl TEMED and 250µl am-
monium persulphate (25% stock).  With the top of the gel cast propped up at an angle, the mix
was then pippetted into the space between the glass plates, constantly shifting so no bubbles were
allowed to form within the gel mix.  When full, a shark tooth comb was then inserted in an in-
verted position, making a gel with a flat horizontal edge.  More gel mix was then pipetted onto
the comb so as to cover most of it to prevent the gel drying out.  The top of the gel cast was
draped over with a wad of paper towel soaked in 10X TBE, then covered with Saran Wrap and
allowed to set overnight propped up at an angle.  After the gel had set, the shark tooth comb was
inverted and inserted so the teeth just entered the gel surface.  The trough adjacent to the gel cast
was then emptied of water and replaced with 1X TBE and connected up.  Before running sam-
ples, the sequencing gel apparatus was pre- run by passing 50W of power  through it for about
90 minutes to warm it up to 50oC, indicated by the temperature strip on the gel kit, at which
sequencing gels run best.
Composition of Solutions
Sequagel Concentrate (Flowgen) Sequagel Diluent (Flowgen)
237.5g/l acrylamide 500g/l 8.3M urea 
12.5g/l methylene bis-acrylamide 
500g/l 8.3M urea
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10X TBE Buffer
0.89M Tris base ,0.89M boric acid pH 8.0, 20mM EDTA
Section 2.2.11 Sequence Analysis
DNA and protein sequences were analyzed using GCG (University of Wisconsin), Staden (Bon-
field et al., 1995), CLUSTALW, PHYLIP and WWW-based software packages at their respec-
tive default values unless otherwise stated.
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Chapter 3 RESULTS
Section 3.1 Cloning of Cyp4a14
Section 3.1.1 λ clone 4
There are currently 4 members of the CYP4A subfamily of genes known in the rat : CYP4A1,
CYP4A2, CYP4A3 and CYP4A8.  The CYP4A subfamily of genes is poorly understood in the
mouse.  To date, only cDNAs belonging to two murine Cyp4a genes have so far been cloned :
Cyp4a10 and Cyp4a12, which are most similar to the rat CYP4A1 and CYP4A8 respectively.
No murine Cyp4a gene has been cloned thus far.  Furthermore, it is not clear if other genes in
the subfamily exist in the mouse.  To further our understanding of the murine gene subfamily, a
genomic cloning project was undertaken to isolate clones belonging to the Cyp4a subfamily.
The murine genomic library used was constructed in the λ FIX II vector which accepts inserts
from 9 to 23kb (Statagene).  In this library, the manufacturers prepared genomic inserts partially
digested with Sau 3A and cloned into the compatible Xho I site of the vector without re-creating
the Xho I site.  Wild type λ phage contain active red and gam genes in the stuffer fragment; thus,
only recombinant phages with these genes replaced by a genomic fragment are able to grow on
strains lysogenic for P2 phage lysogens, such as XL1-Blue MRA (P2), taking advantage of the spi
(sensitive to P2 inhibition) selection.
 λ genomic clone 4 was originally isolated (D.R. Bell) when the library of 5 X105 plaques was
screened with riboprobes transcribed from murine Cyp4a10 and Cyp4a12 cDNA sequences of
Bell and coworkers (1993).  The clone was mapped, particularly with restriction enzymes which
excise the phage arms, subcloning and sequencing.  On this occasion, Xba I (which cuts in the
polylinker thus releasing the genomic insert) and Not I restriction enzymes were used, both singly
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and in combination with other enzymes like Bam HI and Eco RI.
Section 3.1.2 Restriction digestion map of λ 4 clone
Single restriction digestion of λ 4 with XbaI yielded 2.2 kb, 2.6 kb, 4 kb and 4.5 kb fragments
together with the phage arms of 9kb (right) and 20kb (left) (Figure 3.1). Double restriction digest
with XbaI and BamHI enzymes gave 1.7kb, 2.5kb and 5kb fragments together with the phage
arms.  To identify which fragments would be of most interest, a 1.2 kb partial rat CYP4A1
cDNA was used in hybrization experiments.  This clone, named pIV2, was derived from the full
length 2.1 kb cDNA of Earnshaw and coworkers (1988).  pIV2 spans from nucleotide position
900 to the 3’ end of the cDNA, and corresponding to the 3’ region of CYP4A1 commencing
from exon 8 of the gene.  The gel was blotted onto Hybond N+ membrane by Southern transfer
and hybridized with the riboprobe as described  in the Materials and Methods.  From Figure 3.1,
the 2.2 kb Xba I fragment hybridized most strongly to the riboprobe pIV2. In Xba I/Bam HI
double digests, the riboprobe hybridized very strongly to the 1.7 kb fragment, indicating that
Bam HI cuts within the 2.2 kb Xba I fragment, thus releasing the 1.7 kb fragment.  This was fur-
ther proved when sequencing revealed a Bam HI site within this Xba I fragment.
Section 3.1.3 Subcloning and sequencing of λ 4 clone
All Xba I fragments obtained from λ 4 clone were subcloned into pGEM7 vector and sequenced
by oligonucleotide-directed automated sequencing.  Preliminary sequence data obtained for λ
4:6 showed that λ 4 was distinct from the known murine Cyp4a cDNA sequences, Cyp4a10 and
Cyp4a12.
Instead, comparisons with the rat CYP4A genes indicated that λ 4:6 subclone which contains a
2.2kb Xba I fragment and which hybridized strongly to the pIV2 riboprobe, was similar to the
rat CYP4A2 / CYP4A3 sequences, corresponding to nucleotide positions 6333 to 8351 of the
rat CYP4A2 gene.  λ 4:6 was further deduced to be most 5’ of the clone because sequencing
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using Universal primers revealed a sequence which corresponded to the polylinker region of the
λ FIX II vector. Since the exon sequences were distinct from both Cyp4a10 and Cyp4a12, this
proves that λ 4 clone was part of a novel murine gene. This gene has since been designated
Cyp4a14 by consultation with the cytochrome P450 nomenclature committee (D.R. Nelson,
personal communication).
2.2 kb
9 kb
20 kb
Figure 3.1 λ 4 clone mapped by restriction digest (A) and Southern hybridization (B).   Large-scale
DNA was extracted from λ 4 phage plaque as described in Materials and Methods, restriction digested and run on
a 0.7% agarose gel to separate the fragments.  The gel was then blotted onto Hybond N+ membrane by Southern
transfer and hybridized with the rat CYP4A1 partial cDNA pIV2 riboprobe (nucleotide positions 900 - end, correspond-
ing to exon 8 - end) at 65 oC in 0.5M sodium phosphate buffer (pH7.2) containing 7 % SDS, 1 % BSA and 1mM
EDTA.  The membrane was then rinsed twice in 40mM sodium phosphate (pH 7.2) containing 0.1% SDS at room
temperature and twice again at 65 oC for 30 minutes each and exposed using the BioRad GS-250 Molecular Imager
Solid arrows indicate the size of Xba I fragments, while dashed arrows indicate the positions of  the λ arms at 9 and
20kb.  Lane 1 : XbaI digest, Lane 2 : Xba I + Bam HI digest, Lane 3 : Bam HI + Eco RI digest.
2.2 kb
Lanes
A B
1.7 kb
Lanes 1 2 3
kb
1.7 kb
  1   2  3
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The 2.9 kb and 5.4 kb Xba I subclones, designated λ 4:22 and λ 4:5 were sequenced and con-
tained exons 11 and 12 between them. However, no Xba I fragment was subcloned which con-
tained exon 10.  To confirm the deduced positions of these subclones and subclone a fragment
that would cover exon 10, λ 4 was restriction digested with both Not I (which, like Xba I,  re-
leases the vector arms) and Eco RI (Figure 3.2).  All Not I/Eco RI fragments were subcloned into
pBlueScript vector.  The 6.3 kb Not I/Eco RI fragment, when sequenced, was shown to overlap
sequences from subclones λ 4:6 and λ 4:22; additionally, exon 10 was also found to be contained
in this 6.3 kb Not I/Eco RI fragment, between these two fragments (see Fig 3.3).  Therefore, this
6.3 kb fragment spanned exons 6 through to 12 of this novel Cyp4a14 gene.
Lanes 1 2 3 4
6.3 kb
1.6 kb
3 kb
Figure 3.2 Double restriction digest analysis of λ 4 clone. DNA was prepared by a large-scale extraction
method from λ 4 phage as described and double restriction digested with Not I + Eco RI (Lane 2), Not I + Bam HI
(Lane 3) and Xba I + Eco RI (Lane 4). Products were then run on a 0.6 % agarose gel prestained with ethidium bro-
mide to visualize the fragments.  A 1 kb ladder was run in Lane 1.  Not I/Eco RI fragments from Lane 2 were sub-
cloned into pBlueScript vector and sequenced.  Solid arrow points to a 6.3 kb Not I/Eco RI fragment.  Dashed arrows
point to two fragments of the kb ladder.
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Section 3.1.4 Map of λ4 clone
The deduced map of λ 4 is shown in Figure 3.3. 
To obtain the whole of the gene, a riboprobe was transcribed, as described in Materials and
Methods, from λ 4:6, which is the 5’ most Xba I subclone of  λ 4 to re-screen the library.  The
genomic library of 5 x 105 phage plaques was plated onto 150mm agar plates and DNA was then
transferred in duplicate onto circular Hybond N+ membranes according to Amersham’s Hybond
protocol, orientated using a needle, and denatured for seven minutes and then neutralized twice
at three minutes each.  Membranes were then  baked at 80oC to fix the DNA onto the mem-
branes and prehybridized at 65oC in a solution of 40mM sodium phosphate buffer (pH 7.2) con-
taining 7% SDS, 1% BSA and 1mM EDTA for 2 hours in a Techne Hybridizer.  λ 4:6 riboprobe
Right
arm
Left
arm
SX N
X X X X
S N X
BS
λ 4:6
1 kb
λ 4:22
λ 4:5
λ 4:2
E
Not I/Eco RI subclone
EEN
6.3 kb
Figure 3.3 Map of λ 4 clone. Genomic DNA, indicated by a thick, bold line, was mapped with Xba I, Sac I, Not
I and Eco RI.  Xba I and Not I/Eco RI fragments were subcloned into pGEM7 vector and sequenced by automated
fluorescent sequencing.  λ 4 XbaI subclones and a Not I/Eco RI subclone are indicated at the bottom of the diagram,
with λ 4:6 indicated by a bold line.  Within λ 4:6, Sac I and Bam HI restriction sites mapped about 1kb and 1.7kb
away from the right arm respectively.  Xba I, Not I and Sac I sites are located within the polylinker of the vector.
Arrowheads indicate the positions of the T3 (right arm) and T7 (left arm) bacteriophage promoters.  X : Xba I, N :
Not I, S : Sac I, B : Bam HI, E : Eco RI.  The grey box denotes an Xba I fragment which was not successfully subcloned
but which was contained within the Not I/Eco RI subclone of 6.3 kb.  Only key restriction sites are shown.
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was then added to the tubes at the same temperature and left overnight.  After hybridization, the
membranes were then rinsed twice in 40mM sodium phosphate (pH 7.2) containing 0.1% SDS
at room temperature and twice again in fresh wash buffer at 65 oC for 30 minutes each.  The
membranes were then exposed to autoradiographic film at -80 oC.  Because the library was
screened at very high density, secondary and tertiary screens were performed in which a small
area surrounding a candidate plaque were picked and replated, thereby repeatedly reducing the
density of the library until a pure candidate clone could be isolated.  An example of a tertiary
screen is shown in Figure 3.4.
Section 3.1.5 λ clone 12 
Eleven independent candidate clones were identified by screening the library with the λ 4:6 ri-
Figure 3.4 Autoradiograph showing a tertiary screen. A small area surrounding a positive candidate clone
was picked from a primary screen of a genomic library, appropriately screened in a secondary screen at lower den-
sity, and the process repeated at an even lower density so as to obtain single distinct plaques in a tertiary screen
as shown above.  Hybond N+ membranes were used to transfer DNA from the phage genomic library in duplicate
for the tertiary screen, orientated using a needle and re-hybridized with a riboprobe.  Membranes were hybridized at
65 oC in 0.5M sodium phosphate buffer (pH7.2) containing 7 % SDS, 1 % BSA and 1mM EDTA.  The membranes
were then rinsed twice in 40mM sodium phosphate (pH 7.2) containing 0.1% SDS at room temperature and twice
again at 65 oC for 30 minutes each and exposed to autoradiographic film for 72 hours at -80oC.  Arrows point to a
candidate plaque which has hybridized to the probe in duplicate.  Crosses within the autoradiograph denote the po-
sitions of assymmetrical needle-marks which were used to orientate the membranes relative to each other and to
the library plate.
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boprobe.  To identify which fragments of the clones hybridized to the λ 4:6 riboprobe, the can-
didate clones were restriction digested with Xba I (to excise the vector arms) and blotted onto
Hybond N+ membrane and hybridized with the λ 4:6 riboprobe under stringent conditions as
described.  From the resulting autoradiograph in Figure 3.5, the riboprobe identified a higher
molecular weight Xba I fragment (ca 5.5kb) in all but two candidate clones compared with the λ
4 2.2 kb Xba I fragment, the  positive control. This indicated that clones have been isolated which
contained sequences immediately upstream of the 5' end of and overlapping λ 4, an extension of
approximately 3.3 kb.  Of the eleven new clones, candidate clone number 1 had the least 5' se-
quences due to 2.9 kb Xba I fragment binding to the probe - an extension of just 0.7 kb.
Section 3.1.6 Detailed analysis of λ 9 and λ 12 clones 
From Figure 3.5, nine λ clones out of the eleven were shown to have a 5.5 kb Xba I fragment
which hybridized to the λ 4:6 riboprobe, thus having a similar 3.3 kb extension.  Two clones
belonging to this class, λ 9 and λ 12, were picked for detailed analysis by restriction digest and
Southern hybridization, prior to establishing a strategy for subcloning and sequencing of the
clones.  DNA was prepared from the phage clones and restriction digested with Not I (which
excises the phage vector arms) and various other restriction enzymes (not shown) (Figure 3.6).
1.7 kb and 1.3 kb Not I fragments were observed for λ 9 and λ 12 respectively. It is known that
λ4 has a Not I site at its 3’ end (Figure 3.3). Therefore, λ 9 and λ 12 have similar 5’ extensions
as observed in Southern hybridizations in Figure 3.5, but have different 3’ ends.  Thus, restriction
digest with Not I, excised the vector arms of λ 9 and λ 12 and revealed that λ 12 is approximately
0.4 kb shorter than λ 9 on the 3’ end.
As it was not possible to deduce from restriction mapping which of the two clones had a greater
5’ extension, clones λ 9 and λ 12 were then further analyzed by directly sequencing the phage.
Very pure DNA from the clones was extracted using the protocol according to the manufacturers
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Qiagen and sequenced by priming from the vector arms.   The partial sequencing data revealed
that λ 12 was in fact longer than λ 9 by about 200 nucleotides on the 5’ end (data not shown).
Therefore, λ 12 was the clone chosen for further manipulations due it being the longer clone on
the 5’ end.
2.2 κβ
λ χλονεσ 
2.9 κβ
2
3
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   λ 4 
1
Figure 3.5 Mapping of  λ clones by restriction digest (A) and Southern hybridization (B).  DNA
was prepared from the eleven genomic clones isolated from the genomic library when screened with λ 4:6 ribo-
probe.  Clones were then restriction digested with Xba I and size-fractionated on a 0.7 % agarose gel.  The gel was
then blotted onto Hybond N+ membrane by Southern transfer and hybridized with λ 4:6 riboprobe at 65oC in 0.5M
sodium phosphate buffer (pH 7.2) containing 7 % SDS, 1 % BSA and 1mM EDTA.  The membrane was then rinsed
twice in 40mM sodium phosphate (pH 7.2) containing 0.1% SDS at room temperature and twice again at 65 oC
for 30 minutes each and exposed  to autoradiographic film at -80 oC. DNA from λ 4, the original clone isolated,
was run alongside as a positive control, designated “control”.  The phage clones are indicated above as λ clones
1 to 13 while the sizes of the hybridized fragments are indicated on the side of the diagram with a bold arrow.
Dashed arrows indicate the size of fragments from the 1 kb ladder.  ‘kb’ denotes the 1kb ladder in diagram A.
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Section 3.1.7 Subcloning and sequencing of λ 12  
Since Xba I produced a 5.5 kb fragment in λ 12 which hybridized to the λ 4:6 riboprobe, this
enzyme was chosen to digest λ 12 to produce fragments for subcloning.  In particular, the goal
was to subclone  a 5’ extension of the gene.  λ 12 DNA was extracted by the large-scale method
as described, and restriction digested with Xba I and an aliquot run on a 0.7% agarose gel to en-
sure the digest was to completion.  DNA was then ethanol-precipitated and ligated with appro-
priately digested pGEM7 vector overnight.  The ligation mixture was then ethanol precipitated
Λανεσ κβ  9  12
Figure 3.6 Not I digest of λ 9 and λ 12. Large scale DNA was extracted from λ phages 9 and 12 as de-
scribed and were digested with Not I restriction enzyme .  Products were then run on a 0.7 % agarose gel prestained
with ethidium bromide to visualize the fragments.  Solid arrows point to a 1.7 kb and a 1.3 kb Not I fragment for λ
9 and λ 12 respectively.  ‘kb’ refers to the 1 kb ladder. 
1.7 κβ
1.3 κβ
λ
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and electroporated into E. coli XL1-Blue host cells and selected on appropriate media containing
IPTG and X-Gal as described in Materials and Methods.  White colonies were picked and plas-
mid-extracted as described, and re-digested with Xba I to release any insert cloned into the vec-
tor.  Initially, 48 candidate clones were shown to be Xba I subclones but no 5.5 kb Xba I fragment
was cloned, although other Xba I fragments were successfully ligated into the vector.
An alternative cloning strategy was employed in which Not I (which also excises the vector arms)
and Bam HI ( which cuts about 0.4kb inside the 3’ end of the 5.5 kb Xba I fragment) were used
for restriction digest.  Not I and Bam HI double digests should therefore produce a 5.1 kb frag-
ment covering an identical upstream extended region, in addition to two other fragments (3 kb
and 6.2 kb, data not shown).  Similarly, after plasmid extractions from 120 white candidate
clones, and Not I/Bam HI double digests, no 5.1 kb fragment was observed, but both the 3 kb
and 6.2 kb Not 1/Bam HI fragments have been successfully subcloned.  Thus, all Xba I and Not
I/Bam HI fragments have been cloned into pGEM7 except the 5’ extended region.
A method, using ‘colony lifts’, was then devised to screen much larger numbers of bacterial col-
onies for the 5’ extended fragment.  XL1-Blue transformed with Xba I or Not I/Bam HI ligation
mixtures were spread on sterile Hybond N+ membranes laid on agar plates and incubated over-
night.  Membranes were then orientated using four needle-marks, then peeled off, denatured and
neutralized as described in the Amersham Hybond Handbook and hybridized with the λ 4:6 ri-
boprobe.  Initially, good positives were obtained in duplicate from the high-density primary
screen, but with every secondary and tertiary screen to enable isolating a single colony, the ra-
dioactive signals were lost.  This, together with the failure to clone the fragment after repeated
attempts, suggested that the 5’ extended region had a DNA structure which might be unstable
due to a repetitive sequence.
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Another attempt was made to clone the 5’ extended region with a change of host cells from XL1-
Blue to E. coli MRA cells, which were the original host cells of the phage library.  Since the
Cyp4a clones in the phage library apparently propagated stably in E. coli MRA cells, the unstable
DNA fragment could be accommodated more efficiently in these original host cells.  The original
host cells are deficient in the E. coli restriction enzymes McrA and McrCB, thus DNA is expected
to be more stable in these cells.  After plasmid extractions from 96 white candidate colonies,
again, all Xba I and both the 3 kb and 6.2 kb Not I/Bam HI fragments from λ 12 were cloned
except the 5.5 Xba I or 5.1 kb Not I/Bam HI fragment.  Another change to recombination-de-
ficient host cells E. coli SURE (Stratagene) and DH10B (Gibco) also produced no positive result
after analysis of 48 subclones.
λ 12 was also digested with Sac I ( which also excises the phage vector arms) and Bam HI in com-
bination to map it as an aid to subcloning smaller fragments of the DNA (Figure 3.7).  The gel
was blotted onto Hybond N+ membrane to identify specific extended fragments in a hybridiza-
tion with λ 4:6 riboprobe.  The resulting autoradiographic image (Figure 3.7) indicated the iden-
tification of  a 3.6kb fragment generated from the double digest.  The latter was deduced to be
a Sac I-only 3.6kb fragment as a Sac I restriction map of λ 12 also demonstrated the presence of
a fragment of the same size (Figure 3.8), and this Sac I fragment also hybridised to the riboprobe
(not shown).
In an attempt to solve the problem of subcloning a whole DNA fragment which was unstable,
attention was then focussed on subcloning the 5’ extended region in parts; a Sac I fragment of
3.6 kb was particularly of interest because it hybridized to the λ 4:6 riboprobe, and was therefore
immediately upstream of it.  This indicates Sac I cuts within the 5.5 kb Xba I fragment.  Since
Sac I cuts within λ 4:6 about 1 kb inside the 5’ end,  it can be deduced that Sac I cuts again within
the extended region, about 3.6kb away from the Sac I site in λ 4:6.  This would explain the 3.6kb
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Sac I fragment hybridizing to the λ 4:6 riboprobe due to a common region of about 1 kb in
length. This hypothesis is confirmed by sequence data of λ 4:6.  A deduced map of λ 12 is shown
in Figure 3.9. 
λ 12 was digested with Sac I and ligated into pGEM7 vector.  After electroporation into both
SURE and DH10B cells, and DNA extracted from 168 and 84 candidate clones each, again, the
3.6kb Sac I fragment was resistant to cloning.  Six other Sac I fragments were successfully sub-
cloned into pGEM7 vector (see Table 3.1).
λ Χλονεσ  12  4
3.6 κβ
9 κβ
20 κβ
Figure 3.7 Mapping of Cyp4a14 clones λ 4 and λ 12 by double restriction digest with Bam HI and 
Sac I (A) and Southern hybridization (B).  Large-scale DNA was extracted from both phage clones as de-
scribed in Materials and Methods, restriction digested and run on a 0.7% agarose gel to separate the fragments.
The gel was then blotted onto Hybond N+ membrane by Southern transfer and hybridized with the rat CYP4A1 cDNA-
derived pIV2 riboprobe (nucleotide 900 to end) at 65 oC in 0.5M sodium phosphate buffer (pH7.2) containing 7 %
SDS, 1 % BSA and 1mM EDTA.  The membrane was then rinsed twice in 40mM sodium phosphate (pH 7.2) contain-
ing 0.1% SDS at room temperature and twice again at 65 oC for 30 minutes each and exposed using the BioRad
GS-250 Molecular Imager
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A new vector, pZErO (Invitrogen), was then used for subcloning the 3.6 kb Sac I fragment.  This
vector is a component of Invitrogen’s Zero Background/Kan Cloning Kit which is based on the
vector containing the lethal E. coli gene, ccdB.  Insertion of a DNA fragment disrupts expression
of the ccdB gene, thereby permitting growth of only positive recombinants upon induction with
IPTG.  The recommended host strain for pZErO is E. coli TOP10F’.  λ 12 was digested with
Sac I and products run on a 0.7% agarose/TAE gel.  After visualization of the fragments, the
3.6kb fragment was excised from the gel, purified by the geneclean method and ligated into the
appropriately digested pZErO vector, and electroporated into electrocompetent TOP10F’ host
cells, and plated out on media containing kanamycin (which selects for the vector) and IPTG to
select for the positive recombinant colonies.  Using this cloning kit, the unstable 3.6 kb Sac I
3.6 κβ
Figure 3.8 Restriction digest of Cyp4a14 λ clone 12. DNA was restriction digested with Sac I enzyme and
run on a 0.7% agarose gel prestained with ethidium bromide to separate the fragments as described in Materials
and Methods.  A solid arrow on the left side of the picture points to a 3.6kb Sac I fragment while broken arrows on
the right side of the picture indicate the sizes of fragments in the ladder. ‘kb’ denotes the 1 kb adder.
2 κβ 
3 κβ
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fragment, that was so far resistant to subcloning after numerous attempts, was remarkably stable
in pZErO and was thus finally cloned after the first attempt with this vector.
Sac I generated fragments of λ 12 were subcloned into a plasmid vector as summarized in Table
3.1.  Subclone pG711 (which contains a 1.1 kb Sac I fragment) was sequenced by automated flu-
orescent sequencing and was found to be most 5’ of λ 12, containing exon 1 of Cyp4a14 by anal-
ogy with CYP4A2.  Subclone pZ36 (which contains a 3.6 kb Sac I fragment), was found to
contain exons 2, 3, 4 and 5.  This Cyp4a14 subclone also contains a region of CT dinucleotide
repeats spanning over 70 bp in intron 2, which might have contributed to its instability.  The
sequence at the 3’ most end of pZ36 (from λ 12)  was identical to the 5’ end of λ 4.  This dem-
onstrates that both λ 4 (the first λ clone isolated) and λ 12 are contiguous on the genome and
that both clones belong to Cyp4a14. 
Therefore, the first clone isolated, λ 4, was the 3’ half of Cyp4a14, and covers exons 6 through
to 12.  λ 12, the second and overlapping clone isolated, contains the 5’ half of Cyp4a14, and
contains the remaining exons 1 to 5 of the gene (See Section 3.2).  Thus, the whole Cyp4a14
gene was cloned and is contained in these two overlapping phage clones.
Name of Subclone Plasmid Insert size
pG705 pGEM7 0.5 kb
pG711 pGEM7 1.1 kb
pG720 pGEM7 2.0 kb
pG723 pGEM7 2.3 kb
pG728 pGEM7 2.8 kb
pG738 pGEM7 3.8 kb
pZ36 pZErO 3.6kb
Table 3.1  Table of subclones of Cyp4a14.  Large scale DNA was prepared from λ 12 
phage as described and was digested with SacI and subcloned into either pGEM7 or pZErO 
vectors.  The subclones were designated according to the plasmid vector they were cloned into 
and their fragment size.
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A deduced map of λ clone 12 is shown in Figure 3.9.   The extended region was deduced to be
adjacent to the left arm of the vector, by a hybridization experiment in which a Bam HI fragment
was identified by the λ 4:6 riboprobe, which was over 20kb (left arm) in size (not shown).  Direct
sequencing of the phage clone using T7 primer (which primes off the left arm of the vector) con-
firmed that pG711 was adjacent to the arm.
Section 3.1.8 Cloning the 5’ upstream region of Cyp4a14
To elucidate the regulation of the Cyp4a14 gene, the promoter region must be cloned to exam-
ine which regulatory motifs are present.  In order to isolate an overlapping phage clone that con-
tains the promoter region of the gene, the genomic library of 5 x 105 phage plaques was screened
again, using a riboprobe transcribed from pG711 subclone (containing the 1.1 kb Sac I fragment
and exon 1), the 5’ most subclone of λ 12.  After a tertiary screen, eight independent phage can-
didate clones were isolated.  DNA was extracted from these eight phage clones using a large-scale
DNA extraction method as described in Methods and restriction digested with Sac I again (since
Sac I excises the phage arms to release the genomic DNA).  All phage clones possessed the same
Sac I restriction map (not shown).  After Southern blotting, the Hybond N+ membrane was hy-
bridized with the pG711 riboprobe to identify any extended regions.  On this occasion, the
probe hybridized to 1.1 kb Sac I fragments obtained from all eight positive phages (not shown).
This, together with the identical Sac I maps for all eight phages, indicated an identical 5’ end to
λ 12.  This could mean that the Cyp4a14 promoter region might be poorly represented in this
particular genomic library.  To solve the problem, a PCR-based approach was used to clone a
small portion of the promoter region initially, with the option to then re-screen the genomic
library using a probe derived from this PCR product if required. 
Clontech’s PromoterFinder DNA walking kit was used to clone regions upstream of the
Cyp4a14 start site after extensive library screening failed to identify any phage clones apart from
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clones identical to λ 12.  This kit contains five libraries of uncloned genomic DNA fragments,
all ligated to an adaptor of known sequence.   In the construction of the libraries by Clontech,
genomic DNA was isolated from mice, and five separate aliquots of DNA were then thoroughly
digested with five different restriction enzymes : EcoR V, Sca I, Dra I, Pvu II and Ssp I.  Each
pool of DNA fragments was then ligated to the PromoterFinder adaptor.  Each walk consisted
of two PCR reactions : The primary PCR reaction used the outer Adaptor Primer AP1 provided
in the kit and an outer, gene-specific primer (GSP1) derived from the gene.  The primary PCR
reaction mixture was then diluted and used as a template for a secondary PCR using the nested
Adaptor Primer AP2 and a nested gene-specific primer (GSP2), upstream of GSP1 of the gene.
Where appropriate, DNA bands of interest obtained from the primary PCR were also excised
from the gel and purified by the gene-clean method as described in Materials and Methods.
These DNA samples were then resuspended in a suitable volume of water and subjected to sec-
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Figure 3.9 Map of the 5’ end of λ 12 clone. Genomic DNA, indicated by a thick, bold line, was mapped with
Sac I and subcloned into pGEM7 and pZErO vectors.  λ 12 Sac I subclones pG711 and pZ36 are indicated beneath
the phage map, with λ 4:6 riboprobe indicated by a bold line.  Only the Xba I, Not I and Sac I sites within the polylinker
of the left arm (20kb) are indicated.  The arrowhead indicates the position of the T7 bacteriophage promoter.  The
dashed line refers to 3’ region of the gene mapped in less detail.  X : Xba I, N : Not I, S : Sac I, B : Bam HI, E : Eco
RI.  The 5’ end of the gene is on the left hand side of the diagram.   The vector arm is not drawn to scale.
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ondary PCR for confirmation.
In the primary PCR reaction, a gene-specific primer GSP1 (bottom strand, 5’-ΓΑΓ ΑΤΑ ΧΧΑ ΤΧΧ
ΑΑΓ ΤΑΧ ΧΤΤ ΓΤΑ Γ-3’,  corresponding to nucleotide positions 47 to 23 of the Cyp4a14 cDNA)
derived from exon 1 of Cyp4a14 and Adaptor  Primer AP1 (top strand, 5’-ΓΤΑ ΑΤΑ ΧΓΑ ΧΤΧ
ΑΧΤ ΑΤΑ ΓΓΓ Χ-3’) were primers used for primary PCR at the recommended annealing and
extension temperature of 67 oC as specified in the Clontech protocol.  From the resulting pri-
mary PCR, distinct bands of various molecular weights were observed  when PCR products
from the Dra I, Pvu II and Ssp I libraries in particular were run on an agarose gel (not shown).
The products were then diluted 1 in 20 with clean UHP water and subjected to secondary PCR
Lanes 1 2 3 4 +
1.2 kb
Figure 3.10 Identification of Cyp4a14 secondary PCR products.  Primary PCR reaction from the three librar-
ies was diluted 1 in 20 and subjected to secondary PCR confirmation using Cyp4a14 gene specific primers and adap-
tor specific primers as described in Materials and Methods.  5µl of the 50µl secondary PCR reaction were run on a
1.2% agarose gel.  The arrow points to a 1.2 kb PCR fragment identified in Lane 2.  This fragment was then gel-
excised and cloned into pGEM-T vector and named pGT12.  Lane 1: kb ladder; Lane 2 : Dra I library; Lane 3 :  Pvu II
library; Lane 4 : Ssp I library.  ‘+’ denotes positive control performed with Dra I library using positive control primers
as described in the Clontech manual.  ‘-’ denotes negative control performed with no genomic DNA.  Primary PCR
used GSP1 (bottom strand, 5’-ΓΑΓ ΑΤΑ ΧΧΑ ΤΧΧ ΑΑΓ ΤΑΧ ΧΤΤ ΓΤΑ Γ-3’, corresponding to nucleotide positions
47 to 23 of the Cyp4a14 cDNA) while secondary PCR used GSP2 (bottom strand, 5’-ΧΧΧ ΑΤΓ ΓΤΤ ΑΓΤ ΑΓΤ ΤΤΧ
ΤΓΓ ΑΤΧ ΓΑΓ-3’) located upstream of GSP 1 within the 5’ untranslated region of exon 1 of Cyp4a14. 
-
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confirmation using a second, internal gene-specific primer GSP2 (bottom strand, 5’-ΧΧΧ ΑΤΓ
ΓΤΤ ΑΓΤ ΑΓΤ ΤΤΧ ΤΓΓ ΑΤΧ ΓΑΓ-3’) located upstream of GSP1 and within the untranslated
region of exon 1 of Cyp4a14 and Adaptor Primer AP2 (top strand, 5’-ΑΧΤ ΑΤΑ ΓΓΓ ΧΑΧ ΓΧΓ
ΤΓΓ Τ-3’).  5 µl of the 50 µl PCR products from each library were run on an agarose gel (Figure
3.10).  The longest secondary PCR product, a 1.2 kb fragment from the Dra I library was then
chosen for further analysis.  This PCR fragment was excised from the gel, purified by the gene-
clean method, and cloned into pGEM-T vector and named pGT12.  This clone was then puri-
Λανεσ 1 2 3 4 5 6 +
3.2 κβ
Figure 3.11 Identification of Cyp4a14 secondary PCR reaction products.  Primary PCR reaction was di-
luted 1 in 20 and subjected to secondary PCR confirmation using Cyp4a14 gene specific primers derived from
pGT12 subclone and adaptor specific primers as described.  5µl of the 50µl secondary PCR reaction were run on
a 1.2% agarose gel.  The arrow points to a 3.2 kb PCR fragment identified in Lane 3 (Sca I library).  This fragment
was then excised from the gel, purified by the gene-clean method, and cloned into pGEM-T vector and named
pGT32.  Lane 1: kb ladder; Lane 2 : EcoR V library; Lane 3 :  Sca I library; Lane 4 : Dra I library; Lane 5 : Pvu II
library; Lane 6 : Ssp I library. ‘+’ denotes positive control performed with Pvu II library using positive control primers
as described and produced a fragment with the expected molecular weight for this particular library.  ‘-’ denotes
negative control performed with no genomic DNA.  Primary PCR reaction used GSP 1 (bottom strand, 5’-ΓΓΑ ΤΑΓ
ΧΤΑ ΓΓΑ ΑΓΓ ΧΧΧ ΤΓΑ ΓΓΑ ΤΧ-3’) and Adaptor Primer AP1 (top strand, 5’-ΓΤΑ ΑΤΑ ΧΓΑ ΧΤΧ ΑΧΤ ΑΤΑ ΓΓΓ
Χ-3’) and secondary PCR used a nested secondary primer GSP 2 (bottom strand, 5’-ΧΤΑ ΓΓΑ ΓΑΓ ΓΤΤ ΓΓΑ ΓΓΑ
ΑΓΓ ΑΑΓ ΓΑ-3’) upstream of GSP1 and Adaptor Primer AP2 (top strand, 5’-ΑΧΤ ΑΤΑ ΓΓΓ ΧΑΧ ΓΧΓ ΤΓΓ Τ-3’).  
−
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fied by a Qiagen DNA extraction protocol and fully sequenced on both strands by automated
fluorescent sequencing.
To walk further upstream of the gene, a separate set of PCR reactions was performed using prim-
ers derived from the 5’ most sequences of the pGT12 clone.  Primary PCR reaction using GSP
1 (bottom strand, 5’-ΓΓΑ ΤΑΓ ΧΤΑ ΓΓΑ ΑΓΓ ΧΧΧ ΤΓΑ ΓΓΑ ΤΧ-3’) derived from pGT12 and
Adaptor Primer AP1 (top strand, 5’-ΓΤΑ ΑΤΑ ΧΓΑ ΧΤΧ ΑΧΤ ΑΤΑ ΓΓΓ Χ-3’) was performed again
at the annealing and extension temperature of 67oC according to the Clontech protocol as de-
scribed in Materials and Methods.  Primary PCR performed on all five Clontech libraries yielded
bands of various molecular weights when reaction products were run on an agarose gel (not
200 βπ
Λανεσ 1 2 3 4 5 6 7 −
100 βπ
400 βπ
Figure 3.12 Analysis of junction sequence between Cyp4a14 subclones pGT12 and pGT32. The two
subclones were analyzed for contiguity on the Cyp4a14 gene by PCR analysis.  PCR was performed on mouse ge-
nomic DNA, represented by all five Clontech libraries, according to the secondary PCR protocol as detailed in Ma-
terials and Methods.  5µl of the 50µl PCR reaction of each library was analyzed on a 1.2 % agarose gel.  Lanes 1
& 2 : 100 bp ladder, Lane 3 : Eco RV library; Lane 4 : Sca I library; Lane 5 : Dra I library; Lane 6 : Pvu II library;
Lane 7 : Ssp I library.  ‘-’ denotes a negative control performed with no genomic DNA.  The PCR reaction used
primers derived from pGT12 (bottom strand, 5’-ΓΓΑ ΤΑΓ ΧΤΑ ΓΓΑ ΑΓΓ ΧΧΧ ΤΓΑ ΓΓΑ−3’) and pGT32 (top
strand, 5’- ΑΑΓ ΑΤΑ ΑΤΧ ΑΤΓ ΑΤΧ ΧΑΓ ΓΤΓ ΑΓΓ ΑΧΑ-3’).  The solid arrow indicates 200 bp fragments iden-
tified which correspond to the calculated distance between the PCR primers across the junction while broken ar-
rows indicate the sizes of fragments of the ladder.
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shown).  PCR reaction products from all five libraries were then diluted 1 in 20 and secondary
PCR was then carried out using a nested secondary primer GSP 2 (bottom strand, 5’-ΧΤΑ ΓΓΑ
ΓΑΓ ΓΤΤ ΓΓΑ ΓΓΑ ΑΓΓ ΑΑΓ ΓΑ-3’) upstream of GSP1 and Adaptor Primer AP2 (top strand, 5’-
ΑΧΤ ΑΤΑ ΓΓΓ ΧΑΧ ΓΧΓ ΤΓΓ Τ-3’).  Secondary PCR products were then run out on a gel to
visualize the fragments.  The longest fragment, a 3.2 kb band obtained in the Sca I library was
chosen for further analysis, excised from the gel, purified by the gene-clean method and cloned
into pGEM-T vector and named  pGT32 (Figure 3.11). 
To confirm that clones pGT12 and pGT32 which were obtained by PCR are contiguous on the
genome, PCR was performed across the junction using primers derived from pGT12 [bottom
strand, 5’-ΓΓΑ ΤΑΓ ΧΤΑ ΓΓΑ ΑΓΓ ΧΧΧ ΤΓΑ ΓΓΑ ΤΧ-3’] and  derived from pGT32 [top strand,
5’-ΑΑΓ ΑΤΑ ΑΤΧ ΑΤΓ ΑΤΧ ΧΑΓ ΓΤΓ ΑΓΓ ΑΧΑ-3’].  This will produce a calculated 200 bp frag-
ment (the distance between the primers) if the 2 PCR clones are contiguous on the chromosome.
As shown in Figure 3.12, 200bp fragments were observed thus demonstrating that pGT32 is in-
deed located upstream of pGT12.
Section 3.1.9 Transcription start site of Cyp4a14
In order to determine the start site of transcription, primer extension analysis experiments were
performed.  Six male C57Bl6 mice, weighing 25-30 g each, were treated, in groups of three,
with corn oil control (300µl volume) or methylclofenapate (MCP; 25 mg/kg, in 300µl corn oil
vehicle volume) by i.p. injection for 3 days daily (A. Bell, N. Horley and D. Brady).  Liver RNA
was then extracted by the methodology of Cathala and coworkers (1983) as described in Mate-
rials and Methods and was pooled.
Two primers were used for primer extension.  Primer 1 used was a 25-mer oligonucleotide (bot-
tom strand, 5’-ΓΑΓ ΑΤΑ ΧΧΑ ΤΧΧ ΑΑΓ ΤΑΧ ΧΤΤ ΓΤΑ Γ-3’) derived from exon 1 of Cyp4a14
and corresponding to nucleotide positions 47 to 23 of the deduced cDNA and primer 2 was a
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27-mer oligonucleotide (bottom strand, 5’-ΧΤΓ ΑΓΧ ΑΑΓ ΑΑΓ ΓΧΧ ΧΑΤ ΤΓΓ ΑΑΓ ΑΑΧ-3’) and
corresponding to nucleotide positions 77 to 51 of the Cyp4a14 cDNA.  Primers were end-la-
belled with [γ-32P] ATP using T4 kinase. 2pmoles of the radiolabelled oligonucleotide were
mixed with  30µg of liver RNA at an annealing temperature of 55oC for 20 minutes and extend-
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Figure 3.13 Primer extension analysis of the Cyp4a14 gene. Male C57Bl6 mice were treated with
25 mg/kg methylclofenapate (M) or corn oil control (C) for 4 days, and 30µg of liver RNA, extracted by the
method of Cathala and coworkers (1983),  were used for primer extension analysis, at an annealing temper-
ature of 55 oC, with primer 1 (bottom strand, 5’-ΓΑΓ ΑΤΑ ΧΧΑ ΤΧΧ ΑΑΓ ΤΑΧ ΧΤΤ ΓΤΑ Γ-3’) corresponding
to nucleotide positions 23 to 47 of the Cyp4a14 cDNA, endlabelled with [γ-32P]-ATP as described.  A subclone
of λ 12, pG711, was used for sequencing with the same oligonucleotide primer and run in parallel on a dena-
turing 10 % acrylamide sequencing gel.  The sequencing tracks are labelled c, t, a and g.  The nucleotide se-
quence is indicated on the side of the gel, and the position of the major and minor primer extension products
are indicated by a solid and dashed arrow respectively.  The nucleotides indicated in bold correspond to nu-
cleotides upstream of the primer where the extension has terminated.  
C
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ed using the Superscript II Reverse Transcriptase supplied by Gibco BRL as detailed in Ma-
terials and Methods.  The extension products were then run on a 10% denaturing acrylamide
gel alongside a DNA sequencing ladder of a λ 12 subclone pG711 as a size marker, sequenced
using primer 1.  In the first instance, using primer 1, the principal extension product from
RNA extracted from livers of MCP-treated mice was markedly more abundant than that
from mice treated with the corn oil control (Figure 3.13).
∗
Σεθυενχινγ
Figure 3.14 Primer extension analysis of the Cyp4a14 gene with two primers. Male C57Bl6 mice
were treated with 25mg/kg methylclofenapate (+) or corn oil control (-) for 3 days, and 30µg of liver RNA were
used for primer extension analysis as described.  A subclone of λ 12, pG711, was used for sequencing with
the original primer 1(bottom strand, 5’-ΓΑΓ ΑΤΑ ΧΧΑ ΤΧΧ ΑΑΓ ΤΑΧ ΧΤΤ ΓΤΑ Γ-3’, corresponding to nu-
cleotide positions 23 to 47 of the Cyp4a14 cDNA) and run in parallel on denaturing 10% acrylamide sequencing
gel.  The sequencing tracks were not  visible at this exposure.  The positions of the major and minor primer
extension products are indicated by a solid and dashed arrow respectively.  The asterisk (*) denotes an extend-
ed product (only in MCP-treated livers) with primer 2 (bottom strand, 5’-ΧΤΓ ΑΓΧ ΑΑΓ ΑΑΓ ΓΧΧ ΧΑΤ ΤΓΓ
ΑΑΓ ΑΑΧ-3’),corresponding to nucleotide positions 51 to 77 of the Cyp4a14 cDNA).  Sequencing tracks, primed
with primer 1, are not visible on this exposure, but were clearly legible on extended exposure.
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However, a slightly longer extension product of less abundance was also detected in corn oil ve-
hicle-treated liver and only marginally induced by MCP.  In order to rule out the possibility of
the gene having an alternate transcription start site, primer extension analysis was carried out with
an additional primer, primer 2 (corresponding to nucleotide positions 51 to 77 of the cDNA).
This primer only detected a single, major transcription start site (Figure 3.14).  No bands were
observed that were of a higher molecular weight that would correspond to the minor band seen
in Figure 3.13.  Thus, the minor band seen with primer 1 is an artefact and not reproducible with
primer 2. Here, primer extension assays using two gene specific primers confirmed that only one
transcription start site exists for Cyp4a14; this was mapped to a T nucleotide,  26 nucleotides up-
stream of the putative start of protein translation.
πΓ711
πΖ36πΓΤ12
πΓΤ32
Figure 3.15 Cartoon summarizing the λ clones obtained for the murine Cyp4a14 gene. Cyp4a14 clones
λ 4, λ 12 were isolated from the genomic library, and the clones pGT12 and pGT32 were obtained by PCR. .  Black
boxes indicate positions of exons, grey areas indicate regions where sequencing was performed in full while unshad-
ed areas indicate regions where only partial sequencing was performed.
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Section 3.2 Sequence analysis of λ clones 
In this genomic cloning project, λ clones of the murine Cyp4a genes, Cyp4a10, Cyp4a12 and an
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Figure 3.16 Sequencing scheme of subclones (A) pG711, (B) pZ36, (C) pGT12. Phage DNA was ex-
tracted as described, restriction digested with either Xba I (for pG711) or Sac I (for pZ36) cloned into the respective
sites of pGEM7 vector or pZErO respectively.  For pGT12, a 1.2kb PCR product obtained after confirmation with
secondary gene-specific primers was gel-excised and subcloned into pGEM-T vector.  All clones were sequenced
by oligonucleotide-directed automated sequencing. Arrows denote direction and approximate length of sequencing
runs.  The names of the primers are indicated above the primers.  The positions of the exons (empty boxes) of the
gene are indicated beneath the diagram. 
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entirely novel Cyp4a14, have been isolated and characterized.  In Figure 3.15, a cartoon sum-
marizes the λ clones and genomic clones produced by PCR obtained for the murine Cyp4a14
gene, also showing the positions of the exons and the regions of full or partial DNA sequencing.
Subclones from λ clones 4 were sequenced according to primers designed by S. Kuo and D.R.
Bell.  All other subclones were sequenced by automated fluorescent sequencing by oligonucle-
otide-walking and the detailed scheme and direction of  sequencing runs for Cyp4a14 subclones
are presented in detail in Figure  3.16.
Section 3.2.1 Genomic Sequence of Cyp4a14
The Cyp4a14 gene spans about 13 kb and contains 12 exons (a translational stop codon, followed
by a poly-A addition site is found located within exon 12; S.Kuo and D.R. Bell).  The genomic
sequence, from the  1.2 kb 5’ flanking region up to and including exon 4 of Cyp4a14, was thus
assembled from the sequencing data separately obtained from the subclones pGT12, pG711 and
pZ36. This complete sequence is shown in Figure 3.17.
-1100
          TTAACTATAG GGCACGCGTG GTCGACGGCC GGGGCTGGTA AAATTTATTT 
          TTTATTTAAT TTTTTTCATG CAATATAATT TGATCATATT CCTTCCTTCC 
-1000
          TCCAACCTCT CCTAGATCCT CAGGGCCTTC CTAGCTATCC ATCTTCATGT 
          TAATGGATAG ACTGACAACC AAAACATTCT TTCTCTGCTT AAATAATATC 
-900
          TCCATAAAAT CTATAAATAA ATGAGGTAGT TGGAAACTAT CTCAGCACTT 
          TTCAATTGAT TGGCTAGTAA TCCTTCAATA TCTCATTTTT TTAACTTTCG 
-800
          CTTTATCTAT TCTGTGTGTA CATTAATTTT TTTCAGGCAA GGCATAATAT 
          ATATATAATT GGACTGATTT CTTTATTAGA GTTTGCCCTA TGTGAGGTCA 
-700
          AGAAATATTC TTAAATTAAT GAGTGACTGA ATAAGTGATG GGCAATTTAA 
          GTTTTTAGAA AAGAAAGGTT TTATTATTCC ATTCAGTCAA GATAGTGAGA 
-600
          CAGAGAAAGA GTCTGTCACA GGCTGTGTAT GTGGTGAGGC TGATTGAGTC 
          TTGAGCCACC TGAATGCAAC TGCACTGTTC CACCTGCTGG CACATCCATC 
-500
          CTGGATCAAT CTGGAGTGTG ACTGTGACAA GTCTCAGATA AAATGGAAGA 
          AACAGCTGGA TTTGGAGTCC AGATGCAAAG ATGACTATAG GTAGAAACTT 
-400
          TCAGCAATTA CATTCATCTG AACACACCAA CTACTGTTGT CATCATTTCA 
          CCCTGAAATT AGGAAAATAG TACAAGCAGC TACACCTATT ACATGTTTGG 
-300
          TAAATTAGAA TGTGAATTTC TTAATATCCA GGTTAATGTC TAGTCCATGA 
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          CTTTACCTCA TCAGCAAGGG ATATACATAA CATGCAATAT GTGCTCAATA 
-200
          AATAGTTGTG AGTTAGTTCA GAGAAATGGG AATTGGTATA CATATAGATG 
          TTACCAAGAC TAGATACTAG AGATTTGTTT TTACTGTTTA CCAAAGCTGA 
-100
          TGTTGCAGAT TAATAAACTT TGGATTCTGA GGTCAGTCTC TGTCTGTCTT 
          CTCCATTCCC CCCTCCCACA AGTAGGTGTG TCTACCTTCT CATGACTTAA 
+1
          ATGAATTAAC CCTCACTAAA GGGAGTCGAC TCGATCCAGA AACTACTAAC 
          CATGGGTTTT TTTTTATTTA GCCCTACAAG GTACTTGGAT GGTATCTCTG 
            M  G  F   F  L  F   S  P  T  R   Y  L  D   G  I  S
                                  100
          GGTTCTTCCA ATGGGCCTTC TTGCTCAGTC TATTTCTGGT GCTGTTCAAG 
          G  F  F  Q   W  A  F   L  L  S   L  F  L  V   L  F  K
          GCAGTCCAAT TCTACTTACG AAGGCAGTGG CTGCTCAAGA CCCTCCAGCA 
           A  V  Q   F  Y  L  R   R  Q  W   L  L  K   T  L  Q  H
200
          TTTCCCATGC ATGCCTTCCC ACTGGCTTTG GGGGCACCAT CTGAAGGTAG 
            F  P  C   M  P  S   H  W  L  W   G  H  H   L  K
          GAAGAAGGGA GAGGGTGGAA GAGTGTGAAG AGCTGAATGA AGCTATGAGA 
 300
          GTTTAGTATT AGTATACAGG GCAGTCTGCT GAGTGGTAAG CATGTAGTTT 
          CTGAAGAACG CTGGGTTTAC TTCTAAGAGT GGGTTTGCCC TTAGTCATGT 
400
          GGAGCATGAT TTCTTTTTAA AGGACACATT ATGACAATGG ACTCAAATCT 
          CAGGCTGTAG AAGGGCATGG GAAAATGTGG TGTCAGCTAC AGAGAAACAA 
500
          CTAATCTAGG TTGTTCTCTG AGAGAAATTG TAGAAGTGAT GATTTCTATG 
          TTGTATATCA ATTTCCTCTG AGATTGAAAC TGCCCATTTT GGAGAGAAAT 
600
          GTCTGATTAC AATACAGGGC TTTCTAGAGG TAAAATATTC CATCTAGAAA 
          GAAAGCCTCT TACAATAAAG AAAGTTCTTT GGGCAGGTGA AACTGGCTGG 
700
          ATTCATTTGC CATTCCCATC CTCAAGTGTA TGTAAGCAGT AAGAATGGCT 
          GACTATGCTA CTAACTCTCA GTATAATGTA ATTTTGTAAG GGTCTGCATG 
800
          AAGAGTCACT CACTGAGGGC TCACACGCTA GCCACATTTA AGAAGAGCAA 
          AATTCAGAAT TACTACAGAA CACAGAAGTT CTTACCACAG TAGCTTCTCT 
900
          AAGGAGCTTT AGTTTCATCT AACAAGACTC CAGGATCTGG CCAGGACAAG 
          TCCTGGGACA CAGCAATGGT CTGAATAGAA GAAAAAAAAA AGACAGATTA 
1000
          TCAAACCAAC CCAAATTTTT ACCCTTTCTT GAACATGCCA GAGTTATGCC 
          CCTGTGGTGG TCCTGACTCT TCCATACCAC ACAAAGTACT TGATGTCAAA 
1100
          GAACATCTTC GTGAATTCAA CTTTTCTTTG ATGTTCTGTT CCCAAAGGAC 
                                                              D
          AAGGAGCTCC AGCAGATTCT TATATGGGTA GAGAAATTCC CAAGTGCCTG 
           K  E  L   Q  Q  I  L   I  W  V   E  K  F   P  S  A  C 
1200
          CTTACAGTGT CTCTCGGGGA GCAATATACG AGTCCTGCTT TATGATCCTG 
            L  Q  C   L  S  G   S  N  I  R   V  L  L   Y  D  P
          ACTATGTGAA GGTGGTTCTG GGGAGATCAG GTGAGAGTCC AAACTCATTA 
          D  Y  V  K   V  V  L   G  R  S
1300
          CAGCTGTAGC ATATCTGCCA CCCAACATTC AAGACCCAAG TCTGTGTAAT 
          TTTAGAAAAG AGTGACACTT CAGCCATCAA TGTCTAAATA ATACCTACCA 
1400
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          TTCTTTCTGT CCAGAGACCA ACATATGGTT AGCAAATACT TACATAGTTC 
          TCATCACTTA AAATACTTGC ACAAGGCTTA AATTCTCTCT CTCTCTCTCT 
1500
          CTCTCTCTCT CTCTCTCTCT CTCTCTCTCT CTCTCTCTCT CTCTCTCTTC 
          TGTTTTTTCT TTTGCTCTTA AAACATATTG AGTGGATATG TTTTACAAAT 
1600
          TTCCCAAACG TTATAATGGC AGAGACTTCA GCTGCTGGTA CATTGAAGTT 
          CTCTTTCCTA AGTCCAGCTA ACAGGCAACA CAAAGACAGA AAGGAATGGG 
1700
          AGGTAGTTTG AGTGAAAAGG CAGCAGCATG AAATCGACAG AAAACTAATG 
          TTGTGGTCGC TGAAATGGAT GGACTGGTTT TGTTGCTCAA GCCCAATGAC 
1800
          CTAATTTTAA GCCCTGAGAC CCACATTGAA AATGGGGTGA ATGAACCAAC 
          TCCACAAATT TACCTTCTGA ACTCCACACA GACACTGTAG TAGGTGCAAT 
1900
          TCTGAAAAAC TAAAGGAAAG CTTGCAGTTT GAACACCATC CCCCATCTGG 
          TCCTCAAGAC CTGTCTTACA TTTCAGATCC AAAGGCTTCT GGAATTTATC 
                                      D  P   K  A  S   G  I  Y
2000
          AATTCTTTGC TCCCTGGATT GGTAAGTATA TTAAAACAAG AAGTGTGTTT 
          Q  F  F  A   P  W  I
          TCTTCACTGC TCTTTGGCTA ATGGAGAACA ACAGGTAACT AGTCACAAGT 
2100
          ATCACAATCC AGTCCTAAAT CAAGCTTTAT TTCTCTTCTT CCAATCAGTC 
          CTTAGTCCTT TTTAATGCTG GTGTGAGTGT GCATGATACC TGGATTCTGC 
2200
          AATATTATTT CTTCAGACAC TCATTGCCAG ACATTTTTAT ATTTCCCTCT 
          TGACATGACC CCAACACATT TTCATCCCTC ATTTCACTTC TGTCTTAGTC 
2300
          ACAGCAGATT TATCAGACAC ACTGGAAATC TCACTTTCTG TCTTTGTCTA 
          AAAGAAAAAA AAAACCTCAC TATTACTGAA CTTTGATTTC CCCTTTTTTA 
2400
          AATCCCAGTG AATGTAACCA AATGATTCCA GGGGTACTCT TAATTCCACT 
          TCTGTCAGAC ACATTCACAT ATCAGTCTCT GGCACAGGTT ATGGTTTGCT 
                                                  G   Y  G  L  L
2500
          CCTGTTGAAT GGGAAGAAGT GGTTCCAGCA TCGGCGGATG TTGACTCCAG 
            L  L  N   G  K  K   W  F  Q  H   R  R  M   L  T  P
          CCTTCCACTA TGACATCCTC AAACCCTATG TCAAAATCAT GGCGGACTCT 
          A  F  H  Y   D  I  L   K  P  Y   V  K  I  M   A  D  S
2600
          GTCAATATAA TGCTAGTGAG TTGCTCTGTC CCTTTCTCAT TTTATTACAC 
           V  N  I   M  L
          CCACTCAACA GCATAGCCGC
Figure 3.17 Genomic sequence of Cyp4a14 spanning only the 5’ flanking region and exon 4. The
Cyp4a14 gene begins at the transcription start site position +1 and  the start of protein translation is indicated in a
bold ATG codon at position +26.  The amino acids, in their single letter abbreviations, are indicated beneath the four
exon sequences from which they are deduced.  The (CT) dinucleotide repeats in intron 2 are indicated in bold.
Exons 6 to 12 were sequenced by S. Kuo and D.R. Bell.  Within pZ36 subclone, intron 4 was
not sequenced to completion due to its length  (850 bp).  Therefore, exon 5 was sequenced sep-
arately using oligo-directed automated sequencing from the 3’ end of pZ36.  Exon 5 sequence
is presented in Figure 3.18.
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     1    GATAAATGGG AGAAGCTTGA TGGCCAGGAC CACCCTCTGG AGATCTTCCA
           D  K  W   E  K  L  D   G  Q  D   H  P  L   E  I  F  H
    51    CTGTGTTTCA TTGATGACAC TGGACACTGT TATGAAGTGT GCTTTCAGCT
            C  V  S   L  M  T   L  D  T  V   M  K  C   A  F  S 
   101    ACCAAGGCAG TGTTCAGTTG GATGAG
          Y  Q  G  S   V  Q  L   D  E
Figure 3.18 Sequence of Cyp4a14 exon 5.   Exon 5, in pZ36 subclone, was sequenced by automated fluores-
cent sequencing.  The deduced amino acid residues are indicated beneath the nucleotide sequence by their single
letter abbreviations.  Numbers are arbitrary and refer to the nucleotide positions in the exon.  Deduced cDNA se-
quence of Cyp4a14
Section 3.2.2 Analysis of Cyp4a14 promoter
To further the understanding of the regulation of the Cyp4a14 gene expression, the promoter
region of the gene was analyzed for any transcription factor binding sites and other putative reg-
ulatory motifs (Figure 3.19).  In the region upstream of the transcription start site, no consensus
TATA box was found.  However, a 19 bp element and a GAATTAA  box were present, located
at a similar distance (49 bp and 17 bp respectively) from the transcription start site as in CYP4A1
and CYP4A2.  Both motifs are conserved in the rat CYP4A1 and CYP4A2 genes (Kimura et al.,
1989a).  Interestingly, the 19bp element has been shown to be crucial for the basal transcription
of the rat CYP4A1 (Bell and Elcombe, unpublished results) and is thus likely to have a similar
role for this gene.  It is also a putative binding site for Sp1, an ubiquitous transcription factor.  By
utilizing the Transcription Element Search Software (TESS) using the Transfac database, two sep-
arate PPRE half sites were identified approximately 90 bp and 725 bp of the start of transcription.
No recognizable PPRE, a directly-repeated AGGTCA motif spaced by one nucleotide, was de-
tected.  Other putative transcription factor binding sites include those for SP1 and HNF-1.
DNA sequence similarity with CYP4A2 in the 5' non-coding region is relatively high (84 %) for
approximately 350bp upstream of the transcription start site but is reduced sharply thereafter (data
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not shown).  Interestingly, this region of reduced similarity corresponds to the position of a repeat
in the CYP4A2 gene.
−1100  Σπ1
          TTAACTATAG GGCACGCGTG GTCGACGGCC GGGGCTGGTA AAATTTATTT 
          TTTATTTAAT TTTTTTCATG CAATATAATT TGATCATATT CCTTCCTTCC 
                                  -1000                    HNF-1
          TCCAACCTCT CCTAGATCCT CAGGGCCTTC CTAGCTATCC ATCTTCATGT 
          TAATGGATAG ACTGACAACC AAAACATTCT TTCTCTGCTT AAATAATATC 
                                   -900          GATA-1
          TCCATAAAAT CTATAAATAA ATGAGGTAGT TGGAAACTAT CTCAGCACTT 
          TTCAATTGAT TGGCTAGTAA TCCTTCAATA TCTCATTTTT TTAACTTTCG 
                                   -800
          CTTTATCTAT TCTGTGTGTA CATTAATTTT TTTCAGGCAA GGCATAATAT 
                                                         1/2 PPAR
          ATATATAATT GGACTGATTT CTTTATTAGA GTTTGCCCTA TGTGAGGTCA 
                                   -700 
          AGAAATATTC TTAAATTAAT GAGTGACTGA ATAAGTGATG GGCAATTTAA 
                                                     GATA-1
          GTTTTTAGAA AAGAAAGGTT TTATTATTCC ATTCAGTCAA GATAGTGAGA 
                                   -600 
          CAGAGAAAGA GTCTGTCACA GGCTGTGTAT GTGGTGAGGC TGATTGAGTC 
          TTGAGCCACC TGAATGCAAC TGCACTGTTC CACCTGCTGG CACATCCATC 
                                   -500         GATA-1
          CTGGATCAAT CTGGAGTGTG ACTGTGACAA GTCTCAGATA AAATGGAAGA 
          AACAGCTGGA TTTGGAGTCC AGATGCAAAG ATGACTATAG GTAGAAACTT 
               HNF-1               -400
          TCAGCAATTA CATTCATCTG AACACACCAA CTACTGTTGT CATCATTTCA 
          CCCTGAAATT AGGAAAATAG TACAAGCAGC TACACCTATT ACATGTTTGG 
                                   -300 
          TAAATTAGAA TGTGAATTTC TTAATATCCA GGTTAATGTC TAGTCCATGA 
          CTTTACCTCA TCAGCAAGGG ATATACATAA CATGCAATAT GTGCTCAATA 
                    AP-1           -200
          AATAGTTGTG AGTTAGTTCA GAGAAATGGG AATTGGTATA CATATAGATG 
          TTACCAAGAC TAGATACTAG AGATTTGTTT TTACTGTTTA CCAAAGCTGA 
 -100  1/2 PPAR
          TGTTGCAGAT TAATAAACTT TGGATTCTGA GGTCAGTCTC TGTCTGTCTT 
                     Sp1
          CTCCATTCCC CCCTCCCACA AGTAGGTGTG TCTACCTTCT CATGACTTAA 
                                     +1
          ATGAATTAAC CCTCACTAAA GGGAGTCGAC TCGATCCAGA AACTACTAAC 
                     
          CATGGGTTTT TTTTTATTTA GCCCTACAAG GTACTTG 
Figure 3.19 Analysis of 5’ flanking sequence of Cyp4a14.  Nucleotide sequence from the promoter region of
Cyp4a14 was analyzed for putative transcription factor binding sites by utilizing the Transcription Element Search Soft-
ware (TESS) using the Transfac database on the WWW.  Putative transcription factor binding sites are overlined.  The
start of gene transcription, denoted by +1, as determined by primer extension analyses is an enlarged T nucleotide,
located 26 nucleotides upstream of the start of translation.  The conserved 19bp element (indicated in bold) and the
GAATTA box  (double-underlined) are located 49 and 17 nucleotides upstream of the start of transcription respectively.
Double arrows 350 bp upstream of the transcription start site indicate the region where similarity with CYP4A2 is
reduced sharply.
Section 3.2.3 Analysis of exon/intron junctions of Cyp4a14 
The exon/intron junctions of Cyp4a14 are analogous to the previously reported positions in the
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rat CYP4A2.  By analysis of the Cyp4a14 gene, the sequence of exon 1 contains a putative ATG
codon, the start of protein translation.  26 nucleotides upstream of this triplet is located the start
of transcription, a T nucleotide, that has already been determined by primer extension using
primers derived from exon 1 of the Cyp4a14 gene. Additionally, the sequence of exon 12 con-
tains a stop codon followed by a consensus poly-A addition site downstream from the stop
codon, indicating that exon 12 is the final exon of this gene (not shown, S. Kuo and D.R. Bell).
All exons of the murine and rat CYP4A genes are compared in Table 3.2.
From the table, Cyp4a14 showed highest similarity to the rat CYP4A2 and CYP4A3, and mar-
ginally more similar to CYP4A3.  Specifically, exons 4, 8, 11 and 12 were very highly conserved,
with up to 95 % or more nucleotide similarity between Cyp4a14 and CYP4A2 / CYP4A3, as
indicated by a single asterisk.  Compared with the other CYP4A genes, these exons are also most
highly conserved.  Additionally, exon 3 was also highly similar between Cyp4a14 and CYP4A3,
but not CYP4A2.  The exon sequences demonstrate that Cyp4a14 is slightly more similar to
CYP4A3 than to CYP4A2. 
Similarities of the introns or regions within introns may also provide information about evolution
in the CYP4A subfamily.  Table 3.3 shows the similarities of several introns compared between
Cyp4a14 and CYP4A2, by halves. 
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The full lengths of the introns of Cyp4a14 may be compared by BESTFIT with the correspond-
Exon/
Gene
CYP4A1 CYP4A2 CYP4A3 CYP4A8 Cyp4a10 Cyp4a12
     1         70        91        90        69        67          -
     2         69        87        89        77        72          -
     3         70        91  **  98        70        73          -
     4         84  *    98   *   98        81        84          -
     5         76        93        92        76        75          -
     6         64        87        88        69        63          -
     7         83        92        94        78        83          -
     8         86   *   96   *   97        79        88         80
     9         79        92        92        86        78         85
   10         75        88        91        79        73         75
   11         78   *   93   *   94        82        78         81
   12         85   *   95   *   95        91        85          -
Average         77        92        93        78        77          -
Table 3.2 Comparison of Cyp4a14 exon nucleotide sequences with rat and mouse CYP4A genes.   
Individual exons of Cyp4a14 are compared by BESTFIT for similarity with respective exons in rat and mouse CYP4A 
genes. Single asterisks ‘*’ denote key exons of Cyp4a14 and CYP4A2 / CYP4A3  which share high sequence 
similarity (93% and over) while double asterisks ‘**’ denote an especially high sequence similarity in exon 3 
between Cyp4a14 and CYP4A3 only.  Only exons 8 - 11 are sequenced in Cyp4a12 (Bell et al., 1993).
Intron
% similarity 
5’ half 
 % similarity 
3’half
                  1             86           82 
                  2             84           82 
                  3             89           88 
                  6             81           84 
                  7              88           92 
                  8             85           86 
                 10             70           95
Table 3.3 Comparison of intron sequences Cyp4a14 with CYP4A2. Only introns 1, 2 and 
3 and 6, 7, 8 and 10 are compared, by halves, with the corresponding regions of  CYP4A2.  The 
value in bold refers to the 3’ half of introns 7 and 10, adjacent to the highly conserved exons 8 and 
11, which show very high nucleotide conservation between Cyp4a14 and CYP4A2.  Sequences for 
Cyp4a14 introns 6, 7 8 and 10 are obtained from S. Kuo and D.R. Bell.
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ing introns of CYP4A2, giving similarities of up to 90 % (intron 7).  However, the similarities of
the seven introns between Cyp4a14 and CYP4A1 were consistently very poor.  An example of
this is intron 2 (total of 696 nucleotides) of Cyp4a14, where only 166 nucleotides at 66 % identity
with a corresponding region in CYP4A1 (not shown) while the whole intron in Cyp4a14 is 83%
similar to that in CYP4A2.  Thus, from the relatively high conservation of  intron sequences, it
is possible to deduce that the mouse Cyp4a14 gene is more similar to the rat CYP4A2 than
CYP4A1.
Additionally, the analysis of the introns in detail, as summarized in the table above, revealed that,
specifically, the 3’ halves of intron 7, which is adjacent to the highly conserved exon 8 (96% nu-
cleotide similarity), are more conserved between Cyp4a14 and CYP4A2 than the 5’ halves.
Exon 8 in fact encodes for a highly conserved 13 amino acid motif, which is unique only to
CYP4 proteins (Bradfield et al., 1991; see later sections).  Similarly, the 3’ half of intron 10, which
is adjacent to exon 11, is 95% identical to the corresponding region in CYP4A2.  Exon 11 is
highly conserved, and together with exon 12, code for the PFSGG(A/S)RNCIG amino acid
motif that is highly conserved in all CYP4 proteins (see later sections).  Thus, in these two ex-
amples, the intron sequences immediately upstream of the highly conserved exons 8 and 11, are
highly conserved together with the exons themselves.
Within intron  2 of Cyp4a14 is located a region of (CT)n dinucleotide repeats, where n=32.
Such a feature was also found in CYP4A1 (3’ UTR, n=25) but not in CYP4A2 (although there
are twenty-four (CA) repeats in intron 2).  These (CT)n repeats have previously been reported
to be located upstream of a Drosophila heat shock protein hsp26 gene, which appeared to play a
role in formation of the wild-type chromatin structure and the DNAse I hypersensitive sites of
the gene, thus regulating its gene expression (Lu et al., 1992).  It would be interesting to see if
these repeats have a role in organizing the chromatin structure of Cyp4a14 (or indeed the rat
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CYP4A genes) and contributing to its expression.
Section 3.2.4 Deduced amino acid sequence of Cyp4a14
The protein coding sequence of Cyp4a14 was deduced from its predicted exon regions.  The
start of transcription of the Cyp4a14 RNA was determined by primer extension and mapped to
a T nucleotide 26 bases upstream of the putative start of protein translation.  Thus, the cDNA
sequence of the gene was deduced and the amino acid sequence of the protein predicted; these
are presented in Figure 3.20.
      1   TCGACTCGAT CCAGAAACTA CTAACCATGG GTTTTTTTTT ATTTAGCCCT
                                       M  G   F  F  L   F  S  P             8
     51   ACAAGGTACT TGGATGGTAT CTCTGGGTTC TTCCAATGGG CCTTCTTGCT 
          T  R  Y    L  D  G  I   S  G  F   F  Q  W   A  F  L  L            25
    101   CAGTCTATTT CTGGTGCTGT TCAAGGCAGT CCAATTCTAC TTACGAAGGC 
            S  L  F   L  V  L   F  K  A  V   Q  F  Y   L  R  R             41
    151   AGTGGCTGCT CAAGACCCTC CAGCATTTCC CATGCATGCC TTCCCACTGG 
           Q  W  L  L   K  T  L   Q  H  F   P  C  M  P   S  H  W           58
    201   CTTTGGGGGC ACCATCTGAA GGACAAGGAG CTCCAGCAGA TTCTTATATG 
           L  W  G   H  H  L  K   D  K  E   L  Q  Q   I  L  I  W           75
    251   GGTAGAGAAA TTCCCAAGTG CCTGCTTACA GTGTCTCTCG GGGAGCAATA 
            V  E  K   F  P  S   A  C  L  Q   C  L  S   G  S  N             91
    301   TACGAGTCCT GCTTTATGAT CCTGACTATG TGAAGGTGGT TCTGGGGAGA 
          I  R  V  L   L  Y  D   P  D  Y   V  K  V  V   L  G  R           108
    351   TCAGATCCAA AGGCTTCTGG AATTTATCAA TTCTTTGCTC CCTGGATTGG 
           S  D  P   K  A  S  G   I  Y  Q   F  F  A   P  W  I  G          125
    401   TTATGGTTTG CTCCTGTTGA ATGGGAAGAA GTGGTTCCAG CATCGGCGGA 
            Y  G  L   L  L  L   N  G  K  K   W  F  Q   H  R  R            141
    451   TGTTGACTCC AGCCTTCCAC TATGACATCC TCAAACCCTA TGTCAAAATC 
          M  L  T  P   A  F  H   Y  D  I   L  K  P  Y   V  K  I           158
    501   ATGGCGGACT CTGTCAATAT AATGCTAGAT AAATGGGAGA AGCTTGATGG 
           M  A  D   S  V  N  I   M  L  D   K  W  E   K  L  D  G          175
    551   CCAGGACCAC CCTCTGGAGA TCTTCCACTG TGTTTCATTG ATGACACTGG 
            Q  D  H   P  L  E   I  F  H  C   V  S  L   M  T  L            191
    601   ACACTGTTAT GAAGTGTGCT TTCAGCTACC AAGGCAGTGT TCAGTTGGAT 
          D  T  V  M   K  C  A   F  S  Y   Q  G  S  V   Q  L  D           208
    651   GAAAATTCCA AGTTGTATAC TAAGGCTGTC GAGGATCTAA ACAACCTGAC 
           E  N  S   K  L  Y  T   K  A  V   E  D  L   N  N  L  T          225
    701   TTTCTTTCGC CTGCGGAATG CCTTTTATAA GTACAACATC ATCTACAATA 
            F  F  R   L  R  N   A  F  Y  K   Y  N  I   I  Y  N            241
    751   TGTCCTCTGA TGGACGTTTG TCCCACCATG CCTGCCAGAT TGCTCACGAG 
          M  S  S  D   G  R  L   S  H  H   A  C  Q  I   A  H  E           258
    801   CACACAGATG GAGTGATCAA GATGAGGAAG TCTCAGCTGC AGAATGAGGA 
           H  T  D   G  V  I  K   M  R  K   S  Q  L   Q  N  E  E          275
    851   AGAGCTGCAG AAGGCCAGGA AGAAGAGACA CTTGGATTTC TTGGACATCC 
            E  L  Q   K  A  R   K  K  R  H   L  D  F   L  D  I            291
    901   TCTTGTTTGC CAGAATGGAG GATAGGAACA GCTTGTCTGA TGAGGACCTG 
            L  L  F  A   R  M  E   D  R  N   S  L  S  D   E  D  L         308
    951   CGTGCAGAGG TGGACACATT CATGTTTGAG GGTCATGACA CTACAGCCAG 
            R  A  E   V  D  T  F   M  F  E   G  H  D   T  T  A  S         325
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   1001   TGGAATTTCC TGGATTTTCT ATGCTCTGGC CACCCACCCT GAGCACCAAC 
             G  I  S   W  I  F   Y  A  L  A   T  H  P   E  H  Q           341
   1051   AGAGATGCAG AGAGGAGGTG CAGAGCATTC TGGGTGATGG AACCTCTGTC 
          Q  R  C  R   E  E  V   Q  S  I   L  G  D  G   T  S  V           358
   1101   ACATGGGACC ATCTGGGCCA GATGCCCCTA CACCACCATG TGCATCAAGG 
           T  W  D   H  L  G  Q   M  P  Y   T  T  M   C  I  K  E          375
   1151   AGGCCCTGAG GCTCTATCCA CCAGTAATAT CTGTGAGTGG AGAGCTCAGC 
            A  L  R   L  Y  P   P  V  I  S   V  S  R   E  L  S            391
   1201   TCACCTGTCA CCTTCCCAGA TGGACGCTCC ATACCCAAAG GTATCACAGC 
          S  P  V  T   F  P  D   G  R  S   I  P  K  G   I  T  A           408
   1251   CACAATTTCC ATTTATGGCC TACATCATAA CCCACGTTTC TGGCCAAACC 
           T  I  S   I  Y  G  L   H  H  N   P  R  F   W  P  N  P          425
   1301   CAAAGGTGTT TGACCCCTCT AGATTTGCAC CAGATTCTTC TCACCATAGC 
            K  V  F   D  P  S   R  F  A  P   D  S  S   H  H  S            441
   1351   CATGCTTATC TGCCATTCTC AGGAGGATCA AGGAACTGCA TTGGGAAACA 
          H  A  Y  L   P  F  S   G  G  S   R  N  C  I   G  K  Q           458
   1401   GTTTGCTATG AACGAGCTGA AGGTGGCTGT GGCCCTGACC CTGCTCCGCT 
           F  A  M   N  E  L  K   V  A  V   A  L  T   L  L  R  F          475
   1451   TTGAATTGCT GCCAGATCCC ACCAGGATCC CAGTCCCCAT TGCAAGACTT 
            E  L  L   P  D  P   T  R  I  P   V  P  I   A  R  L            491
   1501   GTGTTGAAGT CCAAGAATGG GATCCACCTG TGTCTCAAGA AGCTAAGATA 
          V  L  K  S   K  N  G   I  H  L   C  L  K  K   L  R  *           508
   1551   ATA
Figure 3.20 Deduced cDNA and amino acid sequence of Cyp4a14.   An ATG triplet (underlined), at position 
+26, denotes the putative start of protein translation.  An enlarged T nucleotide at position 1 denotes the start of 
transcription as determined by primer extension.  Nucleotide numbering is given at the left hand side while peptide 
numbering is given at the right hand side of the figure.  Sequence from exons 6 to 12 are from S. Kuo and D.R. Bell.  
Amino acids are indicated by their single letter codes. ‘*’ refers to the stop codon.
Section 3.2.4.1 Comparison of amino acid sequence of Cyp4a14 
When the genomic sequence of Cyp4a14 was analyzed and compared with the rat CYP4A2 gene
structure, it was found that the Cyp4a14 exon positions were analogous to those in CYP4A2.
The predicted open reading frame for Cyp4a14 was found to encode a protein of 508 amino ac-
ids.  The predicted amino acid sequences encoded by each exon were compared with corre-
sponding amino acid sequences between CYP4A14 and the rat and mouse CYP4A proteins
(Table 3.4).  
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A comparison of the amino acid sequence with other CYP4A genes shows that Cyp4a14 is, on
average, more similar to the rat CYP4A2 / CYP4A3 proteins ( 92 / 93 %), than it is to the mu-
rine Cyp4a10 protein (77%;  Table 3.4).  Additionally, the amino acid sequences, deduced exon
by exon, were compared with corresponding peptide sequences of rat and mouse CYP4A pro-
teins.  From the comparison above, amino acid sequences corresponding to exons 4, 8 and 12
were very highly conserved between CYP4A14 and CYP4A2 and CYP4A3 proteins.  These
same exons were also very highly conserved at the nucleotide level, as shown previously in Table
3.2.  Additionally, deduced amino acid sequence corresponding to the translated exon 3 had a
uniquely high similarity only between CYP4A14 and CYP4A3 proteins.  Thus, in exon 3,
CYP4A14 was significantly more similar to CYP4A3 protein than to the CYP4A2 protein, es-
Exon  / 
Protein
CYP4A1 CYP4A2 CYP4A3 CYP4A8 CYP4A10 CYP4A12
       1        58         87        85        54        61         -
       2        66         85        87        69        59         -
       3        73         75 **   93        73        67         -
       4        91  *     98  *    98        88        91         -
       5        80         95        95        80        80         -
       6        57         82        84        67        63         -
       7        83         94        97        81        86         -
       8        90   *    97  *    97        86        92         95
       9        84         93        93        84        84         89
      10        82         82        86        73        82         68
      11        85         85        85        85        85         85
      12        93   *    95  *    96        95        93         -
Average        79         89        91        78        79         -
Table 3.4 Percent identity of peptide sequences by exon between Cyp4a14 and the rat and mouse 
CYP4A genes. Amino acid sequences were deduced from individual exons of Cyp4a14 and compared with the 
corresponding amino acid sequences in rat and mouse proteins.  “*’ denotes peptide sequence of extremely high 
similarity (95% and over) between CYP4A14 and CYP4A2 and CYP4A3 proteins.  ‘**’ denotes an especially high 
peptide sequence similarity deduced from exon 3, between CYP4A14 and CYP4A3 only.  Only exons 8 to 11 are 
sequenced in Cyp4a12 (Bell et al., 1993).
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pecially at the protein level.  This was due to a distinctive 3 amino acid deletion in CYP4A2, but
not in any other CYP4A protein.
For CYP4A1, CYP4A8 and CYP4A10 proteins, all twelve exons showed relatively low deduced
amino acid sequence similarity with the corresponding exons of CYP4A14, except for exon 12.
Exon 12 was the most highly conserved exon, encoding for a highly conserved cysteine residue
and several others around it, all of which comprise the haem-binding domain which is an essen-
tial feature of all cytochrome P450 proteins.
Section 3.2.5 Distinction between murine CYP4A2 and CYP4A3 homologues
Comparison of the deduced amino acid sequences of Cyp4a14 with the closely related CYP4A2
and CYP4A3 proteins revealed that in exon 3, CYP4A2 can be distinguished from CYP4A3 and
CYP4A14 proteins by a 3 amino acid deletion after amino acid 113 of CYP4A2 but not
CYP4A3 or CYP4A14.  This corresponded to a 9-nucleotide deletion in the cDNA of
CYP4A2, but not in CYP4A3 and CYP4A14 (Figure 3.21).
To examine if any of the λ phage clones isolated were similar to CYP4A2 or CYP4A3 in this
region, DNA was extracted from phage clones which contain exon 3 and spotted onto Hybond
N+ membrane, and after fixing, were hybridized with an oligonucleotide probe spanning a 
CYP4A2 389 ΧΧΑ ΑΑΓ ΧΧΤ             ΤΑΤ
Προ Λψσ Προ             Τψρ
 CYP4A3 343 ΧΧΑ ΑΑΓ ΓΧΤ ΤΧΤ ΓΓΑ ΑΤΤ ΤΑΤ
Προ Λψσ Αλα Σερ Γλψ Ιλε Τψρ  
Cyp4a14 356 ΧΧΑ ΑΑΓ ΓΧΤ ΤΧΤ ΓΓΑ ΑΤΤ ΤΑΤ
Προ Λψσ Αλα Σερ Γλψ Ιλε Τψρ
Figure 3.21 Scheme showing the region in exon 3 where CYP4A2 differs from CYP4A3 and Cyp4a14. 
 Numbers denote the nucleotide positions of the respective sequences in the cDNA.  The deduced amino acid for
each protein is indicated beneath each codon.
corresponding region of deletion in the CYP4A2 homologue.  The oligonucleotide, (5’-ΧΧΑ
ΑΑΓ ΓΧΤ ΤΧΤ ΓΓΑ ΑΤΤ ΤΑΤ-3’), which corresponds to nucleotides 356 to 376 in the Cyp4a14
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cDNA, was used (with the nucleotides in bold the deleted region in CYP4A2 homologues).
CYP4A2 equivalents would lack the nucleotides indicated in bold and would therefore not hy-
bridize to the probe.  As shown in Figure 3.22, all clones hybridized to the oligonucleotide, in-
dicating an identical sequence in this region to the radiolabelled oligonucleotide.  Thus, all the
genomic clones containing exon 3 were identical to CYP4A3 in this region
Section 3.2.6 Conserved regions in Cyp4a14 and non-CYP4 proteins
To better understand the structure/function relationship of P450 proteins, the three-dimensional
structures of CYP101, CYP102 and CYP108 have previously been compared (Ravichandran et
al., 1993).  The authors compared this alignment with other P450 proteins and reported that only
3 residues were absolutely conserved in the P450 superfamily of proteins.  These were the Cys
residue in the haem-binding region and the Glu and Arg residues in the K helix.
As shown in Figure 3.23, which shows an alignment of primary structures of P450 proteins,  sev-
eral common residues are present in all P450 proteins regardless of family.  This agrees with the
observations of Ravichandran and coworkers (1993) in the following ways : A Cys residue at
position 454 of CYP4A14 is absolutely conserved.  Surrounding this cysteine residue in
CYP4A14 in the haem-binding region, Pro446, Phe447 residues and a Gly450 are also common.
Additionally, Glu375 and Arg378 residues are conserved; these correspond to the same residues
in the same helix as assigned by Ravichandran and coworkers (1993) for CYP102 and assigned
by Edwards and coworkers (1989) for CYP2 and CYP17 families.
From Figures 3.23 and 3.24, regions 1 to 6 have previously been proposed to be key substrate
binding areas (substrate recognition regions, SRS) in CYP2 proteins (Gotoh, 1992).  Since then,
extensive work on various CYP2 subfamilies have shown that virtually all residues identified as
critical for the substrate specificity of CYP2 proteins fall within or near the putative SRSs pro-
posed (eg, Straub et al., 1993).  Here, the sites of substrate binding of CYP4A14 were inferred
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from the primary sequence alignment with the CYP2C4 protein.  In site 4,  two threonine res-
idues located at positions 322 and 323 appear to be essential to all P450s with an Asp or Glu just
N-terminal to it, as is a Gly319 residue. 
It has been found preferable to compare secondary structure of proteins as this is often sacrificed
in alignment of primary sequence (Edwards et al., 1989) in favour of primary sequence homolo-
gy.  Thus, hydropathy plots of CYP2C4 and CYP4A14 were compared with each other to assess
the accuracy of the assignments of the SRSs in CYP4A14 (Figure 3.24).  CYP4A14 possesses a
slightly longer N-terminal tail, but the hydropathy profile matched well generally with that of
λ χλονεσ
13
14
15
16
17
18
19
20
21
22
23
24
25
λ χλονεσ
+
−
26
27
ΧΟΝΤΡΟΛΣ
Figure 3.22 Dot hybridization of λ clones to detect a 3 amino acid deletion.   λ clones were dot-blot-
ted, in duplicate, onto Hybond N+ membrane, and hybridized with a radiolabelled oligonucleotide, 5∏−ΧΧΑ ΑΑΓ
ΓΧΤ ΤΧΤ ΓΓΑ ΑΤΤ ΤΑΤ−3’ (which corresponds to nucleotides 356 to 376 in the Cyp4a14 cDNA), overnight at
60oC and was then rinsed in 2X SSC at room temperature.  The membrane was then washed twice in TMACl Wash-
ing Buffer at 60oC according to the method of Dilella and Woo (1987) before exposing to autoradiographic film at
-80oC for 24 hours.  The middle 9 bp of this oligonucleotide (in bold) are absent in the corresponding region in exon
3 of CYP4A2 but not in CYP4A3 and Cyp4a14.  λ clones are indicated on the sides of the figure.  Positive control
used λ 12 while negative control used λ 4 which lacks exon 3.  λ clones 14, 24 and 25 were false positives ob-
tained during the library screen while λ 13 was previously shown to be similar to λ 4.
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CYP2C4.  It has been proposed that the α-helical domains of the cytochrome P450 families are
Figure 3.23 Alignment of cytochrome P450 proteins by primary sequence similarity. Deduced amino
acid sequences were aligned using PILEUP and highlighted using BOXSHADE programmes.  Identical residues have
a black background and white text, conserved residues have a dark grey background, and similar residues have a
light grey background; a dot represents a space introduced into the alignment. Substrate recognition sites (SRS) have
been proposed (Gotoh, 1992) and similar regions are deduced in CYP4A14 by reference to  CYP2C4.  These regions
are enclosed in a dashed box labelled (1 to 6).  A single arrowhead points to the conserved Cysteine residue in the
haem-binding domain at position 454 in CYP4A14.  CYP2C4 (2c4), CYP3A4 (3a4), CYP4A14 (4a14), CYP17A (17)
and CYP102 (102) residue positions are indicated to the right of the alignment.
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well conserved, including the CYP2 family (Edwards et al., 1989). This comparison suggests that
this is the case, and extends previous data suggesting that the three-dimensional structure of cy-
tochrome P450 proteins is fairly well conserved and this is applicable to CYP4A14.
Section 3.2.7 Putative substrate binding regions of Cyp4a14  
As shown in Figure 3.23, putative substrate recognition sites  (SRS) of CYP4A14 were inferred
by first aligning its deduced primary amino acid sequence with that of CYP2C4. Hydropathy
plots of CYP2C4 and CYP4A14 matched each other well (Figure 3.24), and the SRS positions
tentatively assigned in CYP4A14 appear to be in a similar three-dimensional environment to
those in CYP2C4.  Thus, taken together with the primary sequence alignments, it is likely that
these regions in CYP4A14 could have a similar role in substrate recognition.  But, differences
between the two proteins also exist - most notably, in site 4, where CYP2C4 is much more hy-
drophobic than CYP4A14, and the N-terminal end of site 1 in CYP2C4 is distinctly more hy-
drophobic than in CYP4A14.  These differences in hydrophobicity are not surprising since
CYP2 and CYP4 proteins have different substrate requirements.  Thus, sites 1 and 4 could play
a role in the substrate specificities of the two proteins.
Section 3.2.8  Sequence alignment of Cyp4a14 and other CYP4 proteins
A comparison of the peptide sequence of CYP4A14 with all vertebrate members of the CYP4
family is shown in Figure 3.25.    This alignment indicates there are many stretches of amino acids
which are very similar in CYP4 proteins, especially in and around the six tentatively assigned sites
1-6.  In site 1, motif PWIGYGLLLL is absolutely conserved in the CYP4A proteins and re-
mained highly similar in the CYP4B, CYP4F, CYP4C and CYP4D subfamilies.  From Figures
3.23 and 3.24, this region was highly divergent between the families.  This specific region might
play a role in the different substrate specificities of different families of P450 enzymes.  Just C-
terminal to site 1 is another motif that is highly conserved in CYP4 proteins and previously un-
reported.  This motif, HR RMLLTPGFHYDIL, is located between residue positions 139 to 152
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and encoded by exon 4 in CYP4A14.  As noted, exon 4 is one of several exons highly conserved
at the nucleotide level in CYP4A proteins.  In substrate recognition site 4, a 16 amino acid motif,
Figure 3.24 Hydropathy profiles of CYP2C4 (A) and Cyp4a14 (B) proteins obtained with the parame-
ters of Kyte and Doolittle (1982). (A)  Regions 1 to 6 are putative substrate recognition sites (SRS) identified
by Gotoh (1992) in CYP2C4.  (B)  Regions 1 to 6 are putative substrate binding sites inferred from primary sequence
homology with CYP2C4 obtained in Figure 31.  SRS 1 to 6 are boxed with dashed lines, while the haem binding
domain, which contains a conserved cysteine residue common to all P450 proteins is boxed with longdash lines.  
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Figure 3.26 Alignment of CYP4 proteins by primary sequence similarity. Deduced amino acid sequenc-
es were aligned using PILEUP and highlighted using BOXSHADE.  Regions enclosed in a dashed box denote puta-
tive substrate binding sites (1 to 6) and were inferred by aligning CYP4A14 with the published substrate recognition
sites (SRS) of CYP2C4 as deduced by Gotoh (1992).  Double arrow heads indicate regions where CYP4A and
CYP4B primary protein sequences differed from CYP4F.  A single arrowhead points to the conserved Cysteine res-
idue at position 454 in CYP4A14.  A bold bar indicates the region of a 3 amino acid deletion in CYP4A2 but not in
CYP4A3.  Protein sequences of  YP4A14 (indicated by “4a14”) , CYP4B1 (4b1), CYP4F1 (4f1) to CYP4F6 (4f6),
CYP4C1 (4c1) and CYP4D1 (4d1) to CYP4D2 (4d2) are indicated to the left of the alignment.  Prefixes m, r, h, c
and dm denote rabbit, human, cockroach and Drosophila proteins respectively.  
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LRAEVDTFMFEGHDTT, was most notably non-divergent between CYP4A and CYP4B
proteins.  From Figure 3.23, the motif (E/D)TT within this sequence was conserved in all P450
proteins.  This region is thought to play a role in oxygen activation and would thus be a key
requirement in all P450 enzymes (Raag et al., 1989; Raag et al., 1991).  In  the haem-binding
region, the motif RNCIG appears to be highly conserved in the CYP4 protein and in non-
CYP4 proteins (in Figure 3.23).  Indeed, this region has been proposed to be a signature for the
cytochrome P450 superfamily (Gonzalez, 1989).
CYP4A2 and CYP4A3 are very similar to each other but can be distinguished between each oth-
er by a 3 amino acid deletion in CYP4A2 but not in CYP4A3, indicated by a bold bar.This de-
letion, indeed was not present in any other CYP4 proteins and is thus unique to CYP4A2.
There are  several regions in the protein sequences, as indicated, where CYP4A and CYP4B pro-
teins differ from CYP4F proteins, either through insertions or deletions of 2 to 5 residues.  In-
deed, phylogenetic analysis of the CYP4 proteins suggest that CYP4A proteins are more similar
to the CYP4B proteins than to the CYP4F proteins and vice versa (Figure 3.27). 
Section 3.2.9 Phylogenetic analysis of Cyp4a14 
Human, mouse and rat proteins of CYP4A, CYP4B and CYP4F subfamilies and the invertebrate
CYP4C and CYP4D proteins were aligned and analyzed using CLUSTALW, which utilizes the
Neighbour-Joining Method of Saitou and Nei (1987).  The rat CYP2C4 was used as the out-
group, a sequence that was distinct from all the other proteins and should branch to the outside
of the tree.  From Figure 3.27, it appears that CYP4A, CYP4B and CYP4F proteins form three
distinct clusters.  Within the CYP4A cluster, CYP4A14 is most related to  CYP4A2 / CYP4A3
proteins while CYP4A1 is most similar to the CYP4A10.  In the CYP4B cluster, mouse
CYP4B1 and rat CYP4B1 are more similar to each other than to the human CYP4B1.  In the
CYP4F cluster, the rat proteins are also quite distinct from the human proteins.  Again, as already
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noted from the primary sequence comparisons, the CYP4A and CYP4B  subfamilies appear to
be more similar to each other than to the CYP4F subfamily.
The CYP4A, CYP4B and CYP4F families consistently form 3 separate clusters in other methods
of analysis like PHYLIP and with CLUSTALW these clusters were shown to be absolutely con-
sistent by BOOTSTRAP analysis (not shown), of Felstenstein (1985).  However, the inverte-
brate CYP4 proteins, CYP4C1, CYP4D1 and CYP4D2 were less confidently placed here and
in various other methods of phylogenetic analyses (not shown).  In Figure 3.27, these proteins
have been placed more distant to the mammalian CYP4 proteins than the designated ‘outgroup’
CYP2C4, which was expected to be the most distant member.  Using PHYLIP and PROT-
PARS, these invertebrate CYP4 proteins were placed more closely with the mammalian CYP4
Figure 3.27 Phylogenetic analysis of CYP4 proteins. CYP4 deduced amino sequences were  aligned and
analyzed by CLUSTALW using the Neighbour-Joining Method (Saitou and Nei, 1987) with CYP2C4 as the outgroup..
‘h’, ‘m’ and ‘r’ denote human, mouse and rat CYP4B1 proteins respectively.
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proteins, leaving the outgroup most distant in the trees which is the ‘expected’ outcome (not
shown).  Therefore, these analyses show that there is no single method of analysis that is ‘correct’,
and that distantly related CYP4 proteins like the mammalian and invertebrate CYP4 proteins
may be less confidently placed relatively to each other in a phylogenetic tree.
Section 3.3 Cloning of Cyp4a12
Section 3.3.1 λ clone 16
λ 16, a gift from D.R. Bell, was the second genomic clone isolated when the genomic library
was first screened with riboprobes transcribed from Cyp4a10 and Cyp4a12 cDNA clones (D.R.
Bell).  In order to map the phage clone, large scale DNA was extracted from λ 16 and was re-
striction digested with Xba I (which releases the genomic DNA from the vector arms), singly and
in a double digest with Bam HI, and blotted onto Hybond N+ membrane and hybridized to the
rat partial CYP4A1 cDNA riboprobe pIV2. (Fig 3.28).
Section 3.3.2 Subcloning and sequencing of  λ 16
DNA was prepared by the large scale method from phage λ 16 and restriction digested with Xba
I enzyme.  Before ligation, an aliquot of the restriction digest was run out on a 0.6 % agarose gel
to make sure the restriction digest was to completion.  All Xba I fragments were subcloned into
pGEM7 by ligation overnight at 4 oC.  Selection for clones was as described in Materials and
Methods.  To prepare for automated sequencing, the 6.5 kb and 3 kb Xba I subclones were pu-
rified by the protocol supplied by Qiagen and sequenced by oligonucleotide-directed automated
sequencing.
Sequence analysis of the 6.5 kb and 3 kb Xba I fragments showed exons 10, 11 and 12 were con-
tained in these two subclones (done by Sharon Kuo).  To identify the gene represented by this
λ clone, the sequences of the exon regions were analyzed in detail : the high sequence similarity
with the published rat CYP4A8 cDNA sequence (Stromstedt et al., 1990) indicated that λ 16 was
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a genomic clone of the murine Cyp4a12 gene, the mouse homologue of the CYP4A8.  A map
of λ 16 is shown in Figure 3.29). 
Section 3.3.3 Strategy for the rescreening of the genomic library
Cyp4a12 gene expression has been shown in this laboratory to be regulated in a male-specific
fashion, with high level expression in male liver and kidney and low levels in females (Bell et al.,
1993; Heng et al., 1997).  It would thus be interesting to examine the regulation of this gene by
Λανεσ 1 2 3
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Figure 3.28 Mapping of  λ 16 clone by restriction digest (A) and Southern hybridization (B). Large
scale phage DNA was extracted as described in Materials and Methods, restriction digested and run on a 0.7% aga-
rose gel to separate the fragments.  To identify the fragments which hybridize to the rat CYP4A1 partial cDNA ribo-
probe pIV2 (corresponding to nucleotide 900 to end), gel was transferred onto Hybond N+ membrane as described
and hybridized overnight with the riboprobe at 65oC in 40mM sodium phosphate (pH 7.2) containing 1% BSA, 7%
SDS and 1mM EDTA.  Membrane was then washed three times in 40mM sodium phosphate buffer (pH 7.2) contain-
ing 0.1% SDS at 65oC before exposing the membrane on X-ray fim at -80oC for 48 hours.  Lane 1 : Xba I digest,
Lane 2 : Xba I + Bam HI digest, Lane 3 : Eco RI + Bam HI digest.  Arrows indicate the two Xba I fragments which
hybridized to the riboprobe. 
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studying the promoter region of the gene in detail.  The intention was then to screen the ge-
nomic library to obtain an overlapping phage clone that would contain the 5’ flanking region of
Cyp4a12.
λ 16:4 was chosen as the Cyp4a12 subclone to be used for riboprobe synthesis for the following
reason : from the sequence analysis, this subclone was found to be the most 5’ clone of λ 16 as it
contained the T3 promoter sequence from the left λ vector arm, followed by exon 10 and then
exon 11 further downstream.  The intron preceding exon 10 was only sequenced on the top
strand so as to ‘walk’ to exon 10 (about 2kb away). However, for the purposes of designing a
riboprobe for library screening, only 500 bp of Cyp4a12 intron sequence immediately 3’ of the
T3 sequence in λ 16:4 were fully sequenced.
Sequence analysis of this 500bp region of λ 16:4 against the databases at EMBL by the FASTA
programme of Pearson and Lipman (1988), revealed this stretch of nucleotides contained repet-
itive sequences, with up to 90 % identity in a 460 bp overlap with the mouse L1Md-9 repetitive
Ριγητ
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Figure 3.29 Map of the λ 16 clone.  Genomic DNA, indicated by a thick, bold line, was mapped with Xba I and
subcloned into pGEM7 vector.  λ 16 Xba I subclones λ 16:4, λ 16:1 and λ 16:2 are indicated beneath the phage
map.  Only the Xba I, Not I and Sac I sites within the polylinker of the left arm (20kb) and right arm (9kb) are indi-
cated.  The arrowheads indicate the position of the T7 (right arm) and T3 (left arm) bacteriophage promoters.  X :
Xba I, N : Not I, S : Sac I.  The 5’ end of the gene is on the left hand side of the diagram.  The vector arms are not
drawn to scale.
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sequence, for example.  This meant that a 500bp riboprobe derived from this region of λ 16:4
would hybridize with many other unrelated genes which might have such a repetitive sequence.
In fact, the genomic library was screened with a riboprobe transcribed from this region and an
inappropriately high number of clones  (at least 800) was identified in a primary screen.   This
probe was thus not suitable for screening the library to isolate Cyp4a12 clones. 
Section 3.4 Cloning of Cyp4a10
Section 3.4.1 PCR Cloning
Cloning of the promoter region of Cyp4a10 was undertaken using Clontech’s PromoterFinder
DNA Walking Kit.  Primary PCR was performed using an adaptor specific primer AP1 (top
strand, 5’-ΓΤΑ ΑΤΑ ΧΓΑ ΧΤΧ ΑΧΤ ΑΤΑ ΓΓΓ Χ-3’), supplied by Clontech, and a gene-specific
primer GSP1 (bottom strand, 5’-ΓΧΑ ΓΧΑ ΓΓΑ ΓΧΑ ΓΑΧ ΧΓΑ ΓΧΑ ΧΑΓ Α-3’) derived from exon
1 of the published Cyp4a10 sequence (Henderson et al., 1990), corresponding to nucleotide po-
sitions 100 to 75.  After running out a tenth of the total volume on a 2% agarose gel to visualize
the amplified fragments (not shown), all five PCR reactions and the positive and negative control
reactions were then diluted 1 in 20 in UHP water and subjected to secondary PCR confirmation
using a Clontech-supplied, nested adaptor specific primer AP2 (top strand, 5’-ΑΧΤ ΑΤΑ ΓΓΓ ΧΑΧ
ΓΧΓ ΤΓΓ Τ-3’) and gene-specific primer GSP2 (bottom strand, 5’-ΓΓΓ ΤΤΓ ΓΓΧ ΤΤΑ ΓΑΓ ΧΑΓ
ΑΓΑ ΧΑΧ ΤΧ-3’) which corresponds to nucleotide positions 37 to 12 of the Cyp4a10 cDNA.
Both primary and secondary PCR reactions were performed at the specified annealing and ex-
tension temperature of 67 oC.  The secondary PCR reaction, which confirmed products ob-
tained from the primary PCR with a second, upstream PCR primer belonging to Cyp4a10, were
run on a 1.2% agarose gel (Fig 3.30) and the longest PCR product, a 1.4 kb fragment was chosen
for further analysis.  The fragment was then excised from the gel, purified using the gene-clean
method and cloned into pGEM-T, designated pGT14 and sequenced.
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Section 3.4.2 Sequence analysis 
The PCR clone, named pGT14, containing 1.4 kb of the 5’ flanking region of Cyp4a10,  was
sequenced completely by automated fluorescent sequencing.  BESTFIT analysis of the DNA se-
quence of pGT14 revealed highest sequence identity with the rat CYP4A1 and was entirely dis-
tinct from the other CYP4A genes in this region, including Cyp4a14, consistent with the fact
that Cyp4a10 is the  murine homologue of CYP4A1.  The pGT14 and the corresponding region
in CYP4A1 show 86 % identity with each other.   Sequence analysis of pGT14 also demonstrated
the presence of a 19 bp element and a GATTTA box upstream of exon 1 (Fig 3.31).  Both motifs
are highly conserved in CYP4A1 and CYP4A2 genes (Kimura et al., 1989a).  PPREs comprise
Figure 3.30 Identification of Cyp4a10 secondary PCR products. Primary PCR reactions from all five librar-
ies were diluted 1 in 20 and subjected to secondary PCR confirmation of bands as detailed in Materials and Meth-
ods.  5µl of the 50µl secondary PCR reaction volume were run on a 1.2% agarose gel.  The arrow points to a 1.4 kb
PCR fragment identified in Lane 2.  This fragment was then gel-excised and cloned into pGEM-T vector and named
pGT14.  Secondary PCR reaction used gene-specific primer GSP 2 (bottom strand, 5’-ΓΓΧ ΤΤΓ ΓΓΧ ΤΤΑ ΓΑΓ ΧΑΓ
ΑΓΑ ΧΑΧ ΤΧ-3’), corresponding to positions 37 to 12 of the Cyp4a10 cDNA, and Adaptor primer AP2 (top strand,
5’-ΑΧΤ ΑΤΑ ΓΓΓ ΧΑΧ ΓΧΓ ΤΓΓ Τ-3’) according to the protocol at the recommended annealing/extension tem-
perature of 67oC.  Broken arrows point to two sized fragments in the ladder.  Lane 1: kb ladder; Lane 2 : EcoR V
library; Lane 3 :  Sca I library; Lane 4 : Dra I library; Lane 5 : Pvu II library; Lane 6 : Ssp I library.  Positive control
(performed with the Dra I library with positive control primers and produced the expected size) and negative control
reactions are not shown on this diagram.
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a AGGTCA direct repeat spaced by one nucleotide, which have been implicated in the transcrip-
tional activity of a CYP4A gene (eg. Aldridge et al., 1995).  No such binding site exists for the
Cyp4a10 in this part of the 5’ flanking region.  However, other putative binding sites are located
for transcription factors like Sp1 and C/EBP.  
                                                     −1400
          ACTATAGGGC ACGCGTGGTC GTTTGAATAT GCTTGGCCCA GGGAGTGGCA 
                      Sp1        C/EBP
          CTATTTGGAG GCGTGGCCTT GTTGCAAGAA CTGTGCCACT GTGGGCATGG 
                                                       -1300
          TCTTTATGAC CCTCATCCTA CCTTCCCTAG AAGCCAGTGT TCTCCTATTT 
                                                             Sp1
          GCCTTCAGAA CAAGATGTTG AACTCTCAGC TCCTCCTGTA CCATGCCTGC 
                                                       -1200 
          CCAGATGCTG CCATGTTCCC TCCTTGATGA TAATGGACTG AACCTATTAA 
          ATTTTGTTCT TTTACAAGTT GCCTTGGTCA TGGTATTTGT TCACAGCAGT 
                                                        -1100
          AAAACCCTAA ATAAGAAAAG CTATGTAGCT GAATAATAGC TGAAGCTTTC 
          TAGTAGTTAT TGAGAAATAA CATGGGCAAC CCAAGTACAG TAAATTAAAG 
           Sp1                                         -1000
          GGCCCCATTT AGATTCAATT GATTTGGTCC TGTTGGAGAC ACACTATATA 
          AAAGCTCTCA CAAGTCCAAG ACAATAATTC TAAAACCAAG AGAAGTATGT 
                                                        -900
          CAAGTCCTAT ATAAGCAAGG CCTTGGTAGA CTAACAGTAG ATTCCACAGC 
          AGAAACTTTT CAAACATGGA TTAAACTCTC CAAGTAAAAG AGTTAAATTG 
                                       c-Myc            -800
          GCTGAATAGA TTTTTTTAAT GAAATTCAAC TGTAGGCTTC TACAGAAAAA 
          AAAAAACCCA CAAGAAGGTG CCGAGGAATG GAAAGAAACC CATTAGCTCC 
                                                        -700
          CCCAAAGCAA AACAAGCACA AGAACCTTTG GCACCCCCAG GCATGGACTG 
          CCCATGAGAC TGGCCTACCT AGATGGATAA GAGCAGCAGT GCCTAGATGT 
                                                        -600
          TCTCCAGTCT GAATCGGCAA CCACTCACCA TCCATTTGGC ATGGACAATT 
                                                         AP1
          CAAAAAACTA TTAGATACTG GATCTGCCAT GGAAACCCAA GTAACTCACA 
                                 Sp 1                   -500
          AAAACAACAA ATAAAGCTAT GGGGCCTGAG AAAGAGCCAG TTTGTGAGGA 
                                           TFIID
          TCCCCATATC ACACAGGACT TCAACAAGAT ATTTATTTTT ATATGACAAC 
                                                        -400
          CTTGTTTGAT GTTTAATAAT TTAATAAAAC TTTGCAAGAA AAGATTAAAA 
          ATAAGTGGAT GAATATTTAA GGAGATTATA ATTGTTCTGC TTAATTTATG 
                                                        -300
          CGTGCAGTAC CCAGGTGTTG AAATATCACA CTACATCGAT AAGTGTAGAC 
          AGCGAATACA ATGAAAAGGA AAATAAAAGG GAAACAACTC AATGCTCTTG 
                                    Sp1                 -200
          ACTCGCACAA CGAAAAGGAA AGTGGGCAGA GGTAGGCACT GACAGCTGGA 
          AAAAAAAATG TTGTCACTGA TTTTTCAAGG GTTAATGATT CCTGTTTATT 
                         1/2 GR                         -100
          TATATTTAAC CAACTGAACT ATGAGATCAA GATTGGTCAG CCTCACCCTT 
             Sp 1
         CTCCCTCCCA CAGGTAGGCG GGCAATCCTT ACAGGGATTT AGGCAGGAGG 
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                +1
          TAGAAAGGAT TATTGAAGAG TGAGGACCTC AACAAAGGTG AACTAT(G)
Figure 3.31 Sequence of the Cyp4a10 5’ flanking region. DNA was cloned by PCR using Nucleotide sequence
from the Cyp4a10 clone, pGT14, was analyzed for putative transcription factor binding sites by utilizing the Transcrip-
tion Element Search Software (TESS) using the Transfac database on the WWW.  Putative transcription factor binding
sites are overlined.  The putative start of protein translation begins at the single-underlined ATG triplet (Henderson et
al., 1990), , denoted by +1.  The conserved 19bp element (indicated in bold) and the GATTTA box  (double underlined)
are located 94 and 59 nucleotides upstream of the start of translation respectively
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Chapter 4 DISCUSSION
The cytochrome P450 4A subfamily (CYP4A) was originally discovered as fatty acid ω-hydrox-
ylating enzymes which are induced by peroxisome proliferating chemicals in the rat (Gibson et
al., 1982; Hardwick et al., 1987). These proteins are rapidly induced and are now believed to be
crucial for peroxisome proliferation in rat liver (eg Kaikaus et al., 1993). Besides being involved
in peroxisome proliferator-induced hepatocarcinogenesis, CYP4A proteins are also believed to
be important in normal lipid and eicosanoid metabolism and the regulation of renal function.
To date, thirteen CYP4A members are listed (Nelson et al., 1996). Four genes have already been
identified in the rat : CYP4A1 and CYP4A2 are cloned as genomic sequences (Kimura et
al.,1989a), while CYP4A3 (Kimura et al., 1989b) and CYP4A8 (Stromstedt et al., 1990) are
cDNA clones identified. While a great deal is known about the rat and rabbit CYP4A genes,
relatively little is understood about the Cyp4a genes in the mouse. To date, only two cDNA
clones have been isolated : Cyp4a10 (Bell et al., 1993; Henderson et al., 1994) and Cyp4a12 (Bell
et al.,1993). It is also not known if other members of this subfamily exist in the mouse. Thus, this
genomic cloning project was undertaken to study the Cyp4a gene subfamily in detail in the
mouse and, as a prelude to future gene-targetting studies, to take advantage of the widely utilized
techniques in murine genetic manipulation.
For cloning the genomic Cyp4a10, two separate gene-specific primers derived from exon 1 of
the published cDNA sequence of Cyp4a10 (Henderson et al., 1994) were used in a genomic
PCR walking strategy to identify and confirm Cyp4a10 genomic fragments. After secondary
PCR reaction, various genomic fragments were isolated (Figure 3.30). However, only the long-
est DNA fragment, a 1.4 kb fragment was chosen for cloning and analysis. This fragment was
amplified in the first PCR and it was then important, for it to be confirmed by re-amplification
in secondary PCR using another primer derived from the sequence of Cyp4a10. The 3' end of
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this PCR clone, designated pGT14, shared an identical nucleotide sequence with the 5' end of
the cDNA sequence of Cyp4a10. Additionally, pGT14 showed very high identity with the cor-
responding region in its homologue, the rat CYP4A1 (86%) but not with any other CYP4A
gene. These observations were essential to demonstrate that pGT14 is part of Cyp4a10 and con-
tains the 5' flanking region of the gene.
When a mouse genomic library was screened using riboprobes transcribed from the Cyp4a10 and
Cyp4a12 cDNA of Bell and coworkers (1993), two independent and distinct phage clones were
initially isolated. One, λ clone 16, was found to be a genomic clone representative of the 3' half
of Cyp4a12 (Figure 3.28) : only regions corresponding to exons 10, 11 and 12 were sequenced
and these coding regions were identical in sequence to the corresponding regions of the report-
edcDNA sequence of Cyp4a12 (Bell et al., 1993).
In order to obtain genomic clones spanning the whole of Cyp4a12, the genomic library had to
berescreened for a clone that covered the 5' region of the gene. However, this was unsuccessful
due to the following reason. Initially, only 500bp of genomic sequence on the 5' most end of λ
16 was sequenced to be used as a probe for the hybridization. Unfortunately, this region was
found to contain repeated sequences and when compared against the databases, was highly ho-
mologous to many other genes containing such a repetitive sequence. This meant that a probe
derived from this sequence would hybridize with many other irrelevant genomic sequences. In-
deed, a hybridization experiment using this sequence as a riboprobe confirmed this suspicion; an-
inappropriately high number of positive clones was identified in the genomic library. Therefore,
under the circumstances, the 5' half of Cyp4a12 was not isolated from the library. Instead, atten-
tion was turned to the other clone isolated from the genomic library.
The second phage clone isolated from the original library screen, λ clone 4, was distinct from the
existing murine Cyp4a genes and thus represented the 3' half of an entirely novel murineCyp4a
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member (Figures 3.3 & 3.15). A riboprobe was derived from the 5' most subclone of λ 4, and
used to re-screen the library in order to obtain the whole of the gene. λ clone 12 was subsequent-
ly isolated which was found to contain exon 1 of this novel Cyp4a gene (Figures 3.9& 3.15). This
novel gene has since been designated Cyp4a14. This genomic cloning project has therefore iden-
tified a third and previously unknown member of the murine Cyp4a subfamily. 
Cyp4a14 expression was found to be very highly induced by peroxisome proliferating chemicals
(Heng et al., 1997). In order to determine if any unique protein binding sites are located in the
promoter region of Cyp4a14 which could play a role in the high inducibility of this gene, an
attempt was made to "walk" further upstream of the gene by rescreening the library. The re-
screening of the library was performed using a riboprobe derived from λ clone 12 and containing
exon 1 of Cyp4a14. Unfortunately, all clones isolated and characterized were identical to λ clone
12 and no new clones were isolated. This could be due to poor representation of the promoter
region of Cyp4a14 in the genomic library. 
In order to get around this problem, a PCR-based approach was then undertaken : a primer was
derived from the exon 1 sequence of Cyp4a14, and was used for primary PCR, together with
an adaptor-specific primer supplied. After confirmation by secondary PCR reaction, this time
using a second gene-specific primer upstream of the first primer and within the untranslated re-
gion of exon 1 of Cyp4a14, and a second, nested adaptor-specific primer. The longest PCR
product, a 1.2 kb genomic fragment was then cloned, designated pGT12 and analyzed (Figure
3.10). This fragment was confirmed to be the 5' flanking region of Cyp4a14 as it was amplifiable
using two different primers which were specific for the gene. Also, analysis of the nucleotide se-
quences of the junction sequence between the pGT12 clone and λ clone 12 revealed that the
sequence was identical; this sequence analysis was essential to prove that the two clones belonged
to and were contiguous on the Cyp4a14 gene. A further 3.2kb of sequence, immediately 5' of
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the 1.2kb PCRfragment has been amplified and cloned (Figure 3.11). This was done using two
separate gene-specific primers derived from the the 1.2kb PCR fragment, the product of the first
PCR "walk". This clone has not been completely sequenced, but preliminary sequence data of
this clone showed that it shares the same sequence junction with the 1.2 kb fragment. As further
proof that this clone is contiguous and further upstream of the 1.2kb clone, PCR has been per-
formed across this junction and a fragment of expected size between the PCR primers has been
detected on a gel(Figure 3.12).
Section 4.1 Cyp4a genomic structure
The Cyp4a14 gene contains 12 exons and has a similar exon/intron structure as the rat CYP4A2
gene. To map the transcription start site of Cyp4a14, primer extension experiments were per-
formed. Although initial data showed two primer-extended products (Figure 3.13), a separate
mapping experiment using a second primer was key in establishing that Cyp4a14, in fact, only
had a single transcription start site (Figure 3.14); this was mapped to a T nucleotide, located at a
similar distance from the putative start of protein translation as the rat CYP4A2 gene (Figure
3.17). 
Cyp4a14 is highly similar to the rat CYP4A2 and CYP4A3 genes. It shares 92 % and 93% identity
at the cDNA level (Table 3.2) and 89% and 91% identity at the peptide level (Table 3.4) to
CYP4A2 and CYP4A3 respectively. Thus, Cyp4a14 is slightly more similar to CYP4A3 than to
CYP4A2. This is further suggested by the presence of a 3-amino acid deletion in exon 3 in
CYP4A2 but not in CYP4A3 or CYP4A14 proteins (Figure 3.21). As this corresponds to a 9
nucleotide deletion in the cDNA, an attempt was made to examine if all the λ clones isolated
that contained exon 3 lacked this deletion or not; in other words, is there a murine clone that
would be more similar to CYP4A2 than to CYP4A3? An oligonucleotide spanning this 9bp de-
letion was radiolabelled and used in a hybridization experiment with all λ clones containing exon
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3, such that clones that did not hybridize to the probe would contain this 9bp deletion and would
thus be more CYP4A2-like. The result of this experiment demonstrated that all clones hybrid-
ized to the probe and that they were all more similar to CYP4A3, that is, they were all Cyp4a14
clones (Figure3.22).
The implications of this simple hybridization experiment were that no murine homologue for
the rat CYP4A2 gene was identified : there are only three Cyp4a genes in the mouse but the rat
possesses four members in the CYP4A subfamily. The cloning of Cyp4a14, the third and last
Cyp4a member in the mouse is crucial to enable in-depth analyses of the entire Cyp4a gene sub-
family, including aspects of its evolution, enzyme activity, transcriptional regulation and physical
structure.
The rat CYP4A2 and CYP4A3 are themselves very similar to each other (97% amino acid iden-
tity), it is therefore likely that the gene duplication event in the rat giving rise to CYP4A2 must
have occurred after the formation of the rat and mouse lineages. In addition, the three mouse
genes (Cyp4a10, Cyp4a12 and Cyp4a14) are highly similar to the rat genes (CYP4A1, CYP4A8
and CYP4A3) respectively, these three genes must have existed before the speciation of the rat
and mouse.
The promoter regions of Cyp4a10 and Cyp4a14 have been cloned and analyzed in detail. Like
other CYP4A genes, both Cyp4a10 and Cyp4a14 do not contain a TATA consensus sequence
in their promoters. However, a 19bp element is present in both genes. This motif is highly con-
served also in the rat CYP4A1 and CYP4A2 genes (Kimura et al., 1989a). The promoter region
of Cyp4a10 is highly similar to the rat CYP4A1 gene but not to the other Cyp4a genes. Cyp4a14
is highly similar to CYP4A2, in the intron region and even in the 5' flanking region, showing up
to 84% similarity, but not with CYP4A1. However, this high similarity withCYP4A2 is dramat-
ically reduced about 350bp upstream of the start of transcription (Figure 3.19). Interestingly, this
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region is close to the position of two 358bp direct repeats which run from -440to -817 in the
CYP4A2 gene (Kimura et al., 1989a). 
The presence of repetitive sequences in mammalian genomes is well known, although their role-
sare not completely understood. The Alu family of repeats, for example, is a major family of re-
peats in human DNA (Schmid and Jelinek, 1982). These sequences are interspersed throughout
the human genome by insertion into unoccupied DNA sequences (Van Arsdell et al., 1981). Itis
currently believed the large number of Alu repeats inserted in gene regions could have been ma-
jor sources of variation during primate evolution. Indeed, an example of this is the human adult
α-globin-like gene region (Hess et al., 1983). These researchers studied the extensive sequence
homology between the flanking regions of the two human adult α-globin-like genes, α2 and α1,
which are interrupted by regions of nonhomology; one 1kb region 5' to the α2-globin gene and
a 0.5kb and 0.2kb region 5' to the α1-globin gene. Interestingly, these regions and sequences
around them contain Alu family repeats. Thus, this insertion of repetitive sequences may con-
tribute to the diversity between duplicate genes and their flanking regions. In the mouse,insertion
of repeated DNA elements is also not unknown. An example of this is the insertion of the LINE
(long interspersed) repeated DNA (which are also present in the rat CYP4A2 gene; Kimura et
al., 1989a) in the intron of a member of the mouse Proline-rich Protein family of genes (Ann et
al., 1988). 
The role of repeated sequences present in CYP4A2 (but not in Cyp4a14) remains to be eluci-
dated. Characterizing the genomic structure of the rat CYP4A3 would be of interest since it is
more similar to the mouse Cyp4a14, to see if repeated elements also exist. Both the rat CYP4A3
and the mouse Cyp4a14 are not sexually differentiated, (nor are the murine Cyp4a10 and the rat
CYP4A1 which also lack these direct repeats), but the CYP4A2 is male-specific (Sundseth and
Waxman, 1992; Heng et al., 1997). It would thus be interesting to see if the insertion of this re-
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peated sequence after duplication from CYP4A3, could have altered the CYP4A2 locus, and thus
alter the regulation of this gene.
The individual exon sequences of Cyp4a14 share consistently high similarity with corresponding
exon regions in CYP4A2 and CYP4A3. Exons 4, 8, 11 and 12, in particular, show outstandingly
high nucleotide similarity of up to 98 % (Table 3.2). Correspondingly, the amino acids encoded
by these exon sequences are up to 98% identical between CYP4A14 and CYP4A2/CYP4A3
(Table 3.4). Due to their unusually high conservation, these exons might encode functionally-
important regions of the protein.
Introns, on the other hand, are subject to less functional constraint and consequently less preser-
vation of the nucleotide sequences is expected to occur during evolution (Van Den Berg et al.,
1978). Nevertheless, it has previously been noted that certain introns can be relatively more con-
served than others within a gene. Nakajima-Iijima and coworkers (1985) observed that the nu-
cleotide sequences of intron 3 of the β-actin genes were unexpectedly homologous between
human and rat, with up to 89% similarity while other introns only showed 40-59% similarity.
This observation was not repeated between other species. It was thus speculated that this homol-
ogy might contribute to the expression and regulation of the gene specific to mammalian cells,
because between human and chicken, this intron was interestingly the most divergent intron in
the β-actin gene (less than 39% similarity; Nakajima-Iijima et al.,1985). When the intron se-
quences surrounding the conserved exons were analyzed for any possible conservation between
Cyp4a14 and CYP4A2, the following observation is particularly noteworthy : intron halves clos-
est to the conserved exons 8 and 11 were, interestingly, up to 95% similar between Cyp4a14 and
CYP4A2 (Table 3.3). However, by the same token, it is unclear why the 5' and 3' halves of intron
3, adjacent to the highly conserved exon 4, were similarly conserved between Cyp4a14 and
CYP4A2. Thus, not only were exons 8 and 11 highly conserved,the non-coding regions around
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them were also highly conserved, indicating that there exists an important selective bias for the
especial conservation of these exons and their peptide products. Thus, the conserved exons and
their translated protein motifs were of interest. Exon 8 putatively encodes a LRAEVDTFM-
FEGHDTT 16-amino acid motif. This motif contains a stretch of 13 amino acids previously pro-
posed to be a signature for the CYP4 family due to its high conservation, even in the CYP4C1
enzyme isolated from the cockroach Blaberus sp. (Bradley et al., 1991). In CYP101, mutation of
a Thr252 residue (corresponding to the final Thr residue in this motif) to an Ala residue produced
an enzyme in which substrate hydroxylation is uncoupled from electron transfer, producing hy-
drogen peroxide and excess water instead of the CYP101 product, 5-exo-hydroxycamphor
(Raag et al., 1991). Furthermore, X-ray crystallographic analysis of this region indicated severe
distortion in the mutant molecule (Raag et al., 1991). This suggests that the Thr252 is a key active
site residue, forming part of the proton delivery pathway.The importance of the Thr and the res-
idues around it, thus, cannot be overemphasized, and this motif is probably keenly involved in
the ω-hydroxylation of specific CYP4 substrates.
Exons 11 and 12 encode the more well-known RNCIG motif. The cysteine residue is known
to be involved in directly binding haem, as established by a series of experiments, culminating in
conclusive work on the crystal structure of the CYP101 protein (Poulos et al., 1986). This motif
is thus a crucial feature in the P450 protein and has been proposed to be a signature for the cy-
tochrome P450 superfamily of enzymes (Gonzalez, 1989).
Exon 4 encodes for a highly conserved motif HRRMLLTPGFHYDIL, located between resi-
duepositions 139 and 152 in CYP4A14 (Figure 3.26). This observation marks the identification
of yet another highly conserved amino acid motif in CYP4A proteins never before reported. The
role of this motif is undetermined, but could play a role in the ω-hydroxylation of the enzyme
as deduced by comparing the tertiary structures of CYP4A14 with CYP2C4 (vide infra), whose
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substrate binding regions are more well-documented. Exon 3, additionally, was highly conserved
but only between Cyp4a14 and CYPA3 (Table 3.2). As mentioned, this exon contains a 9bp de-
leted region in CYP4A2 only but not in Cyp4a14 or CYP4A3 (Figure 3.21). The consequences
of this deletion with respect to CYP4A enzyme activity remain to be elucidated.
Section 4.2 CYP4A enzyme function
In 1992, Gotoh proposed the existence of six substrate recognition sites (SRS) in the CYP2 pro-
teins based on analyses of amino acid and coding nucleotide sequences. Since then, several reports
have reaffirmed the accuracy of his assignments of the SRS'. Recently, Szklarz and coworkers
(1996), for example, used hybrid enzymes and site-directed mutagenesis at various residues with-
in these proposed SRS'; they found that all mutations caused changes in activity of the CYP2B5
protein. To examine the feasibility of deducing the substrate binding sites of theCYP4A14 pro-
tein, its amino acid sequence has been compared with the CYP2C4 protein based on their pri-
mary sequence homology (Figure 3.23), and their hydropathy indices (Figure 3.24). From the
latter, it is concluded that although the two proteins had poor identity at the amino acid level,
the tertiary structures of the cytochrome P450 proteins are fairly well conserved, an observation
similarly made by Edwards and coworkers (1989). Thus, six SRS' in CYP4A14 are proposed; the
deduced positions of the SRS' of the CYP4A14 protein were located in similar hydrophobic en-
vironments as those of the CYP2 protein. However, as noted, differences in hydrophobicity also
exist, especially in SRS 1 and 4 (Figure 3.24). Due to the CYP2 and CYP4 proteins having dif-
ferent substrate specificities, these sites could have a major role to play in regulating the enzyme
activities of these proteins. 
As previously mentioned, besides the RNCIG amino acid motif in the P450 haem-binding re-
gion, two other motifs were highly conserved only in the CYP4 enzyme : HRRMLLTPGFHY-
DIL andLRAEVDTFMFEGHDTT. Interestingly, these CYP4-specific motifs map very close to
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SRS 1 and within SRS 4 respectively (Figure 3.26). Thus, since these motifs are unique to CYP4
and not CYP2 proteins, they (and SRS1 and SRS4) could play a major part in the enzyme ac-
tivity of the CYP4 protein. All the CYP4A proteins were also compared with one another and
all SRS' were highly conserved, which is not unexpected. 
While the enzymatic activity of the protein encoded by the novel murine Cyp4a14 has not been
demonstrated, it is likely that it metabolizes fatty acid by ω and ω-1 oxidation due to its high
similarity to CYP4A1, CYP4A2 and CYP4A3, proteins of known enzyme activity (Hardwick et
al., 1987; Aoyama et al., 1990). 
Section 4.3 CYP4 family evolution
From the primary sequence alignments of the CYP4 proteins, it appeared that there were several
regions of amino acid deletions and insertions which indicated CYP4A, CYP4B and CYP4F
proteins were rather distinct from one another (Figure 3.26). Moreover, CYP4A and CYP4B
proteins appear to be more different to the CYP4F proteins than they do to each other. This
suggested that CYP4F proteins were a more distant related member of the CYP4 family com-
pared to CYP4A and CYP4B proteins. To study the relationship of these subfamilies in greater
detail,phylogenetic analysis was performed on the CYP4 proteins using CLUSTALW and
PHYLIP with CYP2 as an "outgroup", a sequence which is distinctly different from the proteins.
These methods of analysis consistently showed that the CYP4A, CYP4B and CYP4F proteins
were grouped into three distinct clusters (Figure 3.27). Furthermore, in agreement with obser-
vations made with primary sequence alignments, the phylogenetic tree demonstrated that
CYP4A and CYP4B were, again, more closely related to each other than either of them to
CYP4F. 
It is widely accepted that mammalian gene families normally arise by duplication of an ancestral-
gene and its flanking sequence; thus, family members are usually located close to one another-
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when they first arise. Recently, Trusov and Dear (1996) argued that with subsequent nucleotide
substitutions and continued divergence of these newly duplicated genes, physical distances would
be least between more closely-related family members : the evolutionary tree of the gene fami-
lycould be a good indication of its physical map. Thus, based on the above observations on the
relatedness of the Cyp4a, Cyp4b and Cyp4f subfamilies, the theory of Trusov and Dear would
imply that Cyp4a would be physically closer to Cyp4b than to the apparently more distant Cyp4f
subfamily. 
Recent experimental work done by Sharon Kuo in this laboratory has provided formal evidence
that this is in fact true : not only are all three murine Cyp4a genes physically linked and contained
in a single YAC clone of 220kb, the Cyp4b1 gene is also located in this clone (published in Heng
et al., 1997). Furthermore, while this linkage is replicated in human, the human CYP4F2 gene
is located on a separate chromosome. Thus, the physical relatedness of Cyp4a and Cyp4b would
suggest that the duplication events giving rise to Cyp4a/Cyp4b genes was a more recent occur-
rence, and that in the murine Cyp4 family of proteins, the Cyp4f subfamily would be the more
ancient compared to the Cyp4a/Cyp4b genes.
The mouse Cyp4a genes have previously been localized to mouse chromosome 4 (Bell et
al.,1993; Henderson et al., 1994), which also appears to contain the Cyp4b subfamily (Heng et
al.,1997). This area of co-localization is syntenic to human chromosome 1, which was found by
Nhamburo and coworkers (1989) to contain the human CYP4B1 gene. Thus, this conserved ar-
rangement of the Cyp4a and Cyp4b subfamilies on the chromosome must have existed before the
rodent diverged from humans in evolutionary history. However, each subfamily appears to have
evolved at different rates from each other. The relatedness of the human, rabbit and guinea pig
CYP4A proteins are compared in Table 4.1 while the CYP4B proteins are compared against one
another in Table 4.2.
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As shown, members of the CYP4A subfamily are as low as 72 % identical, compared to members
of the CYP4B subfamily which are no less than 85% identical to one another. Thus, the CYP4A
subfamily members are considerably less conserved across species compared with the CYP4B
gene subfamily despite being in tandem on the same chromosome. This implies that the evolu-
tion of the CYP4A genes are particularly rapid compared with the neighbouring CYP4B sub-
family. Additionally, rabbit and human CYP4A genes are approximately equally similar to the
4a10 4a14 4A1 4A2/3 4A8 4A11 4A13 4A4 4A5 4A6 4A7
Mouse CYP4A10  - 79 91 72 81 77 82 76 76 77 73 
CYP4A14 - 71 90 78 73  78 72 73 72 72
Rat CYP4A1 - 72 76 77  82 75 76 77 75
 CYP4A2/3 - 71 74  77 72 74 73 72
 CYP4A8 - 76  77  74 76 76 75
Human CYP4A11 -  79 80 82 81 79
Guinea Pig CYP4A13 - 80 78 82 82
Rabbit CYP4A4 - 87 88 85
CYP4A5 - 90 85
CYP4A6 - 87
Table 4.1 Similarity of the CYP4A proteins in mouse, rat, human, guinea pig and the rabbit.  The 
relatedness of the CYP4A proteins are expressed as percent identity by BESTFIT analyses.Only full length protein 
sequences are compared.
mCYP4B1 rCYP4B2 hCYP4B1 rbCYP4B1
mCYP4B1  -  92 85 88
rCYP4B2  - 86 88
hCYP4B1 - 90
rbCYP4B1 -
Table 4.2 Similarity of the CYP4B proteins in mouse, rat, human and the rabbit.  The 
relatedness of the CYP4B proteins are expressed as percent identity.The prefixes’m',’r',’h' and’rb' refer 
to the mouse, rat, human and rabbit sequences respectively.
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mouse and rat Cyp4a genes (Table 4.1); therefore, the duplication event giving rise to the Cyp4a
genes must have happened after the human/rabbit/guinea pig lineage diverged from the mouse/
rat. Furthermore, the CYP4A genes appear to have evolved significantly more than the neigh-
bouring CYP4B subfamily in the mouse and rat. Ohta (1989) suggested that once an initial single
duplication of an ancestral gene had occurred, in this case the CYP4A ancestral gene, the chance
of subsequent gene duplication via unequal crossing-over would be increased. Thus, these mo-
lecular events would lead to an increased number of Cyp4a genes, which would then individually
undergo further differentiation. 
There is much debate surrounding whether generation time has a significant effect on the rate of
molecular evolution (Wilson et al., 1977; Kimura, 1983) : are the rates of evolution constant ‘per
generation’ rather than ‘per year’ ? Wu and Li (1985) reported that, when eleven genes from the
mouse and rat were compared with those from other species, the rodent genes seemed to have
higher rates of nucleotide substitution. More recently, when the eta globin pseudogene DNA and
protein sequence data were compared, the rate of evolution is higher in the rodent lineage than
in the primate lineage (Li et al., 1996).In further support of the hypothesis, the Cyp4a genes in
the mouse and rat have evolved at a significantly higher rate compared to these genes in the other
species. The simple explanation for the higher rates in rodents could be that rodents have shorter
generation times and thus, higher mutation rates. Alternatively, it has been speculated that the
difference in evolution rates could be due to differences in DNA repair mechanisms (Catzeflis et
al., 1987) 
The evolution of the rodents themselves is not so straightforward either, and has been rather con-
troversial among biologists. While traditional taxonomy, mainly based on comparative morphol-
ogy, classifies the guinea pig into the order of the Rodents (Novacek, 1992), much recent data
obtained from molecular analysis of mitochondrial DNA has argued in favour of the inclusion of
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the guinea pig in a new mammalian order distinct from Rodentia (D'Erchia et al., 1996; Cao et
al., 1997). Indeed, this confusion is reflected by the data of Table 4.1, which shows that the guin-
ea pig CYP4A13 gene is approximately equally similar to all mouse, rat and human CYP4A
genes as the rabbit CYP4A genes (more than 77% identity), although the mouse and rat genes
themselves are relatively distant to the rabbit genes (less than 77% identity). Thus the guinea pig
CYP4A13 certainly appears to be evolved in a distinct fashion from the CYP4A genes of the
more established rodents, the mouse and rat. 
Section 4.4 Cyp4a expression and significance
The transcriptional activity of several CYP4A genes, for example, CYP4A1, is believed to be-
regulated by the interaction of the peroxisome proliferator activated receptor (PPAR) with
aresponse element located in the 5' flanking region of the gene (Aldridge et al., 1995). Like the
CYP4A1, the Cyp4a14 gene is also highly inducible by a peroxisome proliferator, as demonstrat-
ed both by primer extension experiments (Figures 3.13 & 3.14), and formally, by RNAse pro-
tection assays performed by Paul Jones in this laboratory (published in Heng et al., 1997). The
Cyp4a10 has also previously been shown to be highly inducibleby a peroxisome proliferator (Bell
et al., 1993). As such, the 5' flanking sequences of both genes have been cloned by PCR and
analyzed. However, no classical peroxisome proliferator response element (PPRE) was found in
the sequence immediately upstream of the start of transcription of either Cyp4a10 or Cyp4a14,
although two separate half sites were found in Cyp4a14 (Figures3.19 & 3.31). Recently, addi-
tional experiments provided evidence that not only is the full PPRE site required for transcrip-
tional activation, deletions or mutations within six nucleotides (TGAACT) 5' of the PPRE motif
dramatically diminished PPAR-RXR heterodimer binding in the rabbit CYP4A6 (Palmer et al.,
1995). Thus, the DR1 motif is not sufficient to constitute a PPRE. This six-nucleotide sequence
is highly conserved in CYP4A1, acyl coA oxidase among others (Palmer et al., 1995). However,
this sequence was not seen 5' of the PPRE half sites of Cyp4a14,suggesting that these are probably
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not legitimate binding sites for PPAR-RXR heterodimers. Nevertheless, it remains a possibility
that, like CYP4A1, the response element would be located much farther upstream. Thus,
pGT32, the unsequenced PCR clone containing 3.2 kb of 5' flanking region, could be analyzed
further for any putative binding sites. Even if such a putative PPRE was located within the up-
stream sequences, reporter gene experiments would have to be undertaken to demonstrate its
function in binding PPAR-RXR heterodimers and regulating the transcription of Cyp4a10 and
Cyp4a14 by a peroxisome proliferator. It has recently been shown in this laboratory using
RNAse protection assays that Cyp4a10 RNA (35-fold) and Cyp4a14 RNA(1000-fold) are high-
ly induced in liver tissues treated with a peroxisome proliferator (Bell et al.,1993; Heng et al.,
1997). It is unknown precisely what, if any, additional factors might regulate the extraordinarily
high induction of Cyp4a14.
As noted earlier, the 5' flanking regions of Cyp4a10 and Cyp4a14 do not contain a TATA
box,but possess a 19bp element (5'- (T)CCCCCCTCCCACAAGTAGG-3') which is similarly
conserved in CYP4A1 and CYP4A2 (Kimura et al., 1989a). The integrity of the 19bp element
has been shown to be important in regulating the basal transcriptional activity of CYP4A1 (Bell
and Elcombe, unpublished results) and is therefore likely to have a similar regulatory role in the
murine genes. Analysis of the sequence in and around this 19bp element indicated that its pyri-
dimidine-rich sequence, specifically its ‘CTCCC’ sequence, might serve as a binding motif for
the Sp1 transcription factor (Figures 3.19 & 3.31). 
The Sp1 family of transcription factors are zinc-finger proteins, are abundant nuclear proteins in
most cells (Saffer et al., 1991) and have been implicated in the expression in many genes. Appro-
priate DNA methylation patterns are important for normal development (Li et al., 1992). Recent
experiments have linked Sp1, and its related proteins, to the prevention of methylation of CpG
islands in mammals (Brandeis et al., 1994; Macleod et al., 1994). The Sp1 proteins typically bind
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GC or GT boxes (eg. Hagen et al., 1992). Recently, Jiang and coworkers (1996) showed that the
Sp family of transcription factors are also able to upregulate promoter activity by binding to a
CTCCC motif in the promoter region of the mouse hepatocyte growth factor (HGF) gene, a
motif which is also conserved in the human HGF promoter. However, the regulation of the
Cyp4a genes is likely to be more complicated. Ihn and coworkers (1996) recently identified a
TCCCCC motif in the promoter region of the human α2(I) collagen promoter which appeared
to be a binding site for an unidentified transcriptional repressor. Interestingly, this motif is highly
conserved in the promoters of the novel murine Cyp4a14 gene and of the previously known ro-
dent Cyp4a genes. Furthermore, both these motifs are present in tandem within the 19bp ele-
ment of the Cyp4a genes. Thus, it is entirely conceivable that the basal transcription of Cyp4a
genes is dependent on the complex interaction of both positively- and negatively-acting proteins
on the highly conserved 19bp element.
Sp1 is also thought to be critical for the human β-globin Locus Control Region (LCR, which
contains Sp1 binding sites) activity by maintaining an open chromatin structure (eg. Philipsen et
al., 1993). An open chromatin structure maintained by the upstream LCR of a gene locus has
been associated with the coordinate regulation and expression of a cluster of genes (eg. Ellis et
al., 1996). In Drosophila, CT dinucleotide repeats are believed to have such an effect in the hsp26
gene (Lu et al., 1993). In intron 2 of Cyp4a14, CT dinucleotide repeats are also found which
perhaps might have a similar role in regulating the expression of this gene (Figure 3.17). How-
ever, it remains to be discovered if the Cyp4a locus contains DNAseI hypersensitive sites due to
an open, transcriptionally active chromatin structure and a locus control region that will regulate
the expression of all its genes in this locus.
The expression of the genes in the rat and mouse Cyp4a subfamily are remarkably different and-
complex. It is unclear why such closely related genes have such distinct patterns of expression.
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Even highly identical isozymes within a species may differ in their expression patterns. For ex-
ample, although the rat CYP4A2 and CYP4A3 are 97% identical, theCYP4A2 is male-specific
while CYP4A3 and the highly similar murine Cyp4a14, show no sexual dimorphism (Sundseth
and Waxman, 1992; Heng et al., 1997). Cyp4a14, in RNAse protection experiments, was highly
induced in the liver and kidney of both male and female animal by the peroxisome proliferator,
MCP. Consitutive expression of the novel murine Cyp4a14, however, was extremely low in tis-
sues examined like spleen, lung, brain, gut and gonads (Heng et al., 1997). The homologous rat
CYP4A1 and murine Cyp4a10 are modestly expressed in untreated liver and kidney but are
highly induced by peroxisome proliferators (Hardwick et al., 1987; Bell et al., 1993). As discussed,
the three rat genes CYP4A1, CYP4A3 and CYP4A8 have very similar equivalents in the mouse
designated Cyp4a10, Cyp4a14 and Cyp4a12 respectively and must have arisen before the mouse/
rat divergence. The rat CYP4A8 was shown to be expressed in the prostate and not regulated in
a sex-specific way (Stromstedt et al., 1994), but its murine homologue Cyp4a12 shows very low
expression in the prostate but is constitutively expressed in liver and kidney of male rats (Bell et
al., 1993; Heng et al., 1997). Since it is unknown whether the three Cyp4a genes in the rat/
mouse ancestor previously showed any sex-specificity, it is difficult to predict if the sex-specific-
ity traits of the present Cyp4a isoforms had been gained or lost. However, since the male-specific
CYP4A2 was deemed to have arisen, probably by a recent duplication from the highly similar
CYP4A3 (but which is not sexually differentiated) in the rat, its sexually dimorphic trait must
have been gained only after the rat species had radiated from the mouse.
A search of the database revealed several murine EST (Expressed Sequence Tag) sequenc-
es,which are randomly cloned and sequenced cDNAs, and are a reflection of the expression of
murine Cyp4a genes. These cDNAs (accession numbers Aa123331, Aa268984,
Aa060595,W41435, W13618 and W18764), corresponding to Cyp4a14, have been isolated
from liver and extrahepatic sources like kidney and total foetus. ESTs corresponding to Cyp4a10
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were also identified in a separate homology search, with the accession numbers Aa273591,
Aa10968,Aa473036, Aa073857 and W13605. These RNAs were isolated also from extrahepatic
sources like the kidney, T-cells and the heart in the mouse. These data for Cyp4a10 and Cyp4a14
demonstrate that these genes are expressed at moderate levels in many tissues, and that CYP4A
proteins could well serve a function in organs other than the liver. Oddly, no ESTs correspond-
ing to the Cyp4a12 gene were found from the search of the sequence database, although this gene
is known to be expressed constitutively in the male liver and kidney. 
Interestingly, the enzyme activities and patterns of expression of the Cyp4a genes are distinctly
different in the rabbit. While Cyp4a enzymes in the rat and mouse favour the metabolism of lau-
ric acid (Hardwick et al., 1987), the four rabbit CYP4A proteins, CYP4A4, CYP4A5, CYP4A6
and CYP4A7 were found to exhibit a distinct substrate specificity profile across a panel of sub-
strates, which included lauric acid, palmitic acids and arachidonic acid (Roman et al., 1993). For
example, CYP4A5 showed little activity towards arachidonic or palmitic acids as compared to
that toward lauric acid while CYP4A6 and CYP4A7 were relatively active metabolizers of
arachidonic acid. The regulation of these genes is also quite distinct from the rodent Cyp4a genes
: One CYP4A enzyme, CYP4A4, was found to be highly induced in the lungs of progesterone-
treated or pregnant rabbits (Matsubara et al., 1987) while CYP4A6 was the most inducible by
clofibrate (Roman et al., 1997). Since the enzyme activities and regulation of the rabbit CYP4A
genes are clearly different from the rodents, it must be that the primordial CYP4A locus only
evolved to give rise to these four rabbit isoforms, but only after the rabbit species had formed in
evolutionary history. It is unclear why the rabbit and the rodents, should have Cyp4a subfamily
members which are so closely related but that have evolved to possess such distinct properties. 
Section 4.5 CYP4A proteins in peroxisome proliferation 
In the liver, the elevated expression of Cyp4a genes caused by peroxisome proliferating chemi-
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calsis believed to be a key event prior to peroxisome proliferation in the mouse and rat (eg
Kaikauset al., 1993). In male liver, Cyp4a10 and Cyp4a14 are highly induced by MCP (Bell et
al., 1993;Heng et al., 1997). Cyp4a14 RNA, especially, was induced 1000-fold above control
levels (Heng et al., 1997) and could thus be a major mediator in murine peroxisome proliferator-
induced carcinogenesis. On the other hand, Cyp4a12, due to its high constitutive expression in
liver,might have more of a housekeeping role, maintaining normal lipid metabolism.
Section 4.6 CYP4A proteins in renal function
Cyp4a proteins also have been implicated in the metabolism of eicosanoids such as arachidonic
acid in the kidney, which generates 20- and 19-HETEs (Sacerdoti et al., 1987). Significant
amounts of this eicosanoid can be produced by the thick ascending limb of Henle's loop (TALH).
20-HETE is a potent vasoconstrictor of blood vessels (Ma et al., 1993), inhibits K+ channel ac-
tivity in renal tubules and microvessels and produces a sustained increase in intracellular
Ca2+concentration (Wang and Lu, 1995). Thus, the synthesis of 20-HETE by Cyp4a proteins
may contribute to the tubular ion transport mechanisms, while in the renal vasculature, Cyp4a
metabolites may exert their effects on renal blood flow and tubuloglomerular feedback (Zou et
al., 1994a). The importance of Cyp4a proteins are further emphasized in experiments involving
17-ODYA, a suicide-subtstrate inhibitor of ω-hydroxylation of arachidonic acid (Zou et
al.,1994b). Zou and coworkers found that infusion of 17-ODYA into renal artery or renal cor-
tical interstitium , increases urine flow and sodium excretion, associated with the increase in pap-
illary blood flow and an increase in renal interstitial hydrostatic pressure. These observations
suggest that Cyp4a metabolites of arachidonic acid exert a vasoconstrictor influence on the renal
arteries and affect tubular sodium and water reabsorption. In this respect, due to the very low
levels of expression in the control male kidney of Cyp4a10 or Cyp4a14, these gene products may
have little or no significance in maintaining renal function. However, Cyp4a12 is constitutively
highly expressed in the kidney suggesting there might be a distinct physiological role for the
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Cyp4a12 enzyme. Cyp4a12 could well be the more important Cyp4a gene in the regulation of
renal metabolism and function.
Section 4.7 CYP4A proteins in inflammation control
LTB4, a dihydroxy fatty acid leukotriene B4, has an important role during inflammation as this
signalling molecule induces a cascade of molecular and cellular events that triggers an immune-
response and the gradual congregation of cells from the immune system to the site of injury. The
duration and extent of the inflamed state thus depends on the turnover of the LTB4 molecule in
the body. Interestingly, LTB4 is inactivated through metabolism by the microsomal ω- andper-
oxisomal β-oxidation pathways (Samuelsson et al., 1987; Jedlitschky et al., 1991). Since CYP4A
proteins are ω-hydroxylating enzymes which could thus control the levels of LTB4, there could
be a link between CYP4A enzymes and the control of inflammation. However, Cyp4a genes are
in turn, dependent on transcriptional activation by PPAR binding to response elements in the5'
flanking regions of these genes (eg. Aldridge et al., 1995). Therefore, the increase or decrease in
LTB4 levels, and hence inflammation, could be dependent on the transcriptional activation of
the Cyp4a genes by PPAR. 
Recently, evidence for the possible role of PPAR in inflammation control was published in
which Devchand and coworkers (1996) identified LTB4 as a natural ligand for the PPARα. They
also demonstrated that LTB4 had the ability to induce the transcription of PPAR-regulated
genes, an example of which is the Cyp4a subfamily. Further proof of the role PPAR might play
in inflammation control came about with experiments with PPARα-deficient mice, in which
inflammation was prolonged. However, it is entirely possible that due to the lack of PPARα, the
Cyp4a genes are poorly expressed in these mutant mice, thus leading to the delayed degradation
of LTB4. Unfortunately, no data for the expression of Cyp4a genes was reported in their work.
Nevertheless, this is the first report of a binding ligand of the orphan receptor PPARα. It is thus
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entirely possible that fatty acids and eicosanoids also can regulate their own metabolism by
CYP4A proteins through direct activation of PPAR. 
Section 4.8 Summary and future aims
This project set out to study the murine Cyp4a gene subfamily in detail. Genomic sequences of
the murine Cyp4a genes, Cyp4a10 and Cyp4a12 were cloned. In addition, a novel murine Cyp4a
member, designated Cyp4a14, has been identified, which is crucial for understanding the murine
Cyp4a subfamily in its entirety, in terms of its evolution, regulation and expression and enzyme
activity. The whole of Cyp4a14 has been cloned, including its 5' flanking region. Cyp4a14 is
most similar to the rat CYP4A3 gene and is thus its homologue. 
The cloning of Cyp4a14 demonstrates the presence of a third member of the Cyp4a subfamily
in mouse while there are four CYP4A members in rat. The rat CYP4A2 does not have a homo-
logue in the mouse and must have arisen from CYP4A3 after rat/mouse speciation. In light of
the possible key involvement of the Cyp4a genes in murine physiology, it would be interesting
to examine if mice deficient in Cyp4a genes are susceptible to peroxisome proliferator-induced
carcinogenesis or have impaired renal function and inflammation control. It will then be possible
in the not too distant future to target the entire Cyp4a locus for disruption in embryonic stem
cells and the subsequent generation of mutant "knockout" mice.
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